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Chapter 1. Introduction.  
 
1.1 Protein-protein interaction domains 
 
Virtually all biological processes depend on specific interactions between different molecules 
such as DNA, RNA, proteins and lipids. Within a cell, specific binding is mediated by 
molecular recognition between various biomolecules. Proteins are the organizers of almost all 
cellular processes and have various functions both in the nucleus and the cytoplasm ranging 
from transcriptional regulation, DNA replication, splicing, to protein localization and 
trafficking, metabolism, and protein degradation. Furthermore, protein interactions are 
involved in formation of complex structures such as the cytoskeleton (e.g. Lodish et al., 
1996). These functions generally involve interactions with different macromolecules since 
proteins rarely work in isolation and all proteins in a given cell are believed to be connected 
through an extensive protein-protein interaction network (e.g. Giot et al., 2003; Rual et al., 
2005). For example, DNA-binding transcription factors regulate transcription by either 
activating or repressing defined target genes. However, regulation of gene expression is very 
complex and protein-protein interactions play significant roles in this process by for example 
recruiting co-repressors or co-activators to the promoter of the target gene (for 
comprehensive reviews see Ptashne and Gann, 1997; Lemon and Tjian, 2000; Brivanlou and 
Darnell, 2002; Pawson et al., 2002; Pawson and Nash, 2003). Many classes of DNA binding 
proteins are involved in contacting other proteins and there are several examples of 
transcription factors that have to dimerize in order to bind to the DNA. (e.g. Leucin zipper 
families of transcription factors including Fos/Jun [Kouzarides and Ziff, 1988; Kouzarides 
and Ziff, 1989] activating transcription factor (ATF)/cAMP responsive element (CRE) 
binding proteins (CREB) [Hai and Curran, 1991]).  
Molecular recognition by different proteins is mediated by interacting motifs which consist of 
a small number of residues that fold into an autonomous domain. Many proteins contain more 
than one of such interaction domain (Reichmann et al., 2005). This cassette-like modular 
behavior of these domains suggests an ideal mechanism to build complexes consisting of 
many different components. Although nature provides a highly complex and functionally 
diverse repertoire of protein interactions, the number of domain folds seems to be relative 
small. This suggests that many proteins must fold into similar structures and the large number 
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of specific interactions develop from displaying a diverse set of defined sequences upon these 
stable folds (reviewed in Koonin et al., 2002). To date, structural information has been 
obtained for several of these protein-binding modules revealing how diverse these domain 
folds are. For some of the structural folds generalizations regarding the target recognition 
have been made. An example is the Src-homology-2 (SH2) domain which recognizes and 
binds short tyrosine-phosphorylated sequences, and thereby has a key role in tyrosine kinase 
signaling cascades (Schlessinger and Lemmon, 2003; reviewed in Pawson, 2004). Other 
protein-binding folds such as the ankyrin repeat (reviewed in Sedgwick and Smerdon, 1999; 
Mosavi et al., 2004) or the leucine-rich repeat (reviewed in Buchanan and Gay, 1996 and in 
Kobe and Kajava, 2001) interact with diverse protein partners that do not exhibit common 
features and a universal recognition code has not been proposed yet for these interaction 
modules. Thus, analyzing protein-protein interaction domains to identify general binding and 
recognition modes is still a challenging task in modern biology. 
 
 
1.2 Cys2His2 zinc finger proteins 
 
1.2.1 General 
 
The classical Cys2His2 zinc finger domain (C2H2 ZF) is the most prevalent protein motif in 
human cells (Venter et al., 2001; Lander et al., 2001) and represents the most common DNA 
binding domain found in eukaryotic transcription factors (Pellegrino and Berg, 1991; Jacobs, 
1992; Venter et al., 2001; Lander et al., 2001). It is estimated that there are ~900 C2H2 ZFs 
encoded in the human genome constituting 2-3% of all genes (Tupler et al., 2001; Venter et 
al., 2001; Lander et al., 2001; Huntley et al., 2006). C2H2 ZFs also represent the largest 
transcription factor class in Drosophila melanogaster, Caenorhabditis elegans and 
Saccharomyces cerevisiae (Tupler et al., 2001) but seem to be absent in prokaryotes 
(reviewed in Wolfe et al., 2000). The abundance of these domains reflects their versatility 
evidenced by their abilities to recognize a wide variety of specific DNA sequences. Although 
originally discovered as DNA binding domains, C2H2 ZF have also been implicated in 
protein-contacts with various protein classes. This may provide an explaination for why some 
proteins have C2H2 ZFs that are evidently not involved in DNA-binding (reviewed in 
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Mackay and Crossley, 1998). Furthermore, the C2H2 ZF motif has also been shown to 
mediate protein-RNA intercations (reviewed in Hall, 2005; reviewed in Brown, 2005). Most 
C2H2 ZF proteins contain more then one C2H2 ZF frequently arranged in tandem arrays with 
some proteins having over 30 C2H2 ZFs (reviewed in Iuchi, 2001).  
 
1.2.2 Discovery of the C2H2 ZF motif 
 
The term C2H2 ZF was initially used to define a 30 residue repeated sequence motif that was 
discovered more then 20 years ago in the Xenopus laevis transcription factor TFIIIA (Miller 
et al., 1985). During efforts to isolate and purify 7S particles of Xenopus laevis oocytes 
containing 5S RNA and TFIIIA, Miller and co-workers observed significant concentrations 
of zinc present in these particles. Furthermore, proteolytic digest of the complex of 5S RNA 
and TFIIIA consistently yielded several persistent small peptide fragments of size ~3 K 
Daltons. This suggested that TFIIIA contained several small stable protein domains. 
Subsequently, amino acid sequence analysis demonstrated that TFIIIA harbored nine 
sequence repeats of 30 residues containing two invariant cysteine and two invariant histidine 
residues, which were known to be the most common zinc ligands. These findings suggested 
that TFIIIA was composed of a linear arrangement of small conserved structural motifs that 
can bind zinc via their cysteines and histidines residues and this characteristic motif was 
termed as the C2H2 ZF motif (Miller et al., 1985).  
 
1.2.3 Structural properties 
 
The C2H2 ZF motif is defined by a conserved amino acid sequence of the form (F/Y)-X-C-
X2-5-C-X3-(F/Y)-X5-Ψ-X2-H-X3-5-H, where X represents any amino acid residue and Ψ 
encodes a hydrophobic residue (note that the spacing between the two cysteines and two 
histidines is flexible). Structural studies using nuclear magnetic resonance (NMR) defined the 
C2H2 ZF motif as a β-hairpin followed by an α-helix (ββα-fold) which folds into an 
autonomous protein domain (Lee et al., 1989). Each finger binds a single zinc ion by 
coordinating it tetrahedrally between the two cysteines at one end of the β-sheet termed as the 
“zinc knuckle” (turn containing the two cysteines; Grishin, 2001; Krishna et al., 2003) and 
the two histidines at the carboxy-terminus of the α-helix (Figure 1.1). The overall structure of 
Introduction. 
 
 4
the protein is stabilized by zinc binding as well as by the small well conserved hydrophobic 
core adjacent to the zinc binding side (Miller et al., 1985; Lee et al., 1989; reviewed in Wolfe 
et al., 2000; Pabo et al., 2001; Iuchi, 2001). C2H2 ZFs are completely unfolded in the 
absence of zinc but can also fold in the presence of cobalt in vitro (Frankel et al., 1987). 
Cobalt is frequently substituted for zinc to study metalloproteins since its optical absorption 
spectrum is extremely sensitive to the coordination state, thus allowing one to determine the 
stoichiometry of a complex (Frankel et al., 1987). Additional studies have shown that the 
zinc-coordinating C2H2 motif can be partially substituted by other zinc-ligating motifs (such 
as the Cys4 motif) (Krizek et al., 1993; Green and Sarkar, 1998). Furthermore, Michael and 
co-worker (1992) have synthesized a “minimalist” C2H2 zinc finger peptide containing an 
alanine substitution at every residue position except at positions defining the C2H2 ZF motif 
(i.e. all Xs in the amino acid sequence shown above are replaced by an alanine). This peptide 
can still form complexes with cobalt in vitro (see above), indicating that the defined 
conserved residues of the C2H2 ZF motif are necessary but also sufficient for proper folding 
(Michael et al., 1992).  
 
1.2.4 Interaction of C2H2 ZFs with DNA 
 
C2H2 ZFs are well known for their ability to bind DNA and the molecular details of this 
interaction have been studied extensively. In general, three or more tandemly arranged C2H2 
ZFs are required to recognize DNA motifs that are present in the promoter region of a wide 
variety of defined target genes. An exception is the GAGA factor from Drosophila 
melanogaster, which contains a single C2H2 ZF. GAGA can bind to its specific binding site 
Figure 1.1 The C2H2 ZF motif. C2H2 ZFs 
are characterized by a β-hairpin that contains 
the two zinc-ligating cysteines followed by an 
α-helix that provides the histidine ligand pair. 
The α-helix is colored in blue and the β-
hairpin is colored in purple. The “zinc 
knuckle” connecting the two β-sheets is shown 
in red. Green indicates a loop. Zinc is 
represented as a orange sphere and residues 
that bind zinc are shown as ball-and-stick. This 
Figure was reproduced from Krishna et al. 
(2003).  
C
N
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via its single C2H2 ZF and an amino-terminal extension containing a stretch of basic amino 
acids, but the C2H2 ZF alone is not sufficient for DNA-binding (Pedone et al., 1996; 
Omichinski et al., 1997). The interaction between C2H2 ZFs and DNA is usually very 
specific and occurs with high affinity. The crystal structure of Zif268 bound to DNA was 
solved 15 years ago and provided the first detailed insights into C2H2 ZF-DNA recognition 
(Pavletich and Pabo, 1991). The Zif268 DNA-binding domain (DBD) contains three C2H2 
ZFs and binds to a 10 base pair (bp) target sequence. Each individual finger interacts with a 
sub-site of 3-4 bp by using the amino-terminal end of its α-helix (or recognition helix) to bind 
the major groove of the DNA (Figure 1.2). The orientation of the protein causes the amino-
terminal finger to contact the 3’ end while the carboxy-terminal finger binds to the 5’ end of 
one strand of the DNA (termed the primary strand). Interestingly, each finger in the Zif268 
structure binds to its sub-site in a uniform pattern of residue-base interactions: each finger 
utilizes amino acids at four key positions (-1, 2, 3 and 6) on the surface of the recognition 
helix to contact bases in the DNA (Figure 1.2).  
 
Additional binding affinity is provided by interactions with the phosphate backbone of the 
DNA as well as between neighboring C2H2 ZFs (Pavletich and Pabo, 1991; Elrod-Erickson 
et al., 1996; reviewed in Wolfe et al., 2000 and in Pabo et al., 2001). The linker region that 
connects adjacent fingers plays a role in spacing and orientation of the individual fingers on 
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Figure 1.2 DNA-binding by C2H2 ZFs.  Structure of Zif268 bound to its specific DNA binding site. 
Fingers 1, 2 and 3 of Zif268 are purple, yellow and red, respectively. DNA is colored in blue and zinc ions 
are represented as grey spheres. ZFs insert into the major groove by making specific base contacts with the 
DNA. These contacts are made from residue positions -1, 2, 3 and 6 of each α-helix as indicated in the 
scheme right of the structure. This Figure was adapted from Wolfe et al. (2000) and Pabo et al. (2001). 
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the DNA. Although flexible in the absence of DNA, it becomes well ordered upon DNA-
binding (Foster et al., 1997; Wuttke et al., 1997). The most common linker sequence is 
TGEKP (Pellegrino and Berg, 1991) and mutational analysis has demonstrated that the linker 
is important for high affinity DNA binding (Choo and Klug, 1993). Although the structure of 
the Zif268-DNA complex still serves as the prototype for understanding DNA recognition, 
structural studies of other naturally occurring C2H2 ZFs bound to their DNA subsite have 
revealed important variations on this common pattern, implying that C2H2 ZF mediated 
DNA recognition is more complex than initially thought (reviewed in Klug and Schwabe, 
1995; Wolfe et al., 2000 and in Pabo et al., 2001).  
 
1.2.5 C2H2 ZF engineering 
 
The simple modular behavior of certain C2H2 ZFs together with their versatility in 
recognizing a large number of specific DNA sites was soon availed for protein engineering 
purposes. Many studies from different labs have demonstrated that DNA binding specificity 
can be altered by simply changing key residues in the recognition helix of fingers from 
Zif268 and SpI. Combinations of rational design and selection methods have been 
successfully applied to create individual C2H2 ZF with novel DNA specificities (Desjarlais 
and Berg, 1992; Desjarlais and Berg, 1993; Choo and Klug, 1994; Jamieson et al., 1994; 
Jamieson et al., 1996; Wu et al., 1995). To further create proteins able to bind to DNA with 
high specificity, these individual C2H2 ZFs peptides can be assembled into a protein that 
recognizes an entirely novel DNA site consisting of individual subsites. In an initial study, 
Choo and co-workers (1994) used three individually re-designed C2H2 ZFs and linked them 
together to create a three-finger DNA-binding protein that binds to a novel 9-bp site. This 
protein was able to specifically regulate expression of a reporter gene although the affinity for 
DNA-binding was low (Choo et al., 1994). To account for context-dependent interactions 
between neighboring C2H2 ZFs and subsites that are evidently important for DNA-binding 
(Desjarlais and Berg, 1993), Greisman and Pabo (1997) developed a selection strategy where 
the desired three-finger protein is gradually assembled. In this approach, two wild-type C2H2 
ZFs represent an “anchor” while the randomized third C2H2 ZF is used to perform selections 
for a target subsite. In the next steps the pool of selected reengineered C2H2 ZFs obtained in 
the first step is retained, which allows the selection of a new second (and subsequently third) 
C2H2 ZF that binds DNA in the context of a protein containing the first (and subsequently 
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second) selected finger. This strategy yield optimized C2H2 ZF proteins that display high 
levels of specificity and affinity (Greisman and Pabo 1997). This approach together with 
other optimized selection methods has subsequently been utilized many times to create 
several three-finger proteins with novel DNA-binding specificities (Isalan and Choo, 2000; 
Hurt et al., 2003).  
However, to increase the specificity and affinity of engineered C2H2 ZFs for their target site, 
one has to extend the interaction surface. This is especially desirable considering the fact that 
a DNA sequences has to be at least 16 bp long in order to represent a unique binding site in 
the context of the whole genome. (Calculations expect that there should be ~ 10000 identical 
9 base pair sites present in the human genome while a sequence of 16-18 base pairs should 
occur only once [reviewed in Wolfe et al., 2000 and in Choo and Isalan, 2000]). Thus, arrays 
of tandemly repeated C2H2 ZFs have also been constructed by simply linking three-finger 
domains together into six-finger or nine-finger proteins using linkers of the sequence TGEKP 
(Liu et al., 1997; Kamiuchi et al., 1998). Surprisingly, although these proteins are capable of 
recognizing their extended target site, the affinity enhancements for DNA-binding were only 
modest. In contrast, when a longer linker was used (consisting of eight residues) to connect 
these 3-finger domains the relative affinity could be dramatically increased (Kim and Pabo, 
1998). Moore and co-workers (2000) used a different approach by linking three two-finger 
units together into a six-finger protein which displayed increased levels of specificity and 
affinity. In a parallel study, they also designed optimized “structural” linkers capable of 
connecting two three-finger peptides into a six-finger protein with significant affinity and 
specificity enhancements (Moore et al., 2001).  
It is noteworthy that in addition to these reengineered DNA-binding ZFs, naturally occurring 
single C2H2 ZFs can also be used to create DBDs with novel specificities. For example, Bae 
and co-workers (2003) screened C2H2 ZFs encoded in the human genome for their ability to 
bind to diverse DNA sites. These C2H2 ZFs were then used as modular “building blocks” to 
construct novel specific DBDs (Bae et al., 2003). In summary, re-engineered single fingers 
together with naturally occurring fingers can generally be utilized to create multi-finger 
proteins with novel DNA-binding specificities by linking them together. Several of these 
polyfinger proteins have proven to bind to their targeted sequences with high affinity. 
Connecting these reengineered multi finger proteins to functional domains resulted in the 
design of a wide variety of synthetic transcription factors capable of regulating specific 
endogenous genes both in tissue culture and in whole organisms (Klug, 1999; Blancafort et 
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al., 2004; Blancafort et al., 2005; for comprehensive reviewes see: Falke and Juliano, 2003; 
Jamieson et al., 2003; Lee et al., 2003; Jantz et al., 2004).  
 
1.2.6 Interaction of C2H2 ZFs with RNA 
 
Although best known for their ability to bind to DNA, C2H2 ZFs were originally identified in 
TFIIIA, a protein that associates with 5S rRNA within the 7S particle in Xenopus oocytes 
(see section 1.2.2). TFIIIA binds specifically to the internal control region (ICR) of the 5S 
RNA gene, but can also directly interact with 5S RNA (Pelham and Brown, 1980; see also 
reviews by Shastry, 1996; Brown, 2005; and Hall, 2005). TFIIIA contains nine C2H2 ZFs 
and it has been demonstrated, that DNA binding is mainly accomplished by C2H2 ZF 1-3, 
while C2H2 ZF 4-6 are essential for RNA binding although these fingers can also bind to 
DNA (Hansen et al., 1993; Nolte et al., 1998; Neely et al., 1999; Searles et al., 2000; Lu et 
al., 2003). The crystal structure of C2H2 ZFs 4-6 of TFIIIA bound to a fragment of the 5S 
rRNA was only recently solved and provided striking insights into how C2H2 ZFs mediate 
interactions with RNA (Lu et al., 2003). The structural arrangement of RNA is generally 
more complex than that of DNA and includes the formations of internal loops and helices. 
The secondary structure in 5S RNA that is contacted by TFIIIA consists of loop E (bound by 
ZF4), helix V (bound by ZF5) and loop A (bound by ZF6) (Lu et al., 2003). As expected, 
only a few contacts to nucleotides in the RNA are made (as in the case of DNA-binding 
C2H2 ZFs) and α-helices in the C2H2 ZFs are responsible for these contacts. Binding of ZF4 
involves residue positions -2, -1, +1 and +2 of the α-helix, while ZF6 contacts RNA via 
residues at positions -1, +1 and +2 of the α-helix (Lu et al., 2003; compare to Figure 1.2). 
Thus, both C2H2 ZFs require residues at position -1 and +2 which have also been shown to 
be important for DNA-binding (see section 1.2.4). Surprisingly, ZF5 does not directly contact 
nucleotides in the RNA but binds to its phosphate backbone via multiple contacts made by 
basic amino acid residues (Lu et al., 2003). Thus, these studies revealed both similarities as 
well as differences in RNA-recognition mediated by C2H2 ZFs compared to DNA-binding.  
Other examples of C2H2 ZF proteins capable of binding to both DNA and RNA have also 
been described. One example is the Wilms tumor 1 (WT1) protein, which contains four C2H2 
ZFs and binds to DNA as well as to specific single-stranded RNAs using distinct C2H2 ZFs 
for different RNAs (Caricasole et al., 1996; Bardeesy and Pelletier, 1998). Interestingly, 
alternative splicing of exon 9 inserts (or removes) three amino acids, lysine, threonine and 
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serine (commonly referred to KTS), between the third and the fourth C2H2 ZF. Isoforms 
containing this insertion are impaired in their ability to bind to DNA but can still interact with 
RNA (reviewed in Lee and Habor, 2001). In addition, C2H2 ZFs that bind primarily to RNA 
have also been found. Examples are the Double-stranded RNA-binding proteins zinc finger a 
(dsRBP-Zfa) which contains seven C2H2 ZFs and the Just another zinc finger (JAZ) protein 
which is composed of four C2H2 ZFs (Finerty and Bass, 1997; Yang et al., 1999).  
In summary, several C2H2 ZFs capable of binding to RNA have been described. The ability 
of C2H2 ZFs to bind to RNA provides another example of their versatility, especially 
considering the fact that RNAs provide a wide spectrum of secondary and tertiary structures 
including double-stranded RNA, single-stranded RNA and DNA-RNA duplexes (reviewed in 
Iuchi, 2001).  
 
1.2.7 Interaction of C2H2 ZFs with other proteins 
 
1.2.7.1 Examples 
C2H2 ZF can also mediate protein-protein interactions with a wide variety of protein classes 
(reviewed in Mackay and Crossley, 1998). Interestingly, unlike DNA-binding C2H2 ZFs that 
recognize the defined structural motif of the double-stranded DNA, protein binding C2H2 
ZFs can bind to a wide range of different structures including other C2H2 ZFs, other classes 
of ZFs as well as completely different protein motifs (reviewed in Matthews and Sunde, 
2002). Increasing numbers of reports describe protein-protein interactions mediated by C2H2 
zinc fingers and some of these are shown in Table 1.1. For example, the Repressor element-1 
(RE-1) silencing transcription factor/neuronal restricted silencing factor (REST/NRSF, 
hereafter REST) can specifically bind to the co-repressor protein CoREST by utilizing one 
C2H2 finger (Andres et al., 1999; see also chapter 7). Additional studies describe the 
importance of the C2H2 zinc finger domain for various interactions although it is not clear if 
the C2H2 ZFs always directly participate in the interaction. Examples are the WT1 protein 
that interacts with different classes of proteins including p53, p73, p63, CREB binding 
protein (CBP)/p300, and the Sex-determining region of the Y chromosome protein (SRY) 
(reviewed in Lee and Haber, 2001; reviewed in Scharnhorst et al., 2001; Wang et al., 2001; 
Matsuzawa-Watanabe et al., 2003) as well as the Ying Yang 1 protein (YY1) which binds to 
several cellular factors including TATA binding protein (TBP), CBP/p300, TFIIB, E1A, c-
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Myc, SpI and ATF/CREB (reviewed in Thomas and Seto, 1999). It has been demonstrated 
for both WT1 and YY1 proteins that the zinc finger domain is at least necessary for the 
respective interactions and in some cases a physical interaction directly involving the ZFs has 
been shown (e.g. Lee et al., 1993; Zhou et al., 1995; Matsuzawa-Watanabe et al., 2003).  
 
C2H2 ZF containing protein Interaction partner Reference 
Ikaros Ikaros  Sun et al., 1996 
REST Co-REST Andres et al., 1999 
YY1 SpI, ATF a2 Lee et al., 1993; Zhou et al., 1995 
Roaz Roaz Tsai and Reed, 1998 
Sryδ sryδ Payre et al., 1997 
BMZF2 WT1 Lee et al., 2002 
WT1 SRY Matsuzawa-Watanabe et al., 2003 
ZNF74 RNA Polymerase II Grondin et al., 1997 
 
Table 1.1 C2H2 ZFs involved in protein-protein interactions. Protein pairs are shown in the first two 
columns. For theses pairs a direct involvement of the ZF domain in the interaction has been demonstrated. 
REST, Repressor element-1 silencing transcription factor; YY1, Ying Yang 1; Roaz, Rat olfactory 1 / early B-
cell factor –associated zinc finger protein; Sryδ, Serendipity δ; BMZF2, Bone marrow zinc finger 2; WT1, 
Wilms tumor 1; ZNF74, Zinc finger 74; Co-REST, Co-repressor of REST; ATF, Activating transcription factor; 
SRY, Sex-determining region of the Y chromosome.  
 
1.2.7.2 Structures of protein-binding C2H2 ZFs 
Unfortunately, only a handful of structures of C2H2 ZFs involved in protein binding have 
been described and none of these structures shows an actual C2H2 ZF mediated protein-
protein interaction. Examples include the transactivation domain of ATF-2 containing a 
single C2H2 ZF (Nagadoi et al. 1999), the substrate-binding domain of Seven in absentia 
homolog 1a (Siah1a) containing one C2H2 ZF (Polekhina et al., 2002) and a single C2H2 
finger of the dimerization domain from the transcription factor Eos (Westman et al., 2004). 
These structures have provided some insights about protein-contacting C2H2 ZFs including 
similarities as well as remarkable differences to DNA-binding C2H2 ZFs.  
 
ATF-2: 
Using NMR spectroscopy Nagadoi and co-workers (1999) have solved the solution structure 
of the transactivation domain of ATF-2 which contains a domain termed N-subdomain that 
shows high sequence homology to the C2H2 ZF motif. In fact, the structure of this domain is 
highly similar to the typical ββα motif of a C2H2 ZF. A comparison of the N-subdomain with 
two DNA-binding C2H2 ZFs, ZF1 of Zif268 (Elrond-Erickson et al., 1996) and ZF3 of the 
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human glioblastoma protein (GLI) (Pavletich and Pabo, 1993) indicates that the backbone 
structure of the N-subdomain matches well with the two DNA-binding C2H2 ZFs. In 
particular, the arrangement of the hydrophobic core is almost identical to the DNA-binding 
C2H2 ZFs (Nagadoi et al. 1999). Interestingly, sequence comparison between the N-
subdomain and various DNA-binding C2H2 ZFs demonstrated that residue positions known 
to bind to the phosphate backbone of DNA are only conserved in DNA-binding C2H2 ZFs 
while residue positions that are important for maintaining the typical structure of the C2H2 
ZF are conserved in both the DNA-binding C2H2 ZFs and the N-subdomain (Nagadoi et al. 
1999). Another notable feature that Nagadoi and co-workers (1999) described is the 
difference in surface charge distributions between protein-contacting C2H2 ZFs and DNA-
binding C2H2 ZFs. While the surface of DNA-binding C2H2 ZFs (from GLI and Zif268) is 
highly positive, protein-contacting C2H2 ZFs are either neutral (in the case of N-subdomain) 
or negative (in the case of the protein-interacting ZF1 of GLI). This suggests that the charges 
present on the surface of a C2H2 ZF protein can be a determinant of whether the protein 
binds to DNA or other proteins (Nagadoi et al. 1999).  
 
Eos: 
The C2H2 ZFs of the transcription factor Eos that mediate dimerization have been 
investigated using a combination of different techniques including circular dichroism (CD), 
UV-Vis spectrophotometry and NMR spectroscopy (Westman et al., 2004). Eos contains an 
amino-terminal (N-terminal) domain consisting of four C2H2 ZFs and a carboxy-terminal (C-
terminal) domain which is composed of two C2H2 ZFs. While the N-terminal domain binds 
to DNA, the C-terminal domain is implicated in mediating protein contacts (Perdomo et al., 
2000; Westman et al., 2003; Westman et al., 2004; see also section 1.3.2). Initial UV-Vis 
experiments demonstrated that both C-terminal C2H2 ZFs from Eos can fold in the presence 
of zinc and are likely to take on the typical ββα structure. The solution structure of the second 
C-terminal C2H2 ZF was subsequently solved by NMR spectroscopy (Westman et al., 2004). 
Surprisingly, two distinct sets of conformers (termed EosC2’ and EosC2”) were obtained that 
differ in the arrangement of the polypeptide backbone at the C-terminus (Figure 1.3). Both 
conformers consist of a loose β-hairpin-like fold that positions the two cysteines followed by 
a short (4-7 residues, depending on the conformer) but well-ordered α-helix, which contains 
the two histidines involved in zinc-binding. However, the positions of the two histidine side 
chains are reversed when comparing the two conformers (Figure 1.3). This suggested that the 
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structure of this C2H2 ZF displays some conformational flexibility (Westman et al., 2004) 
which is in contrast to the well accepted view that C2H2 ZFs structures are highly ordered. 
The structure of the two conformers was further compared to the second C2H2 ZF of the 
DNA-binding protein MBP-1 (Omichinski et al., 1992), indicating that the overall structural 
arrangement is similar although the positions of the two zinc-ligating histidines in EosC2” is 
swapped in comparison to the corresponding position in MBP-1 (Figure 1.3, Westman et al., 
2004). It is noteworthy, that the overall arrangement of the hydrophobic core in both 
conformers is conserved, which is somewhat surprising given that the generally invariant 
phenylalanine that is usually present after the second zinc-ligating cysteine in substituted by a 
serine (Westman et al., 2004). The surface charge distributions of both conformers were 
further analyzed, indicating that no patches of positive charge are present which is consistent 
with the involvement of this C2H2 ZF in mediating protein-contacts rather the DNA-binding 
(Westman et al., 2004; Nagadoi et al. 1999).  
 
In summary, these structures have provided initial insights into characteristic features of a 
protein-binding C2H2 ZF. In particular, they demonstrated that the fold of these C2H2 ZFs 
largely conforms to the typical ββα structure of a DNA-binding C2H2 ZFs although 
differences definitely exist. On the other hand, inspection of the charged residue distribution 
on the surface of these C2H2 ZFs clearly indicate that protein-binding C2H2 ZFs lack the 
characteristic regions of positive charges present on the surface of DNA-binding C2H2 ZFs. 
Furthermore, the charge distribution seems to be more flexible (both negative and neutral 
 
 
 
Figure 1.3 Structural comparison of the ZF motif in Eos with the ZF motif of a DNA binding 
ZF. The structures of the two conformers EosC2’ (blue) and EosC2” (yellow) of the second C-
terminal C2H2 ZF are shown overlaid with ZF2 of MBP-1 (white). The side chains of the zinc-
ligating residues are shown as ball-and-stick in dark blue (for EosC2’), red (for EosC2”) and white 
(for MBP-1). The corresponding zinc ion is shown as a colored sphere. N- and C-termini are also 
indicated. This Figure was taken from Westman et al. (2004). 
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charges are present) which could point towards a high level of complexity required for 
protein-interactions as opposed to binding to the regular structure of the negatively charged 
DNA.  
 
1.2.7.3 Structures of protein-protein interactions mediated by C2H2 ZFs 
Only limited structural information of protein-protein interactions mediated by C2H2 ZFs has 
been obtained. For example, the crystal structure of a complex containing the five C2H2 ZFs 
from GLI bound to their DNA site has revealed that ZF1 of GLI is not involved in contacting 
DNA (Pavletich and Pabo, 1993). Instead, ZF1 is packed against ZF2 of GLI and makes 
extensive protein-protein interactions with this finger, although the biological relevance of 
this intra-molecular interaction is unknown. This interaction involves hydrophobic contacts 
made by several residues at the interfaces of both fingers. Furthermore, the linker between 
ZF1 and ZF2 in GLI is two residues longer then the typical five residue linker and seems to 
provide more flexibility (Pavletich and Pabo, 1993). It is noteworthy that these studies are 
consistent with the findings of Nagadoi and co-workers (1999), which describe the surface of 
GLI ZF1 as highly negatively charged (see section 1.2.7.2) and therefore presumably 
involved in protein-protein interactions. 
Structural information has also been obtained for an artificial peptide extension (consisting of 
15 residues) that was linked to the amino-terminus of ZF1 and ZF2 of Zif268 (Wang et al., 
2001). This peptide mediates dimerization of the two C2H2 ZFs, thus permitting them to bind 
to a palindromic DNA-site. The crystal structure of this complex revealed that the peptide 
reaches across the DNA and extensively contacts a hydrophobic patch of residues present on 
the surface of the other C2H2 ZF (i.e. peptide extension of one monomer contacts the ZFs in 
the other monomer and vice versa). Closer inspection of these hydrophobic residue positions 
found in Zif268 ZF1 demonstrate that they match perfectly well to the patch of residues in 
GLI ZF1 and ZF2 identified by Pavletich and Pabo (1993) (Wang et al., 2001). Thus, this 
exposed hydrophobic surface may be generally important in C2H2 ZFs for contacting other 
proteins (Wang et al., 2001).  
In summary, theses structures have provided some insights in the mechanism of protein 
binding mediated by C2H2 zinc fingers, although the molecular details of such interactions 
which are well characterized for DNA recognition by C2H2 ZFs (see section 1.2.4) are still 
missing. In addition, these studies demonstrate that C2H2 ZFs can interact with DNA and 
Introduction. 
 
 14
proteins simultaneously (Wang et al., 2001), which provides further indication that distinct 
protein surfaces are used for these different kinds of interactions. 
 
1.2.8 Other ZF motifs 
 
After the discovery and characterization of the classical C2H2 ZF motif, several other classes 
of zinc-ligating domains have been described and the term ZF is now most commonly 
defined as a protein motif that folds independently around one or more zinc cations. Different 
classes of ZF proteins vary in the nature of their zinc-binding residues, but they all have in 
common that they bind zinc ions in a purely structural manner rather then using it for 
catalytic processes (reviewed in Matthews and Sunde, 2002). Although originally classified 
according to the identity and geometry of the zinc binding ligands (reviewed in Mackay and 
Crossley, 1998), the growing number of structural reports on these proteins suggested that 
classification should be based on structural properties. Using this method, classes of ZF 
proteins are assorted into eight different fold groups (Krishna et al., 2003). However, the 
majority of ZFs belong to two protein folds: the classical C2H2 like finger and the treble clef 
finger (Grishin, 2001; Krishna et al., 2003). Although ZFs are involved in various different 
functions within the cell, they mediate contacts with other molecules such as DNA, RNA, 
proteins, and lipids. Most ZF proteins contain more than one ZF which are frequently 
arranged in tandem arrays suggesting that ZF proteins serve as a platform for assembling a 
range of different biomolecules (reviewed by Klug and Schwabe, 1995; and by Matthews and 
Sunde, 2002).  
 
1.3 The Ikaros transcription factor family 
 
1.3.1 The Ikaros protein 
 
1.3.1.1 Discovery 
Hematopoiesis is the process of producing a functional distinct set of cells that comprise the 
mature blood. These cells arise from pluripotent hematopoietic stem cells that successively 
become more specified by regulated division and differentiation steps. This process is tightly 
controlled and selective changes in gene expression patterns have shown to be important for 
Introduction. 
 
 15
the transition of hematopoietic precursors to a highly differentiated cell (reviewed in Orkin, 
1995; and in Cantor and Orkin, 2001). The regulation of this coordinated program of gene 
activation and silencing is mediated by transcription factors and the search for such factors 
started more then 15 years ago. In an attempt to isolate regulatory proteins involved in the 
control of differentiation of the hematopoietic T cell lineage, Georgopoulos and co-workers 
(1992) identified the Ikaros protein. The T cell lineage is characterized by the presence of the 
CD3-T cell receptor complex which is encoded by the CD3δ gene (Furley et al., 1986; 
Haynes et al., 1989). Ikaros was isolated as a factor that specifically binds to a G-rich 
sequence present in the regulatory elements of CD3δ (Georgopoulos et al., 1992). This factor 
was also shown to encode the Lymphoid transcription factor 1 (LyF-1) protein, which binds 
to functionally important regulatory sites within the lymphocyte specific terminal 
deoxynucleotidyltransferase (TdT) promoter (Lo et al., 1991; Ernst et al., 1993; Hahm et al., 
1994). To further establish its function as a factor involved in the development of the 
hematopoietic system, the expression pattern of the Ikaros protein was analyzed. Ikaros is 
first detected in hematopoietic precursor populations and is later mainly present in mature T 
cells, B-cells and natural killer cells. In contrast, it is downregulated in most differentiated 
erythroid and myeloid lineages including mature monocytes, macrophages and erythrocytes 
(Georgopoulos et al., 1992; Klug et al., 1998). Thus, the temporal expression pattern of 
Ikaros in hematopoietic cell lines is consistent with the idea that it plays a role in lymphoid 
cell development Georgopoulos et al., 1994; Klug et al., 1998; reviewed by Georgopoulos et 
al., 1997; Westman et al., 2002; and by Cobb and Smale, 2005).  
 
1.3.1.2 Ikaros isoforms 
Ikaros is composed of seven exons from which at least eight isoforms (Ik-1 to Ik-8, Figure 
1.4) can be generated by alternative mRNA splicing events (Hahm et al., 1994; Molnar and 
Georgopoulos, 1994; Molnar et al., 1996). As shown in Figure 1.4, each isoform encodes a 
distinct C2H2 ZF protein and most of these isoforms consist of two defined C2H2 ZF 
domains. While the C-terminal C2H2 ZF domain is present in all isoforms, the N-terminal 
C2H2 ZF domain contains different combinations of one to four C2H2 ZFs and two isoforms 
(Ik-6 and Ik-8) have no N-terminal C2H2 ZFs at all. It has been demonstrated that the N-
terminal C2H2 ZFs are required for DNA binding. In addition, DNA specificity of the 
different isoforms was analyzed extensively using gel-shift assays and PCR site selections 
(Molnar and Georgopoulos, 1994) which showed that three N-terminal C2H2 ZFs are 
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necessary to bind to a single binding site of the conserved core motif GGGAA. Thus, only 
three of the Ikaros proteins (Ik-1, Ik-2 and Ik-3) which contain three or four N-terminal C2H2 
ZFs, bind to this sequence. Ik-4 is composed of two N-terminal C2H2 ZFs and binds to a 
tandem recognition site containing an inverted repeat of the consensus motif. On the other 
hand, Ikaros isoforms with only one or no N-terminal C2H2 ZFs (Ik-5, Ik-6, Ik-7 and Ik-8) 
are not able to mediate interactions with DNA (Molnar and Georgopoulos, 1994).  
 
The C-terminal C2H2 ZF domain present in all Ikaros isoforms has been shown to mediate 
dimerization (Sun et al., 1996; McCarty et al., 2003) and is utilized to engage these various 
Ikaros proteins in homo- and heterodimeric complexes. Oligomerization between isoforms 
composed of N-terminal C2H2 ZFs capable of DNA-binding dramatically increases their 
DNA affinity. However, heterodimers consisting of Ikaros proteins with and without a 
functional DNA-binding domain can not bind to DNA. Furthermore, the formation of such 
complexes interferes with the transcriptional activity of DNA-binding isoforms which could 
provide a mechanism to control activity of these isoforms (Sun et al., 1996).  
 
1/2 3 64 5 7
1/2 4 5 6 7
1/2 3 4 7
4 6 7
1/2 3 7
1/2
1/2
5 6 7
6 7
DNA binding Dimerization
F1    F2    F3    F4 F5  F6
1/2
71/2
Ik-1
Ik-2
Ik-3
Ik-4
Ik-5
Ik-6
Ik-7
Ik-8
 
 
 
Figure 1.4 Schematic diagram of the Ikaros isoforms (Ik-1 - Ik-8). Exons are presented as white 
numbered boxes and individual ZFs are depicted as grey rounded rectangles. ZF domains involved in 
DNA-binding and dimerization are also indicated. 
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1.3.1.3 Knock out studies of Ikaros 
To evaluate the role of Ikaros in lymphoid cell development, knock out studies in mice were 
performed. Mice homozygous for a deletion of the N-terminal DNA-binding domain 
completely lack lymphoid progenitors as well as mature B and T lymphocytes and natural 
killer cells (Georgopoulos et al., 1994). On the other hand, mice that are heterozygous for this 
mutation generate abnormal T cells and develop T-cell leukemias and lymphomas (Winandy 
et al., 1995). This suggests that Ikaros is necessary for early development of lymphoid 
progenitors but also plays a role in later T cell maturation. Interestingly, mice homozygous 
for a deletion of the C-terminal C2H2 ZF domain in Ikaros display a phenotype less severe 
than the phenotype caused by the missing N-terminal domain (Wang et al., 1996). This 
deletion is considered to be a null mutation resulting in a complete loss of Ikaros activity 
while the deletion of the N-terminal DNA binding domain is believed to fulfill a dominant-
negative function. Thus, the severe phenotype observed in mice homozygous for the N-
terminal C2H2 ZF domain can be explained by a mechanism in which this mutated protein 
dominantly effects and disrupts other proteins that could otherwise partially compensate for a 
loss of function of the Ikaros protein (see next section).  
 
1.3.2 Ikaros related proteins 
 
1.3.2.1 Discovery  
Shortly after the discovery of Ikaros, several other proteins were identified that have 
functional properties similar to Ikaros suggesting that these proteins compose a family of 
related transcription factors. These proteins were isolated using different approaches that 
were initially aimed at identifying potential interacting targets of Ikaros (see section 1.3.1.3): 
Aiolos and Helios were amplified from a mouse cDNA library using degenerate 
oligonucleotides directed against the N- or C-terminal domain of Ikaros (Morgan et al., 1997; 
Kelley et al., 1998). In addition, a separate independent study identified Helios as a 
component of an Ikaros containing complex isolated by gel filtration chromatography (Hahm 
et al., 1998). Mouse Eos was originally discovered in a screen for upregulated genes in long 
term cultured astrocytes (Honma et al., 1999). At the same time, human Eos and Pegasus 
were identified in a Yeast two-hybrid screen using the C-terminal domain of Aiolos 
(Perdomo et al., 2000). All of these proteins harbor four N-terminal C2H2 ZFs and two C-
terminal C2H2 ZFs and are homologous to each other. The highest level of homology occurs 
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in the C-terminal C2H2 ZF domain (Figure 1.5) and it has been shown that this domain can 
mediate homo- and hetero-typic interactions among these various transcription factors as 
suggested by the way Eos and Pegasus were isolated.  
 
1.3.2.2 Similarities and differences among Ikaros family members 
As in the case of Ikaros, alternative splice variants have been described for some of these 
family members. At least seven additional isoforms have been identified for Helios and five 
for Aiolos whereas no isoforms appear to exist for Eos and Pegasus (Kelley et al., 1998; 
Perdomo et al., 2000; Liippo et al., 2001; Nakase et al., 2002). All isoforms contain the C-
terminal C2H2 ZFs while the arrangement of C2H2 ZFs at the N-terminus is variable. Like 
Ikaros, Aiolos and Helios are present in hematopoietic cell lines where they display a distinct 
and well defined expression profile. For example, Aiolos is detected at low levels in 
hematopoietic progenitor populations and is upregulated at intermediate and late stages of T 
and B cell development (Morgan et al., 1997). On the other hand, Helios is primarily found in 
T cells (Hahm et al., 1998; Kelley et al., 1998). Eos and Pegasus are more broadly expressed 
and their expression is not restricted to the hematopoietic system although they also have 
overlapping expression patterns with Ikaros and Helios (Honma et al., 1999; Perdomo et al., 
2000).  
The DNA binding specificities of the Ikaros family members have been further analyzed. 
While Aiolos and Eos can bind to the conserved Ikaros binding site (GGGAA) with levels of 
specificity and affinity comparable to Ikaros, Helios and Pegasus appear to interact with 
distinct DNA sites. Binding sites for Helios are characterized by the core sequence of GGGA 
or GGAAAA (Hahm et al., 1998), while Pegasus can bind to sites defined by a loose 
consensus of GNNNGNNG (Perdomo et al., 2000).  
           *  *            *   *       *  *            *     * 
Ikaros:  GEQMKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHRFHMS 
Helios:  GEQIRAFKCEHCRVLFLDHVMYTIHMGCHGYRDPLECNICGYRSQDRYEFSSHIVRGEHTFH 
Aiolos:  GEVMDVYRCDHCRVLFLDYVMFTIHMGCHGFRDPFECNMCGDRSHDRYEFSSHIARGEHRSLLK 
Eos:  SEPVKAFKCEHCRILFLDHVMFTIHMGCHGFRDPFECNICGYHSQDRYEFSSHIVRGEHKVG 
Pegasus:  QDPQLLHHCQHCDMYFADNILYTIHMGCHGYENPFQCNICGCKCKNKYDFACHFARG-HITNID 
 
 ZF5 ZF6  
 
 
Figure 1.5 Amino acid alignment of the C-terminal ZF domain of Ikaros-family proteins. The C-
terminal domain contains two ZFs (ZF5 and ZF6). Residue positions that are identical in all proteins are 
in purple while residue positions that a identical in three or more family members are shown in grey. 
Asterisks indicate putative zinc-ligating cysteine and histidine.
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Thus, certain members of the Ikaros family display some similar features consistent with the 
idea that they play a role in regulating lymphoid cell development. However, individual 
proteins also have unique characteristics, suggesting that each Ikaros-family protein is 
involved in distinct functions during hematopoiesis. Furthermore, since these proteins 
apparently possess partially similar DNA binding sites, they could, in principle, compete for 
target sites in the regulatory region of certain genes (Morgan et al., 1997). Although such a 
mechanism has not been demonstrated yet, it may provide an additional strategy of regulating 
gene expression in the developing lymphoid system.  
 
1.3.3 Mechanism of Ikaros action 
 
The function of Ikaros-family members as master regulators of lymphoid cell development 
was proposed briefly after their discovery (Georgopoulos et al., 1992; Hahm et al., 1994; 
Molnar and Georgopoulos, 1994). These proteins are composed of C2H2 ZF domains which 
are most commonly found in DNA-binding transcription factors and putative target site have 
been identified in regulatory elements of several lymphoid-specific genes (Molnar and 
Georgopoulos, 1994; Christopherson et al., 2001; Lopez et al., 2002). The mechanism by 
which Ikaros-family proteins act on gene expression is likely to be very complex and both 
activation as well as repression has been observed for these proteins. For example, Ikaros and 
Aiolos can both activate and repress gene expression when recruited to DNA through a 
heterologous DNA-binding domain (Sun et al., 1996; Morgan et al., 1997; Brown et al., 
1997; Koipally et al., 1999; Koipally and Georgopoulos, 2000; Koipally and Georgopoulos, 
2002). Helios appears to solely act as an activator (Kelley et al., 1998) while Eos and Pegasus 
have been shown to function as repressors (Perdomo et al., 2000).  
Although the details of transcriptional regulations mediated by the Ikaros-family is not well 
characterized, different lines of evidence have shown that localization of the transcription 
factors as well as protein-protein interactions with themselves and other proteins influence 
their regulatory function (see below).  
 
1.3.3.1 Interactions with other proteins 
To mediate their function in the hematopoietic system, members of the Ikaros-family interact 
with a wide variety of different proteins ranging from co-activators and co-repressors to 
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chromatin remodeling factors as well as histone modifying enzymes. By doing so, Ikaros 
proteins participate in different regulatory complexes that either active or repress certain 
genes. For example, Ikaros and Aiolos are present in the nucleosome remodeling and 
deacetylase (NuRD) complex that also contains the ATPase Mi-2 (Kim et al., 1999). This 
complex is involved in transcriptional repression due to its association with histone 
deacetylases (HDACs). On the other hand, Ikaros and Aiolos have also been described as 
components of the SWI/SNF chromatin-remodeling complex which can mediate gene 
activation (Kim et al., 1999). Finally, Ikaros can repress transcription through its interaction 
with the C-terminal binding protein (CtBP) and this mechanism of repression is independent 
of histone deacetylase activity (Koipally and Georgopoulos, 2000). Furthermore, Eos has also 
been found associated with CtBP (Perdomo and Crossley, 2002) whereas Aiolos and Helios 
do not seem to bind to this protein (Koipally and Georgopoulos, 2000).  
 
1.3.3.2 Targeting of Ikaros to pericentromeric heterochromatin  
The potential of the Ikaros proteins to mediate interaction with various proteins may provide 
a molecular mechanism for their ability to function as both activators and repressors. 
However, an additional notable feature of the Ikaros protein is the observation that it can be 
found in regions of condensed chromatin near the centromers termed the pericentromeric 
heterochromatin (PC-HC) which are often associated with inactive genes. In fact, 
immunofluorescence in situ hybridization (immuno-FISH) analysis has demonstrated that 
Ikaros colocalizes with centromeric chromatin and various transcriptionally silenced genes, 
suggesting that Ikaros is responsible for their relocalization in the nucleus (Brown et al., 
1997; Klug et al., 1998). Additional studies have shown that targeting of Ikaros to PC-HC 
requires both its DNA-binding domain and its C-terminal dimerization domain (Cobb et al., 
2000). It is noteworthy that Koipally and co-workers (2002) have found a surprising 
correlation between the localization of Ikaros to PC-HC and its ability to activate 
transcription. These findings led to the proposal of a model where Ikaros can function as a 
“potentiator” of gene expression by for example squelching repressor complexes (such as the 
NuRD complex) away from defined target genes into regions of PC-HC (Koipally et al., 
2002). 
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1.3.4 The Dimerization Zinc Finger (DZF) domain 
 
1.3.4.1 Importance of the C-terminal domain for the function of Ikaros family proteins 
As described above, the main function of the C-terminal C2H2 ZF domain appears to be to 
support homo- and heterodimerization among the various encoded isoforms as well as among 
different Ikaros family members (Sun et al., 1996;; Morgan et al. 1997; Kelley et al. 1998; 
Koipally et al. 1999; Perdomo et al., 2000). There is some evidence that C-terminal C2H2 ZF 
domain can weakly bind to DNA but a consensus binding site has not been identified yet 
(Georgopoulos et al., 1992; Molnar and Georgopoulos, 1994). Furthermore, this domain 
lacks the typical TGEKP linker that characterizes most of the C2H2 ZFs and which has been 
shown to be important for DNA binding. This suggested that the C-terminal C2H2 ZF 
domain of the Ikaros family members might be exclusively involved in mediating protein 
contacts. It has been described that the homo-typic oligomerization mediated by the various 
C-terminal domains is necessary for high affinity DNA binding and subsequent 
transcriptional regulation suggesting that transcription factors of the Ikaros family might 
oligomerize on DNA (Molnar and Georgopoulos, 1994; Cobb et al., 2000; Trinh et al., 2001). 
In addition, these homotypic interactions are essential for localizing Ikaros to PC-HC which 
results in either silencing or activation of Ikaros target genes (Brown et al., 1997; Cobb et al., 
2000; Koipally et al., 2002). It is noteworthy that the C-terminal domain is not directly 
involved in targeting to the PC-HC but appears to be only required for dimerization since 
targeting was also achieved when this domain was replaced by the leucine zipper 
dimerization domain (Cobb et al., 2000).  
 
1.3.4.2 Dimerization ZF domains are also found in other transcription factors 
Interestingly, the Trichorhinophalangeal syndrome 1 (TRPS1) protein also contains a 
homologous dimerization domain at its C-terminus. TRPS1 is a transcription factor that is 
associated with a dominantly inherited human disease characterized by skeletal abnormalities 
(Momeni et al., 2000) and is otherwise not believed to belong to the Ikaros family of 
transcription factors (Momeni et al., 2000). Yeast two-hybrid and co-immunoprecipitation 
assays suggested that TRPS1 interacts with itself and with Eos via its C-terminal zinc fingers 
(McCarty et al., 2003; Westman et al., 2003; Westman et al., 2004). Recently, a dimerization 
domain from the Ikaros homologue Hunchback, a segmentation gap gene involved in 
embryonic pattern formation in Drosophila melanogaster, has been described which can 
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mediate homodimerization but can not heterodimerize with Ikaros in vitro (Tautz et al., 1987; 
McCarty et al., 2003). Further in vitro studies on different dimerization domains have shown 
that both C-terminal C2H2 ZFs are required for efficient dimerization (McCarty et al., 2003; 
Westman et al., 2004). Thus, the two C-terminal zinc fingers found in different transcription 
factors from the Ikaros family, TRPS1 and Hunchback have been shown to be essential as 
well as sufficient for dimerization. These domains are therefore referred to as dimerization 
zinc finger (DZF) domain (McCarty et al., 2003). 
 
1.3.4.3 Specificity determinants of the DZF domain 
Using directed mutagenesis together with chemical crosslinking and co-
immunoprecipitations, McCarty and co-workers (2003) performed initial studies to define the 
molecular determinants of DZF domain mediated interactions. These studies demonstrated 
that interactions between the DZF domains of Ikaros, Hunchback and TRPS1 are highly 
specific since each of these DZF domains can interact with themselves but do not 
heterodimerize with one another. To identify specificity determinants for the Ikaros and 
Hunchback DZF domains, McCarty and co-workers (2003) constructed a series of Ikaros-
Hunchback DZF chimeras by introducing increasing amounts of one protein in the other 
protein. These chimeras were then tested for their ability to interact with either the wild-type 
Ikaros or the wild-type Hunchback DZF domain. As shown in Figure 1.6, minimal regions 
required for selective dimerization for both Ikaros and Hunchback were defined in this way. 
These regions overlap but differ in length (Figure 1.6, McCarty et al., 2003).  
 
β-sheets β-sheets α-helix α-helix 
Ikaros:  GEQLKVYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEHR 
               | |  |   | | | |||||| |   | | |||||           |  |  | 
Hunchback AAAGAIYECKYCDIFFKDAVLYTIHMGYHSCDDVFKCNMCGEKCDGPVGLFVHMARNAHS 
 
 
 
Figure 1.6 Minimal regions required for selective dimerization of Ikaros and Hunchback. Selectivity 
regions defined by analysis of chimeric proteins are indicated by a green line (for Ikaros) and a blue line 
(for Hunchback). Residue positions important for Ikaros dimerization are shown in red. Conserved 
residues are in bold. Residues that are identical in both proteins are connected by a line. Predicted 
secondary structures are indicated above the amino acid sequences. This figure was adapted from 
McCarty et al. (2003).
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Interestingly, one of their chimeras was able to homo-dimerize but could not interact with the 
two wild-type DZF domains (from Ikaros and Hunchback) indicating that this chimeric DZF 
domain possesses a novel interaction specificity. Furthermore, the preferential 
homodimerization of this protein suggests that it interacts using a parallel interaction mode 
(i.e. the N-terminal C2H2 ZFs in each monomer interact with each other and C-terminal 
C2H2 ZFs in each monomer interact with each other). This conclusion was based on the 
reasonable assumption that the individual C2H2 ZFs in this hybrid protein harbor the same 
interaction specificities then the parental DZFs from which they were constructed (McCarty 
et al., 2003). 
To precisely define residues that are important for dimerization, McCarty and co-workers 
(2003) further introduced single or double mutations into the Ikaros DZF domain by 
replacing every amino-acid in Ikaros that differs between Ikaros and Hunchback with the 
corresponding Hunchback amino-acid at the same position. These “swap” mutants were then 
tested for their abilities to homodimerize as well as heterodimerize with the wild-type Ikaros 
DZF domain. As shown in Figure 1.6, eight residues were identified that are likely to be 
important for the Ikaros DZF domain interaction. Interestingly, many of these residues are 
present in the predicted α-helices, suggesting that this structure, like in the case of DNA-
binding, is important for protein-recognition (McCarty et al., 2003).  
 
 
1.4 Goals of this thesis 
 
Over the last decade, much effort has focused on studying DNA recognition by C2H2 ZF 
proteins while their role as protein-binding modules was revealed more recently (reviewed in 
Mackay and Crossley, 1998). The abundance and versatility of ZFs suggests that they 
comprise a favorable motif in nature for evolving a large number of functional properties in 
the cell that are not just limited to DNA recognition. The fold of ZFs itself is relatively simple 
suggesting that the variability within non-conserved regions of this domain must mediate 
binding specialization. Our understanding of how affinity and specificity is provided by such 
a stable framework is still limited. Such knowledge would provide useful information that 
will eventually allow us to predict protein interactions based on sequence information, and 
engineer synthetic interaction domains that can be used for applications in gene therapy and 
biotechnology.  
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The Ikaros family of transcription factor represents an example of C2H2 ZF proteins that can 
mediate interactions with DNA as well as with other proteins. While DNA-binding mediated 
by the N-terminal domain is likely to be similar to other characterized DNA-binding ZFs, 
relatively little is know about the details of the protein interactions mediated by the C-
terminal domain (DZF domain). Therefore, we sought to address this lack of understanding 
by examining the DZF domains found in the Ikaros and Hunchback transcription factor 
family using a combination of genetic, biochemical and functional assays. This should add to 
the existing knowledge of both the ability of C2H2 ZFs to mediate protein-protein 
interactions in general as well as the biological importance of the DZF domain. 
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Chapter 2. Materials and Methods. 
 
2.1 General techniques  
 
Standard buffers and solutions were prepared as described in Sambrook and Russell (2001). 
Use of commercially available solutions and buffers is mentioned at the relevant steps. 
Unless otherwise stated Milli-Q water was used to prepare buffers and HCl or NaOH was 
used to adjust the pH of all buffers. Solutions were filter-sterilized through a 0.2 μm filter and 
media was autoclaved if not mentioned otherwise. Note that all reporter strains and constructs 
including the methods used to generate them are listed in the appendix.  
 
2.1.1 Materials 
 
2.1.1.1 Buffers and solutions 
• 10 x Annealing buffer: 400 mM Tris (pH 8.0), 200 mM MgCl2, 500 mM NaCl 
• 2 x Quick ligation buffer:  132 mM Tris (pH 7.6), 20 mM MgCl2, 2 mM ATP, 15 % 
Polyethylene glycol. Fresh DTT was added to a final concentration of 2 mM. 
• DNA elution buffer: 0.5 M NH4OAc, 10 mM MgOAc, 1 mM EDTA (pH 8.0), 0.1 % 
SDS 
• Competent cell solution A: 10 mM MnCl2, 50 mM CaCl2, 10 mM MES (pH 6.3, pH 
was adjusted with KOH) 
• Transfer buffer: 100 ml of 10 x Tris-Glycin (Biorad), 200 ml of Methanol. Distilled 
water was added to 1 liter. 
• TBST: 20 ml of 1 M Tris-HCl (pH 7.5), 8 g of NaCl, 1 ml of Tween 20. Distilled 
water was added to 1 liter. 
 
2.1.1.2 Antibiotics 
Antibiotic Stock solution Final concentration in plates 
Final concentration 
in liquid medium 
Carbenicillin (Carb) 50 mg/ml in H2O 100 μg/ml 50 μg/ml 
Chloramphenicol (Cam) 30 mg/ml in ethanol 30 μg/ml 30 μg/ml 
Kanamycin (Kan) 30 mg/ml in H2O 30 μg/ml 30 μg/ml 
Tetracycline (Tet) 12.5 mg/ml in 80 % EtOH 12.5 μg/ml 12.5 μg/ml 
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2.1.1.3 Media 
LB agar plates and Liquid LB medium were prepared as described in Sambrook and Russell 
(2001).  
 
Plates:  
LB/C plates  LB plates with Carb 
LB/CA plates  LB plates with Cam 
LB/K plates  LB plates with Kan 
LB/T plates  LB plates with Tet 
 
2.1.1.4 PAGE Gels 
Reagents for preparation of analytical and denaturing polyacrylamid gel electrophoresis 
(PAGE) gels were obtained from National Diagnostics. Note that a ratio of 29:1 
Acrylamide/Bisacrylamide was applied for native gels while a ratio of 19:1 
Acrylamide/Bisacrylamide was used for denaturing gels containing urea. 
 
Analytical Gels: 
Reagent Amount for 5 % gel Amount for 10 % gel 
H2O 40.5 ml 34.25 ml 
10 x TBE buffer 2.5 ml 2.5 ml 
10 % APS 700 μl 700 μl 
TEMED 50 μl 50 μl 
40 % Bisacrylamide Stock 6.25 ml 12.5 ml 
 
Denaturing polyacrylamide urea gel: 
Reagent Oligo 
length (in 
nucleotides) 
% 
Acrylamide Diluent Buffer APS TEMED 25 % Concentrate 
≤ 25 19 7 ml 5 ml 400 μl 20 μl 38 ml 
26-40 15 15 ml 5 ml 400 μl 20 μl 30 ml 
41-100 12 21 ml 5 ml 400 μl 20 μl 24 ml 
 
2.1.1.5 Bacterial strain  
E. coli XL-1 Blue: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB 
lacIqZ∆M15 Tn10 (Tetr)] (Stratagene). 
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2.1.2 Methods 
 
2.1.2.1 PAGE purification of oligonucleotides 
PAGE was used to purify oligonucleotides (oligos, primers) >40 bp using denaturing 
polyacrylamide urea gels at various concentrations (depending on the length of the oligo, see 
section 2.1.1.4) as described in Sambrook and Russell (2001) with a few differences. Eluted 
oligonucleotides were equally mixed with deionized formamide, incubated at 95°C for 2 min 
and stored at 4˚C. The samples along with a sample containing formamide with bromophenyl 
blue were loaded onto a denaturing polyacrylamide urea gel which had been pre-run for 30 
min at 23 watts. Following loading of the sample, the gel was run at 23 watts until the 
bromophenyl blue sample was about 3/4 of the way to the bottom. The oligonucleotides were 
visualized using UV shadowing, excised and eluted by incubating them in 8 ml TE buffer at 
37˚C for 4 hr or overnight (ON). To further purify the extracted oligonucleotides, a C18 Sep-
Pak column (Waters) was prepared by attaching it to the barrel of a 10 ml polypropylene 
syringe and pushing 5 ml 70 % acetonitrile and subsequently 5 ml TE buffer through it. The 
oligonucleotides samples were applied to the column, washed with 2 ml TE and eluted in 3 
ml 70 % acetonitrile. The samples were dried down using a SpeedVac, resuspended in TE 
buffer, EtOH precipitated and pellets were resuspended in TE buffer. The concentration of 
the oligonucleotide was determined by measuring the absorbance at 260 nm using a Beckman 
Coulter DU 640 Spectrophotometer.   
 
2.1.2.2 Polymerase chain reaction (PCR) 
Various PCR strategies were used to synthesize and clone the different target genes (Figure 
2.1). The Expand High Fidelity PCR System (Roche) was used to perform PCR reactions. 
This system contains the thermostable Taq DNA Polymerase and the thermostable Tgo DNA 
polymerase, which provides proofreading activity (Expand High fidelity enzyme mix). The 
corresponding buffer system (10 x Expand buffer) contains MgCl2 at a final concentration of 
15 mM. Resulting final PCR products were purified using gel electrophoresis (see section 
2.1.2.10). 
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Strategy A:  
DNA fragments encoding the various target genes were amplified from either plasmid DNA 
or human cDNA library using PCR. Specific restriction sites used for further cloning 
procedures were incorporated in both PCR oligonucleotides at the 5’ ends (Figure 2.1A). 5-
10 cycles with a partial annealing temperature (Tpa) were performed to allow initial binding 
of the primers to the template. A subsequent step of 15-20 cycles using the full annealing 
temperature (Tfa) was carried out for full binding of the primers to the template. The 
following conditions were used for a 50 μl reaction: 
 
Reaction: 
Reagent Final concentration Volume 
Template DNA 0.1–200 ng Variable 
10 x Expand buffer with 15 mM MgCl2 1 x 5 μl 
10 mM dNTP mix 200 μM of each dNTP 4 μl 
Top strand primer (10 pmol/μl) 200 nM 1 μl 
Bottom strand primer (10 pmol/μl) 200 nM 1 μl 
Expand High fidelity enzyme mix 1.3 U/reaction 0.375 μl 
Sterile dH2O  Add up to 50 μl 
 
Settings: 
 Temperature Time Cycles 
Initial Denaturation 95˚C 5 min 1 x 
Denaturation 
Partial annealing 
Elongation 
95˚C 
45-60˚C 
72˚C 
30 s 
30 s 
1 min 
5–10 x 
Denaturation 
Full annealing 
Elongation 
95˚C 
55-70˚C 
72˚C 
30 s 
30 s 
1 min 
15–25 x 
Final Elongation 72˚C 5 min 1 x 
Cooling 4˚C Unlimited time 1 x 
 
 
Strategy B: 
For de novo synthesis of the template, various overlapping oligonucleotides (P1, P2, P3, P4, 
P5 and P6) were annealed using the following conditions for a 50 μl reaction (Figure 2.1B): 
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Reaction: 
Reagent Final concentration Volume 
10 x Expand buffer with 15 mM MgCl2 1 x 5 μl 
10 mM dNTP mix 200 μM of each dNTP 4 μl 
Primer P1–P6 (10 pmol/μl) 200 nM of each primer 1 μl of each primer 
Expand High fidelity enzyme mix 1.3 U/reaction 0.375 μl 
Sterile dH2O  Add up to 50 μl 
 
Settings: 
 Temperature Time Cycles 
Initial Denaturation 95˚C 5 min 1 x 
Denaturation 
Primer annealing 
Elongation 
95˚C 
45-55˚C 
72˚C 
30 s 
30 s 
1 min 
10 x 
Final Elongation 72˚C 5 min 1 x 
Cooling 4˚C Unlimited time 1 x 
 
The annealed oligonucleotides were purified using a standard QIAgen PCR purification kit 
and eluted with 50 μl of 0.1 x elution buffer (EB buffer). The resulting product was then 
amplified with a pair of external oligonucleotides (P1 and P6) using the following conditions 
(Figure 2.1B): 
 
Reaction: 
Reagent Final concentration Volume 
Template DNA variable 5 μl 
10 x Expand buffer with 15 mM MgCl2 1 x 5 μl 
10 mM dNTP mix 200 μM of each dNTP 4 μl 
Top strand primer (10 pmol/μl) 200 nM 1 μl 
Bottom strand primer (10 pmol/μl) 200 nM 1 μl 
Expand High fidelity enzyme mix 1.3 U/reaction 0.375 μl 
Sterile dH2O  Add up to 50 μl 
 
Settings: 
 Temperature Time Cycles 
Initial Denaturation 95˚C 5 min 1 x 
Denaturation 
Full annealing 
Elongation 
95˚C 
55-70˚C 
72˚C 
30 s 
30 s 
1 min 
20 x 
Final Elongation 72˚C 5 min 1 x 
Cooling 4˚C Unlimited time 1 x 
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Strategy C: 
A three step PCR approach was applied to create target genes consisting of two different 
fragments that are fused together. In the first step (step 1), the 2 fragments of interest were 
individually amplified using standard PCR conditions as described below. Primer P2 and P3 
carried a common region at the 5’ end (red box in Figure 2.1C) which was used for the 
subsequent fusion PCR step (Step 2). In a final step (Step 3), the resulting PCR fusion 
product was amplified with a pair of external oligonucleotides (P1 and P4).  
Step 1 was performed as described in Strategy A. Both amplified fragments were then 
purified using a standard QIAgen PCR clean up kit and eluted with 50 μl of 0.1 x EB buffer. 
To anneal the resulting products together the following conditions for a 50 μl reaction were 
used (Step 2): 
 
Reaction: 
Reagent Final concentration Volume 
PCR Fragment 1 Variable 5 μl 
PCR Fragment 2 Variable 5 μl 
10 x Expand buffer with 15 mM MgCl2 1 x 5 μl 
10 mM dNTP mix 200 μM of each dNTP 4 μl 
Expand High fidelity enzyme mix 1.3 U/reaction 0.375 μl 
Sterile dH2O  Add up to 50 μl 
 
Settings: 
 Temperature Time Cycles 
Initial Denaturation 95˚C 5 min 1 x 
Denaturation 
Full annealing 
Elongation 
95˚C 
55-70˚C 
72˚C 
30 s 
1 min 
1 min 
4 x 
Final Elongation 72˚C 5 min 1 x 
Cooling 4˚C Unlimited time 1 x 
 
The resulting PCR fusion product was purified using a standard QIAgen PCR purification kit, 
eluted with 50 μl of 0.1 x EB buffer and amplified with a pair of external oligonucleotides 
(P1 and P4) as described in Strategy B (Step 3). 
 
Strategy D: 
To introduce site directed mutations into the target sequence, a three step PCR approach was 
applied similar as described in Strategy C (Figure 2.1D). In the first step, the left and right 
cassette of the target gene was individually amplified using standard PCR conditions. 
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Overlapping sequence regions containing the desired point mutation were used as internal 
primers (P2 and P3) for the subsequent fusion PCR step. In a final step, the resulting PCR 
fusion product was amplified with a pair of external oligonucleotides (P1 and P4). All 3 steps 
were performed as described in Strategy C. Note that all constructs harboring single point 
mutations were generated using this strategy if not otherwise stated. 
 
RS I
RS II
RS I RS II
P1
P2
Left cassette Right cassette
Fusion PCR
Final PCR
RS I
RS II
P1
P2 P4
P3
P1
P4
RS I
RS II
Left cassette Right cassette
Fusion PCR
Final PCR
X
X X
X
X
X
P4
P4
P3
P2
P1
P1
Final PCR
Primer annealing
RS I
RS II
P1
P2
P3
P4
P5
P6
P6
P1
A B
C D
 
 
Figure 2.1 Scheme of PCR strategies used to synthesize and amplify target genes. (A) DNA fragments 
encoding the target gene were amplified from available template DNA. Specific restriction sites (RS I and RS 
II) used for further cloning procedures were incorporated in both PCR oligonucleotides (P1 and P2) at their 5’ 
ends. (B) For de novo synthesis of the target gene, various overlapping oligonucleotides (P1, P2, P3, P4, P5 and 
P6, overlapping region depicted as red lines) were annealed together and amplified with a pair of external 
oligonucleotides (P1 and P6). (C) A target gene composed of two different fragments was generated in 3 steps. 
The individual fragments (left and right cassette) were amplified using standard PCR (as described in A). Primer 
P2 and P3 carried a common region at the 5’ end (red box) which was used to fuse the two fragments together. 
The resulting fusion product was amplified with a pair of external oligonucleotides (P1 and P4). (D) To 
introduce site directed point mutations into the target sequence, a left and a right cassette of the target gene were 
individually amplified. Overlapping sequence regions containing the desired mutation (indicated by red X) were 
incorporated in the internal primers (P2 and P3) to subsequently fuse the two cassettes together. In a final step, 
the resulting PCR fusion product was amplified with a pair of external oligonucleotides (P1 and P4). 
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2.1.2.3 Primer annealing 
To clone short DNA fragments consisting of only 10–30 base pairs, a primer annealing 
approach was used. Two complementary oligonucleotides were annealed together to create a 
double stranded DNA fragment bearing specific overhangs that were used for further cloning 
procedures. Annealing was performed using the following conditions for a 200 μl reaction: 
 
Reagent Final concentration Volume 
Oligonucleotide 1 (10 pmol/μl) 50 nM 1 μl 
Oligonucleotide 1 (10 pmol/μl) 50 nM 1 μl 
10 x Annealing buffer 1 x 20 μl 
Sterile dH2O  178 μl 
 
Reaction was incubated at 95°C for 2 min on a heat block. The heat block was shut off 
allowing the reaction to slowly cool down to ~ 35°C. The samples were stored at 4˚C after 
the reaction. 
 
2.1.2.4 Restriction endonuclease digestion of DNA 
Digest reactions were performed using conditions recommended by the manufacturer for the 
specific enzymes. Enzymes and buffer systems were obtained from New England Biolab 
(NEB).  
 
2.1.2.5 Making chemical competent cells 
XL-1 Blue chemical competent cells were prepared as described in the following. 1 l of LB 
medium containing Tet and 15 mM MgCl2 was inoculated with 1 ml of an ON culture of XL-
1 Blue and the culture was incubated at 37˚C with shaking (250 rpm) until cell density 
reached OD600 = 0.3-0.6. Cells were centrifuged at 4000 rpm at 4˚C for 30 min and the cell 
pellet was resuspended in 300 ml of Solution A. The cell suspension was incubated on ice for 
20 min, pelleted by centrifugation and resuspended in 60 ml of Solution A containing 15 % 
glycerol. The resulting chemical competent cells were aliquoted, frozen in a dry ice/ethanol 
bath and stored at -80°C. 
 
2.1.2.6 Ligation and Transformation 
Ligation reactions were performed in 20 μl using the following conditions: 
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Reagent Final concentration Volume 
Purified Bkb DNA Variable 1 μl 
Purified Fragment DNA variable 8 μl 
2 x Quick ligation buffer 1 x 10 μl 
T4 DNA Ligase (NEB) 400/reaction 1 μl 
 
The ligation reaction was incubated at room temperature (RT) for 5 min and stored at 4˚C 
after the reaction for further transformation procedure. Ligations were transformed into 
chemically competent XL-1 Blue E. coli cells essentially as described (Sambrook and 
Russell, 2001). 
 
2.1.2.7 Plasmid purifications 
Plasmid DNA from ON cultures grown from single colonies was purified using the Qiagen 
Miniprep kit according to the manufacturer’s protocol using 50 μl of 0.1 x EB buffer for 
elution. The DNA was verified by restriction analysis and sequencing (by sending them to the 
Massachusetts General Hospital (MGH) sequencing core facility). To obtain larger amounts 
of plasmid DNA, sequence verified plasmids were re-transformed to perform Midi- or Maxi-
preps using the QIAgen Midi or Maxi kit, respectively.  
 
2.1.2.8 DNA precipitation 
Ethanol (EtOH) precipitation was used to concentrate DNA as described in Sambrook and 
Russell (2001).  
 
2.1.2.9 Purification of DNA fragments and digests 
To clean up PCR intermediate products and restriction digests of PCR fragments, a standard 
QIAgen PCR purification kit was used according to the manufacturer’s protocol using 20-50 
μl of 0.1 x EB buffer for elution. 
 
2.1.2.10 Gelisolation of Plasmid/Fragment DNA and PCR Fragments 
Plasmid digests and final PCR reactions were separated using Gel electrophoresis. We 
generally used agarose gel electrophoresis for fragments from > 1kb and polyacrylamide gel 
electrophoresis (PAGE) for smaller fragments (20 bp to 800 bp). Agarose gels were run in 1 
x TAE buffer (Sambrook and Russell, 2001) at 100 V and separated fragments were extracted 
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and purified using the QIAgen Gel extraction kit according to the manufacturer’s protocol. 
PAGE was performed in 0.5 x TBE buffer (Sambrook and Russell, 2001) at 200 V and the 
purification of extracted fragments from a PAGE gel was essentially done as detailed in 
Sambrook and Russell (2001). Briefly, DNA fragments were excised, crushed and extracted 
by eluting them in 700 μl of Elution buffer at 37˚C for 4 hr or ON. The samples were 
centrifuged twice and the supernatants were transferred to a new tube. An EtOH precipitation 
was performed and the resulting DNA pellets were resuspended in dH2O.  
 
2.1.2.11 SDS-Polyacrylamide Gel electrophoresis of proteins 
Analytical electrophoresis of proteins was carried out using 10–20% precast gels (Biorad) 
which were run in 1 x TGS (Biorad) buffer at 100 V. Staining of SDS-polyacrylamide gels 
was performed using either Coomassie staining or silver staining (for more sensitive 
detection) following standard protocols (Sambrook and Russell, 2001).  
 
2.1.2.12 Western blot analysis 
To transfer proteins from SDS-polyacrylamide gels to a membrane, a Trans-Blot SD semi-
dry transfer cell (Biorad) was used according to the manufacturer’s instructions. Proteins 
were transferred at a constant voltage of 25 V for 1 hr in transfer buffer and the membrane 
was subsequently rinsed in TBST buffer. To block nonspecific binding sites, the membrane 
was submerged in 5 % milk (dissolved in TBST) and incubated at 4˚C ON. Following the 
blocking, the membrane was rinsed 3 x in TBST buffer and subsequently incubated with the 
primary antibody diluted in TBST/5 % milk for 1-2 hr at RT with slow shaking. Upon 
completion of the incubation, the membrane was rinsed 3 x with TBST and washed 3 x for 10 
min at RT with shaking. Secondary antibodies were linked to the enzyme Horseradish 
Peroxidase (HRP) for subsequent detection. This antibody was added in TBST/5 % and the 
membrane was incubated for 1-2 hr at RT with slow shaking. Washing was performed as 
before and ECL Plus kit (Amersham) was used for visualization according to the 
manufacturer’s protocol.  
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2.2 Genetic techniques  
 
2.2.1 Materials 
 
2.2.1.1 Buffers and solutions  
• Z buffer: 16.1 g of Na2HPO4·7H2O, 5.5 g of NaH2PO4·H2O, 0.75 g of KCl; 0.246 g of 
MgSO4·7H2O. Distilled water was added to 1 liter. 2.7 μl β-mercaptoethanol was 
added per 1 ml prior to use.  
• 5 x PEG/NaCl solution: 17.5 % PEG 8000, 12.5 % NaCl 
• Amino acid mixture: Amino acid mixture containing 17 different amino acids (Phe 
0.99 %, Lys 1.1 %, Arg 2.5 %, Gly 0.2 %, Val 0.7 %, Ala 0.84 %, Trp 0.41 %, Thr 
0.71 %, Ser 8.4 %, Pro 4.6 %, Asn 0.96 %, Asp 1.04 %, Gln 14.6 %, Glu 18.7 %, Tyr 
0.36 %, Ile 0.79 % and Leu 0.79 %) was prepared as described in Giesecke and Joung 
(2005).  
 
2.2.1.2 Media 
LB agar plates and liquid LB medium, liquid 2 x YT medium and SOC medium were 
prepared as described in Sambrook and Russell (2001).  
 
Liquid NM medium: for 500 ml:  
  dH2O      418 ml 
  10x M9 salts (Miller recipe)     50 ml 
  20% glucose       10 ml 
  20 mM adenine HCl        5 ml 
  Amino acid mixture (see above)    15 ml 
  1 M MgSO4      0.5 ml 
  10 mg/ml thiamine     0.5 ml 
  10 mM ZnSO4      0.5 ml 
  100 mM CaCl2 (was added last)   0.5 ml 
  Medium was filter-sterilized through a 0.2-μm filter. 
 
Plates: 
LB/T/C plates  LB plates with Tet and Carb 
 LB/C/K plates  LB plates with Carb and Kan 
 LB/C/K70 plates LB plates with Carb and Kan (70 μg/ml) 
 LB/T/K plates  LB plates with Tet and Kan 
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 LB/T/K/S plates LB plates with Tet, Kan and 5% sucrose 
 LB/CA/K plates LB plates with Cam and Kan 
 LB/C/CA/K plates LB plates with Carb, Cam and Kan 
 NM plates: 
For 500 ml of plates, 418 ml of dH2O with 7.5 g of Bacto-Agar was autoclaved in 
a flask containing a stir bar. Agar was cooled to 65–70oC and the basic NM 
components (as for the liquid NM medium) were premixed and added to the agar.  
 
NM/C/CA/K plates NM plates with Carb, Cam and Kan 
Selection plates NM/C/C/K plates with isopropyl-beta-D-thiogalactopyranoside 
(IPTG, 50 μM), 3-Aminotriazole (3-AT, 25 mM) and 
streptomycin (40 μg/ml). 
 2 x YT/T plates 2 x YT plates with Tet 
 
2.2.1.3 Bacterial strains 
• CSH100: [F’lacproA +, B+ (lacIq lacPL8) / araD (gpt-lac)5].  
• E. coli KJ1C: ΔhisB463, Δ(gpt-proAB-arg-lac)XIII, zaj::Tn10 [F’ Tetr] (Joung et al., 
2000). 
 
2.2.2 Methods 
 
2.2.2.1 Construction of bacterial two-hybrid reporter strains 
 
Overview: 
To construct reporter strains, the promoter region containing the DNA binding site (DBS) for 
a DNA binding protein of interest is introduced onto a plasmid termed pSB: For constructing 
lacZ reporter strains, the DBS was assembled on the pSB-lacZ plasmid which harbors the 
lacZ gene to assess reporter activity by performing β-galactosidase assays (see section 
2.2.2.2). For constructing his3/aadA selection strains, the DBS was introduced into the pSB-
his3/aadA plasmid which also harbors the bacterial aadA gene and the his3 gene (Joung et 
al., 2000; Hurt et al., 2003). While the aadA gene confers resistance to streptomycin, the his3 
gene permits histidine biosynthesis. Co-cistronically expression of these genes allows E. coli 
cells to grow on selective medium containing streptomycin but lacking histidine (see section 
2.2.2.16).  
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After introducing the DBS onto the respective pSB plasmid, it is subsequently moved onto a 
F’ episome using homologous recombination. In a final step, the F’ episome is transferred 
into a “clean” background strain that represents the desired reporter strain (Whipple, 1998).  
The pSB plasmid is a derivate of the pFW11 plasmid which contains the 3’ end of the lacIq 
gene and the 5’ end of the lacZ gene (Whipple, 1998). The region between the lacIq and lacZ 
fragments harbors a Kan resistance gene and an EcoRI-SalI segment. This segment also bears 
the -35 and -10 hexamers of the promoter that controls lacZ and a pair of SapI restriction 
sites. In addition, plasmid pSB carries the sacB gene outside the lacIq–lacZ region which 
leads to sucrose sensitivity upon expression in E. coli. When pSB is transformed into 
CSH100 cells which contain an F’ episome bearing the complete lac operon (including the 
lacIq and lacZ genes), the region between the lacIq and lacZ fragments can recombine onto 
the F’ episome via double homologous recombination using the lacIq and lacZ homology 
regions. Because single recombination events will also occur on the episome, one has to 
select for the double recombination events. Doubly F’ recombinants can be distinguished 
from singly and non-recombinants because they will lose the sacB marker gene upon 
completion of the double recombination (in contrast to singly recombinants) but will obtain 
Kan resistance (in contrast to non-recombinants). Thus, in a final step the F’ episome is 
moved into the Tet resistant recipient strain KJ1C (Joung et al., 2000) via conjugation and the 
cells are plated on medium that contains Tet, Kan and sucrose. Only cells that have received 
the F’ episome containing the double recombination product will be able to form colonies on 
these plates (Whipple, 1998; Joung et al., 2000).  
 
Crosses: 
Crosses for reporter strain construction were essentially done as described in Whipple (1998) 
with a few differences. The pSB stuffer plasmids were transformed into CSH100 strains and 
plated on LB-agar plates containing Kan as the selective drug. The plates were incubated at 
37°C for 12–18 hr. For each reporter strain, starter cultures of the plasmid-containing 
CSH100 strain were inoculated. To do this, the bacteria lawn was scraped off the plates with 
a sterile wooden stick, transferred to 10 ml LB medium and resuspended by vortexing. 0.2 ml 
of the resulting cultures was then used to inoculate tubes containing 10 ml LB0 medium. An 
additional tube with 10 ml LB0 medium was inoculated with 0.2 ml of a KJ1C ON culture. 
The CSH100 cultures, the KJ1C culture and a tube with only 10 ml LB0 medium as a control 
were incubated at 37°C for 2 hr without agitation.  
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After the 2 hr incubation, crosses and cross controls were set up as followed: 
• reporter containing CSH100 + KJ1C (actual crossing) 
• reporter containing CSH100 + LB0 medium (negative control) 
• KJ1C + LB0 medium (negative control) 
• LB0 medium + LB0 medium (negative control) 
To do this, 1 ml of each component was gently mixed together and incubated at 37°C for 1 hr 
without agitation. The mixtures were then placed on the wheel for 1.5 hr at 37°C. Upon 
completion of the 1.5 hr incubation, 0.3 ml of each actual cross was plated on LB/T/K plates 
as well as on LB/T/K/S plates. In addition, 20 μl of the various crossing controls were spotted 
on both type of plates. The plates were incubated at 37°C for 12–18 hr. After the ON 
incubation, there should be a >10-fold reduction in the number of colonies on the LB/T/K/S 
plates compared to the LB/T/K plates and the controls should be clean. If these two 
conditions were met, 2 candidates (A and B) for each reporter were picked from the 
LB/T/K/S plates and re-streaked twice on LB/T/K/S plates. Two individual tests were 
performed to check if the complete F’ episome of strain CSH100 was transferred to KJ1C: 
(1) The original KJ1C strain harbors a deletion of genes involved in proline and arginine 
biosynthesis. Upon complete conjugation, KJ1C strains should obtain intact copies of these 
genes from the episome of the CSH100 strain and therefore be able to grow on plates without 
proline and arginine. Thus, colonies from the second re-streak were patched on plates lacking 
these amino acids to test whether they were able to grow on these plates. (2) ON cultures 
were inoculated with the same colonies and were then used as templates to perform PCR with 
specific primers that bind to the lacZ gene to test, if the complete lacZ gene was moved to the 
KJ1C strain. At the same time, glycerol stocks were made from the remaining ON cultures. If 
both test turned out positive, the reporter strains were made chemically competent.  
 
2.2.2.2 β-galactosidase reporter assays 
Double transformations into bacterial two-hybrid reporter strains and β-galactosidase assays 
were performed as previously described (Thibodeau et al., 2004; Giesecke and Joung, 2005). 
Briefly, LB supplemented with Carb, Cam, Kan, 10 μM ZnSO4, and 50 μM IPTG was 
inoculated with ON cultures grown from single colonies that harbored two plasmids. 
Logarithmic phase bacterial cultures were lysed using a commercially available lysis reagent 
(BugBuster, Novagen). The resulting extracts were assayed for β-galactosidase activity by 
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assessing the ability of this enzyme to cleave Ortho-Nitrophenyl-βD-galactopyranoside 
(ONPG) which results in a detectable color change. To do this, kinetic assays were performed 
in a 680 Microplate reader (Biorad) by measuring the absorbance at 415 nm (relative to a 
blank) for ~ 30 min.  
β-galactosidase reporter assays for the Bacterial one-hybrid system were essentially 
performed as described above with a few differences. Plasmids encoding the various peptides 
were introduced by single transformation into reporter strain FW123. 20 μl of cell lysates 
from logarithmic phase cultures grown in LB containing Kan, Cam and IPTG at various 
concentrations were mixed with 1 x chlorophenolred-ß-D-galactopyranoside (CPRG, 
Stratagene) and kinetic assays were performed in a 680 Microplate reader by measuring the 
absorbance at 570 nm (relative to a blank) for ~ 30 min at 37˚C.  
 
2.2.2.3 Western Blot analysis of β-galactosidase cultures 
For Western blot analysis of the expression level of peptides expressed to perform β-
galactosidase assays, whole cell lysates from 0.5 ml cultures used for β-galactosidase assays 
were obtained by pelleting the cells and resuspending the pellets in 60 μl of 2 x SDS sample 
buffer (Biorad). The amount of total protein loaded was normalized by the OD595 and were 
resolved on a SDS-polyacrylamide gel. Western blot analysis was performed using the anti-
FLAG M2 monoclonal antibody (Sigma) as described in section 2.1.2.12.  
 
2.2.2.4 Making electroporation competent cells 
To prepare electroporation competent cells, a XL-1 Blue ON culture grown from a fresh 
single colony was used to inoculate 6 l of 2 x YT medium supplemented with Tet. The 
cultures were incubated at 18˚C with shaking (250 rpm) for ~ 2 days until cell density 
reached OD600 = 0.3-0.6. The cultures were centrifuged at 4000 rpm at 4˚C for 30 min using 
six pre-chilled centrifuge bottles. Each cell pellet was resuspended in 225 ml of cold miliQ 
water and washed twice using the same conditions. After the second wash step each cell 
pellet was resuspended in 225 ml of 10 % pre-chilled glycerol. The cells were centrifuged at 
6000 rpm at 4˚C for 20 min, resuspended in a total volume of 50 ml of 10 % pre-chilled 
glycerol, centrifuged again and resuspended in 10 % glycerol using a final volume of 6 ml. 
The resulting electroporation competent cells were aliquoted, frozen in a dry ice/ethanol bath 
and stored at -80°C.  
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2.2.2.5 Growing M13K07 helper Phage 
2 μl of M13K07 (NEB) helper phage was streaked out on 2 x YT/Tet plates and covered with 
~ 3.5 ml of Top agar containing ~ 0.2 ml of a XL-1 Blue ON culture. Following an ON 
incubation at 37°C, a piece of agar containing dozens of phage plaques was scooped of the 
plate and used to inoculate 1 l of 2 x YT medium supplemented with Tet. After 2 hr 
incubation at 37˚C with shaking, Kan was added to the cells to a final concentration of 70 
μg/ml and the culture was grown at 37°C for 24 hr. To harvest the phage, cells were pelleted 
by centrifugation and the supernatant containing the phage was filtered through a 0.2-μm PES 
filter.  
To further concentrate the helper phage, PEG precipitation was used. 4 volumes of phage 
were added to 1 volume of 5 x PEG/NaCl solution and the samples were incubated on ice for 
~ 16 hr. The phage was centrifuged at 10000 rpm at 4˚C for 45 min and the phage pellet was 
resuspended in a small volume of 2 x YT containing 15 % glycerol. The titer of the phage 
was determined as described (Giesecke and Joung, 2005).  
 
2.2.2.6 Overview library construction 
To construct libraries of shuffled dimerization zinc finger (ZF) domains (see section 3.3), 
subdomains encoding individual N-terminal and C-terminal ZF fragments were initially 
generated using standard PCR where the internal primers were phosphorylated at their 5’ 
(Figure 2.2). These fragments were then reassembled by performing directional blunt end 
ligation via the phosphorylated internal primers. PCR was used to amplify products of the 
blunt end ligations. Shuffled DZFs were then ligated into the pACYC-α and pBR-UV5-
Zif268 plasmids to express them as fusions to the E. coli RNAP α-subunit and the Zif268 
DNA-binding domain (DBD), respectively (Figure 2.2). Ligations into the pACYC-α 
plasmids were performed after digesting both plasmid and the shuffled fragments with 
BamHI and XhoI. To clone the fragments as fusions to the Zif268 DBD, a Zif268 Bbs I 
“stuffer” plasmid was constructed and treated with the Pfu enzyme in order to create a 
cloning site. Shuffled fragments were processed in a similar manner to generate a 
complementary overhang for the plasmid cloning site. These fragments were then ligated into 
the Zif268 Bbs I “stuffer” plasmid.  
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2.2.2.7 Primer phosphorylation and PCR 
To perform blunt end ligations, the internal primer used to amplify individual ZFs from 
various DZF domains were phosphorylated at their 5’ end using the following conditions for 
a 50 μl reaction: 
 
Reagent Final concentration Volume 
Primer (50 pmol/μl) 6 μM 6 μl 
10 x T4 Polynucleotide Kinase Reaction 
buffer (NEB) 1 x 5 μl 
10 mM dATP 1mM 5 μl 
T4 Polynucleotide Kinase (PNK) (NEB) 10 Units/reaction 1 μl 
Sterile dH2O  33 μl 
 
The reaction was incubated at 37°C for 30 min. The PNK was inactivated by heating the 
reaction at 65°C for 20 min. The various phosphorylated primers were then used to amplify 
the individual N-terminal and the C-terminal ZF fragments using standard PCR. The resulting 
products were purified using a standard QIAgen PCR purification kit as described in section 
2.1.2.9 by eluting the DNA with 50 μl of 0.1 x EB buffer.  
 
Figure 2.2 Schematic 
overview of library 
construction. Light and 
dark colored boxes 
represent N-terminal and 
C-terminal zinc finger, 
respectively. Different 
colors (orange and blue) 
depict domains derived 
from different proteins. 
Grey circles labeled with 
“P” represent phosphate 
groups at the 5’ end of 
the oligonucleotides and 
PCR fragments. White 
circles depict plasmids. 
See text for details. 
P
P
P
P
P
P
P
P
P
P P
P
PCR PCR
Step 1: amplification of 
individual zinc finger fragments 
Step 2: directed blunt-end 
ligation
Step 3: amplification of blunt-
end ligated products 
pACYC-α pBR-Zif268
Step 4: cloning into the pACYC-
α and pBR-Zif268 plasmids
Chapter 2. Materials and methods. 
 42
2.2.2.8 Blunt end ligation and end PCR 
Equal volumes of N-terminal and C-terminal encoding PCR fragments were blunt end ligated 
using the following reaction conditions for a 30 μl reaction:  
 
Reagent Final concentration Volume 
Various PCR products Variable 2 μl of each PCR 
10 x T4 DNA Ligase reaction buffer 
with 10 mM dATP (NEB) 1 x 3 μl 
T4 DNA Ligase Kinase (NEB) 4000 Units/reaction 2 μl 
Sterile dH2O  Add up to 30 μl 
 
Reaction were incubated at RT (RT) for 2 hr and the resulting product were purified as 
described in section 2.1.2.9 by eluting the DNA with 50 μl of 0.1 x EB buffer. To amplify all 
products of the blunt end ligations, PCR was performed using specific external 
oligonucleotides. Aliquots of the resulting PCR products were resolved on a 5 % SDS PAGE 
gel and the corresponding bands were excised as a pool and gel-purified as described in 
section 2.1.2.10. The amount of gel-purified PCR products was quantified using a Beckman 
Coulter DU 640 Spectrophotometer by measuring absorbance at 260 nm.  
 
2.2.2.9 Preparing plasmids and fragments for the Zif268 library 
To clone each shuffled pool of ZFs into the pBR-UV5-Zif268 phagemid, a BbsI “stuffer” 
plasmid (see A1) containing two BbsI restriction sites was digested with Bbs I and purified as 
described in section 2.1.2.9. To clone the shuffled pool of ZFs into the Bbs I “stuffer” 
plasmid, we took advantage of the 3’- to 5’ exonuclease activity of the Pfu polymerase which 
can be used to remove nucleotides from the 3’ end of the DNA. In the presence of 
nucleotides, the polymerase activity will counter the exonuclease activity. However, if only 
one of the four nucleotides is present, the enzyme will continue degrading the DNA until it 
comes to a position where it can fill in the provided nucleotide, thereby producing a specific 
overhang. Thus, the exonuclease activity of the Pfu polymerase was used to create an 
overhang in the digested stuffer and a complementary second overhang in the fragment pool.  
The following reaction conditions were applied to Pfu treated plasmids and fragments in a 
volume of 80 μl.  
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Plasmid DNA: 
Reagent Final amount / concentration Volume 
Plasmid “stuffer” DNA 800 fmol (2 μg) variable 
10 x Pfu buffer (Stratagene) 1 x 8 μl 
10 mM dCTP 1 mM 8 μl 
Pfu DNA polymerase (Stratagene) 8 Units/reaction 3.2 μl 
Sterile dH2O  Add up to 80 μl 
 
Fragment DNA: 
Reagent Final amount / concentration Volume 
Pool of DNA fragments 800 fmol (0.1 μg) variable 
10 x Pfu buffer 1 x 8 μl 
10 mM dGTP 1 mM 8 μl 
Pfu DNA polymerase 8 Units/reaction 3.2 μl 
Sterile dH2O  Add up to 80 μl 
 
The reactions were incubated at 72°C for 15 min and then at 4°C for 2 min. The resulting 
products were purified using a standard QIAgen PCR purification kit as described in section 
2.1.2.9 and the DNA was eluted in 20 μl of sterile dH2O 
 
2.2.2.10 Ligations 
Ligations for all libraries (pACYC-α and pBR-UV5-Zif268 libraries) were performed using 
the following reaction conditions for a 20 μl reaction: 
 
Reagent Final amount / concentration Volume 
Plasmid DNA  0.2 μg variable 
DNA fragment pool 0.05 μg variable 
10 x T4 DNA ligase buffer 1 x 2 μl 
T4 DNA Ligase 4000 Units/reaction 2 μl 
Sterile dH2O  Add up to 20 μl 
 
The Ligation reactions were incubated at 16°C ON. Following the ON incubation, the 
ligations were ethanol precipitated as described in section 2.1.2.8 and resuspended in 7 μl of 
sterile dH2O. 
 
2.2.2.11 Electroporation 
Library ligations were used to electroporate various bacterial strains. The pBR-Zif268 
ligations were transformed into the XL-1 Blue strain which possess an F factor bearing a Tet 
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resistance gene. pACYC-alpha ligations were introduced into the RP45 reporter strain 
harboring the Zif268 binding site. To do this, 70 μl of cells were added to the ligations and 
pulsed at 1.75 kV for a few milliseconds using a Biorad Gene pulser II. The pulsed cells were 
immediately transferred to 1 ml of SOC and incubated at 37°C for 1 hr on a roller wheel.  
 
2.2.2.12 Amplification of the pBR-Zif268 library  
The amplification of the pBR-Zif268 library was performed as previously described with a 
few minor differences (Giesecke and Joung, 2005). Following the 1 hr recover step, a small 
aliquot of cells were serially diluted 10-1 to 10-6 in 2 x YT. 5 μl of each dilution was spotted 
three times on LB/T/C (to assess number of transformants) and LB/C/K (to assess helper 
phage contamination). The plates were incubated at 37°C for 16-18 hr and the resulting titer 
representing the pre-amplification library size was assessed on the next day.  
The reminder of the transformed cells was used to inoculate 9 ml 2 x YT supplemented with 
Carb (selects for presence of the library phagemids) and Tet (selects for the presence of the F 
factor). Following 2 hr growth at 37°C with shaking, a small aliquot of the cells was serially 
diluted, spotted and incubated as described above. The resulting titer of these plates 
representing the post-amplified library size was assessed on the next day. The remaining 
amplified cells were pelleted by centrifugation at 4°C, 4000 rpm for 30 min. The cell pellet 
was resuspended in 2 ml of 2 x YT containing 15 % glycerol, divided into 4 aliquots, frozen 
in an dry ice/ethanol bath and stored at -80°C.  
 
2.2.2.13 Conversion of the pBR-Zif268 library into infectious phage particles  
The conversion of the pBR-Zif268 library into phage was performed as previously described 
with minor differences (Giesecke and Joung, 2005). Briefly, 2 aliquots of the amplified cells 
were thawed and used to inoculate 10 ml 2 x YT supplemented with Carb and Tet. Following 
1.5 hr incubation at 37°C with slow (125 rpm) shaking, the cells were infected with M13KØ7 
helper phage at a multiplicity of infection (moi) of > 100:1 for 30 min at RT. The infected 
cells were then added to 90 ml 2 x YT containing Carb and Tet and incubated at 37°C with 
shaking. After 2 hr a small aliquot of the cells were serially diluted as described above and 
spotted on LB/T/C and LB/C/K70 plates. The plates were incubated at 37°C for 16-18 hr and 
the resulting titer which represented the infection efficiency was assessed on the next day. 
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Kan was added to the remaining culture to a final concentration of 70 μg/ml and the culture 
was grown at 37°C for 18 hr.  
On the next day, the cells were filtered through a 0.2-μm PES filter in order to harvest the 
phage library. The titer of the phage library was determined by calculating the Carb-
transduction units (CTUs). To do this, the phage was serially diluted 10-1 to 10-6 in 2 x YT. 
10 μl of each dilution was used to infect 50 μl of an ON culture of RP45 that harbored a 
plasmid conferring Cam resistance. After 25 min incubation time at RT, 190 μl of 2 x YT was 
added to the cells and the cultures were left for 2 hr at 37°C without shaking. 5 μl of each 
infection was spotted three times on LB/CA/K (to assess number of cells) and LB/C/C/K (to 
assess CTUs) and the plates were incubated at 37°C for 16-18 hr.  
 
2.2.2.14 Preparation of selection strain expressing the pACYC-alpha library 
As described in section 2.2.2.11 pACYC-alpha ligations were introduced into the RP45 
reporter strain using electroporation. Following the 1 hr recover step after Electroporation, a 
small aliquot of the cells was diluted by 1:10 in series to 10-6 in 2 x YT. 5 μl of each dilution 
was spotted three times on LB/CA/K (to assess number of transformants). The plates were 
incubated at 37°C for 16-18 hr and the resulting titer representing the library size was 
assessed on the next day. The remainder of the transformed cells (~ 800 μl) was aliquoted and 
stored as a frozen glycerol stock at -80°C. 
After determining the library size, ~ 103 cells were plated on LB/CA/K and the plates were 
incubated at 37°C for 16-18 hr. On the next day, the cells were harvested by adding 3 ml 
prewarmed NM medium and a dozen sterile glass beads to each plate. The plates were gently 
agitated and the resuspended cells were transferred into a sterile glass tube. The resulting 
selection strain (containing the pACYC-alpha library) was used to inoculate 20 ml of NM 
medium containing Cam, Kan and IPTG50 by diluting them by 1:1000–1:10000. The cells 
were incubated at 37°C with gently shaking (125 rpm) for 16-18 hr. The remaining cells were 
aliquoted and stored as a frozen glycerol stock at -80°C.  
 
2.2.2.15 Introduction of the pBR-Zif268 library into the selection strain 
1 ml of saturated ON cultures (consisting of ~ 1.4 x 109 cells; OD600 > 2.0; number of 
bacteria were calculated assuming that an OD600 value of 1.0 is equivalent to 7 x 108 cells) 
which harbored the pACYC-alpha-library were infected with ~1.25 x 108 CTU of phage 
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containing the phagemid pBR-Zif268 library. Following a 30 min incubation time at RT, the 
infected cells were added to 4 ml of prewarmed NM medium with Cam, Kan and IPTG50 and 
the cultures were incubated for 2 hr at 37°C with slow shaking (110 rpm).  
 
2.2.2.16 Performing the Selection 
Upon completion of the incubation, a small aliquot of the infected cells were serially diluted 
by 1:10 in series to 10-5 in prewarmed NM medium with Cam, Kan and IPTG50. 5 μl of each 
dilution was spotted three times on LB/CA/K (to assess total number of cells), LB/CA/C/K 
(to assess number of transformed cells) and NM/CA/C/K/I50 (to assess number of 
transformed cells capable of growing on His-deficient medium). The plates were incubated at 
37°C for 16-18 hr and the resulting titer was assessed on the next day. The remainder of the 
infected cells was plated on NM selection plates (see section 2.2.1.2) which were incubated at 
37°C for 24-48 hr.  
 
2.2.2.17 Plasmid linkage 
4–12 colonies from the selection plates were used to inoculate 4 ml LB supplemented with 
Cam, Carb and Kan and the cultures were grown ON at 37°C with shaking. Plasmid DNA 
was isolated using the QIAGEN miniprep kit by employing a vacuum manifold essentially as 
described. After applying the vacuum, the columns were washed 3 x with PB buffer and 3 x 
with PE buffer. To elute the DNA from the column, 60 μl of prewarmed (60°C) 0.1 x EB 
buffer was used. To separate the two plasmids, the isolated DNA was diluted by 1:10 and 
transformed into XL-1 Blue cells. Cells were plated on LB/T/C plates and on LB/CA plates 
which selects only for the plasmid harboring the respective antibiotic resistance gene. 5 μl of 
single colony ON cultures were spotted on LB/T/C plates and on LB/CA plates (to assure 
presence of only one plasmid type). Plasmid DNA was isolated from cultures as described in 
section 2.1.2.7 and the same pairs of plasmid originally isolated from the selection strain 
were re-introduced into the bacterial two-hybrid reporter strain to perform β-galactosidase 
assays as described in section 2.2.2.2.  
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2.3 Techniques used for protein analysis in mammalian cells 
 
2.3.1 Materials 
 
2.3.1.1 Buffers and solutions 
• 2 x HBS: 50 mM HEPES, 280 mM NaCl, 1.5 mM Na2HPO4·7H2O. Distilled water 
was added to 500 ml and pH of the solution was adjusted to 7.0.  
• Buffer A: 10 mM HEPES (pH 7.8) 1.5 mM MgCl2, 10 mM KCl, 20 uM ZnCl2, 1 mM 
DTT, 1 mM Benzamidine, 1 tablet of protease inhibitor (Roche) per 5 ml 
• Buffer B: 0.3 M HEPES (pH 7.9), 1.4 M KCl, 30 mM MgCl2 
• RIPA Buffer (McCarty et al., 2003): 50 mM Tris (pH 7.5), 150 mM NaCl, 1 % NP40, 
0.1 % SDS, 0.025 % Sodium Deoxycholate, 1 mM DTT  
 
2.3.1.2 Cells 
Flp-In TRex human embryonic kidney (HEK) 293 cells (Invitrogen). 
 
2.3.2 Methods  
 
2.3.2.1 Plating, transient transfection and induction of HEK 293 cells 
HEK 293 cells expressing the Tet repressor were grown in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10 % fetal bovine serum (FBS) in a 5 % CO2 incubator 
at 37°C. To perform transient transfections, cells were plated in 24-well plates at a density of 
150,000 cells per well 24 hours before transfection. Plasmids encoding fusion peptides (see 
section 3.5) were co-transfected into cells using Lipofectamine 2000 reagent (Invitrogen) 
according to the manufacturer’s protocol using 1 μl of Lipofectamine and 0.5 μg total 
plasmid DNA per well. The medium was removed and replaced with fresh medium 
containing the Tet derivate doxycycline (1 μg/μl) ~ 16 h after transfection to induce the 
expression of the fusion proteins. 24 h after induction the culture medium was harvested to 
quantify secreted VEGF-A levels.  
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2.3.2.2 VEGF-A assay 
The secreted VEGF-A protein levels in the culture medium were quantified using the human 
VEGF-A ELISA kit (R&D Systems). After harvesting the culture medium, the samples were 
centrifuged at 0.3 rpm for 10 min and the supernatant was used directly to perform VEGF-A 
ELISA assays according to the manufacturer’s protocol. A plate washer was used to carry out 
the washing steps and the absorbance was measured at 450 nm with a correction at 570 nm 
(relative to a blank) using a microplate reader (Bio-Rad Model 680). 
 
2.3.2.3 WST-1 proliferation assay 
VEGF-A values of the individual samples were normalized to the number of viable cells in 
the culture which were determined using the cell proliferation reagent WST-1 (Roche). After 
harvesting the culture medium, fresh medium containing ~ 5 % WST-1 reagent was directly 
added to the cells and the cultures were incubated in a 5 % CO2 incubator at 37°C for 45–60 
min. The medium was harvest and the absorbance at 450 nm with a correction at 655 nm 
(relative to a blank) was measured using a microplate reader (Bio-Rad Model 680). OD 
values were scaled by normalizing the OD for each individual sample to the average OD 
value calculated from all samples. These scaled OD values were used to normalize the 
VEGF-A values.  
 
2.3.2.4 Western blot analysis 
Plasmids encoding the SpI-DZF and p65-DZF fusion proteins (each harboring a N-terminal 
FLAG tag, see A1 and section 3.5) were co-transfected into HEK293 cells using 
Lipofectamine 2000, 0.25 μg of the SpI-DZF plasmid and either 0.25 μg or 0.06 μg of the 
p65-DZF fusion plasmid (0.19 μg of pcDNA5 plasmid DNA was used to keep the total DNA 
amount of DNA added constant at 0.5 μg). Inductions were performed as described in section 
2.3.2.1. 24 h after induction, the culture medium and the cells were harvested. Secreted 
VEGF-A levels in the culture medium were quantified using ELISA (R&D Systems).  
For Western blot analysis of the hybrid protein expression levels, whole cell lysates were 
obtained as follows. Phosphate buffered saline (PBS) buffer was used to wash the cells twice 
and detach them from the plates. The samples were centrifuged at 13000 rpm at 4˚C for 2 
min, the supernatant was removed and the cells were lysed using 2 x SDS sample buffer. The 
amount of peptide was normalized by the number of viable cells (determined using WST-1 
reagent as described above) and equal amounts of lysate were resolved on a SDS-
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polyacrylamide gel. Western blot analysis was performed using the anti-FLAG M2 
monoclonal antibody (Sigma). Anti-mouse IgG (Amersham Biosciences) served as a 
secondary antibody and ECL (Amersham Biosciences) was used for visualization. Band 
intensities were quantified using a Biorad Fluor-S MultiImager and Quantity One software.  
 
2.3.2.5 Co-immunoprecipitation assay 
Coimmunoprecipitation assays were performed essentially as previously described (Cupit et 
al., 2003; McCarty et al., 2003). Briefly, confluent HEK 293 cells were transfected with pairs 
of plasmid DNAs (see A1 and section 3.5) encoding the DZF domain either as a fusion to the 
Ikaros isoform I (Ik I) or to a FLAG epitope tag (10 μg total) using the calcium phosphate 
method (Ausubel, 1995). Cells were harvested ~ 40 hours after transfection by washing them 
off the plates with PBS and spinning them at 1000 rpm at 4˚C for 5 min. The cell pellets were 
resuspended in cold Buffer A and were homogenized using a Dounce tissue homogenizer 
(Fisher). The nuclei were pelleted by centrifuging the samples at 1000 rpm at 4˚C for 5 min. 
To clarify the cytoplasmic extract, cold Buffer B was added to the supernatant and the 
resulting samples were centrifuged at 13000 rpm at 4˚C for 10 min. To perform co-
immunoprecipitations, 10-30 μl of clarified cytoplasmic extracts were diluted in 200 μl of 
cold RIPA buffer, added to 15 μl of RIPA buffer-equilibrated Anti-FLAG M2 Affinity Gel 
(Sigma) and the resulting samples were incubated with over-head rotation for 1.5 h at 4°C. 
The beads were collected by centrifugation, washed three times with 1 ml of cold RIPA 
buffer, mixed with 30 μl 2 x SDS sample buffer, boiled, and centrifuged.  
The resulting supernatants (output) and 15 μl of the clarified cytoplasmic extract mixed with 
30 μl 2 x SDS sample buffer (input) were resolved by SDS-polyacrylamide gel 
electrophoresis. Western blot analysis was performed as described in section 2.1.2.12 using 
the Ikaros M-20 antibody (Santa Cruz Biotechnology) directed against the amino-terminal 53 
amino acids of Ikaros. Monoclonal anti-goat IgG (Sigma) was used as secondary antibody.  
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2.4 Protein overexpression and purification 
 
2.4.1 Materials 
 
2.4.1.1 Buffers and solutions 
• Lysis Buffer: 25 mM HEPES (pH 7.9), 100 mM NaCl, 1 mM EDTA, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 10 mM dithiothreitol (DTT), 1 mM 
Benzamidine 
• Wash buffer 1: 50 mM Tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5 % Triton X-
100, 1 mM Benzamidine, 20 mM DTT 
• Wash buffer 2: 0.5 M Urea (freshly de-ionized with amberlite mixed bed resin), 50 
mM HEPES or MES (pH X, X indicates that various pH were applied depending on 
the peptide, see Chapter 5, Table 5.1), 1 mM Benzamidine, 20 mM DTT 
• Solubilization buffer 1: 9 M Urea (freshly de-ionized), 50 mM HEPES or MES (pH 
X), 150 mM DTT 
• Solubilization buffer 2: 4 M Urea (freshly de-ionized), 50 mM HEPES or MES (pH 
X), 150 mM DTT 
• Buffer A for FPLC: 8 M Urea (freshly de-ionized), 50 mM HEPES or MES (pH X), 
10 mM DTT 
• Buffer B for FPLC: 8 M Urea (freshly de-ionized), 50 mM HEPES or MES (pH X), 
10 mM DTT, 1 M NaCl 
• Buffer A for HPLC: 99.9 % MilliQ H2O, 0.1 % TFA. Buffer was filtered through a 
0.2 μm Nylon filter prior to use.  
• Buffer B for HPLC: 90% acetonitrile (HPLC grade), 9.9% MilliQ H2O, 0.1% TFA. 
Buffer was filtered through a 0.2 μm Nylon filter prior to use.  
 
2.4.1.2 Plates 
LB/C/CA plates  LB plates with Carb and Cam 
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2.4.1.3 Bacterial strain 
BL21(DE3)pLysS.: E. coli B F– dcm ompT hsdS(rB– mB–) gal λ(DE3) [pLysS CamR] 
(Stratagene). 
 
2.4.2 Methods 
 
2.4.2.1 Protein induction and expression (described for 1 liter bacterial cell culture) 
Peptides to be purified were cloned into the pET3a expression plasmid (Novagen, see A1 and 
Chapter 5) and the resulting plasmids were transformed into the E. coli strain BL21 (DE3) 
pLysS. 50 ml LB supplemented with Carb was inoculated with a 2 ml BL21 starter culture 
grown from a single colony containing the pET3a plasmid and incubated with shaking at 250 
rpm and 37°C until an OD600 of ~ 0.5 was reached. The 50 ml culture was transferred to a 
flask containing 950 ml of LB/Carb and incubated with shaking at 250 rpm and 37°C until 
OD600 reached 0.6. Expression was induced by adding IPTG to a final concentration of 0.4 
mM and incubation was continued under the same conditions for 3 hr. The induced cells were 
harvested by centrifugation at 4000 rpm, 4°C for 30 minutes. The supernatant was decanted 
and the E. coli pellet was stored at -80°C. 200 μl samples of uninduced and induced cultures 
were collected, harvested by centrifugation at 8000 rpm for 1 min and the cell pellet was 
resuspended in a buffer containing cold 10 mM Tris (pH 8.0) and 2 x SDS sample buffer. The 
samples were boiled for 3-5 minutes and the resulting whole cell lysates were normalized for 
loading based on the OD600 at harvest and resolved by SDS-polyacrylamide gel 
electrophoresis. Coomassie Blue staining was used to visualize the over expressed peptides.  
 
2.4.2.2 Inclusion body isolation 
The cells were lysed using a freeze/thaw strategy as follows: The E. coli cell pellet consisting 
of induced cells was resuspended in Lysis buffer. To complete the lysis 0.3 % NP-40 and 0.5 
mg/ml of lysozyme were added and the resulting mixture was incubated on ice with 
occasional swirling for 30 minutes. 6 mM MgCl2, 1 mM CaCl2 and deoxyribonuclease I 
(DNase I, Worthington) at 2 U/ml were added and the solution was stirred at 4°C for 1 hour 
to digest the DNA. Inclusion bodies containing the overexpressed peptides were harvested by 
centrifugation at 8000 rpm in a Sorvall GSA rotor for 15 minutes at 4°C.  
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To remove contaminants absorbed onto the hydrophobic inclusion bodies, the pellet was 
washed twice using buffers that contained detergents and chaotropic agents. For pellet wash 
1, the inclusion body pellet was resuspended in Wash buffer 1. A DNase I digest was 
performed in 10 mM MgCl2, 1 mM CaCl2 and DNase I at 2 U/ml for 30 minutes at RT. The 
inclusion bodies were harvested by centrifugation at 11000 rpm in a GSA rotor for 15 
minutes at 4°C. Following centrifugation, the inclusion body pellet was resuspended in Wash 
buffer 2. To harvest the inclusion bodies, the solution was centrifuged at 11.500 rpm in a 
SA600 rotor for 15 minutes at 4°C.  
To solubilize the peptides, the inclusion body pellet was resuspended in Solubilization buffer 
1. Solubilization buffer 2 was added and the resulting solution was incubated at 75°C for 20 
min. The solubilized inclusion bodies were harvested by centrifugation at 16000 rpm in a 
GSA rotor for 15 minutes at 4°C and the supernatant containing the peptides was frozen in 
liquid nitrogen and stored at -80°C. 20 μl samples were collected at each step and added to 2 
x SDS sample buffer for SDS-polyacrylamide gel electrophoresis. 
 
2.4.2.3 Cation exchange chromatography 
 
Cation exchange column: 
Cation exchange chromatography was performed using a hand-packed SOURCE 15S column 
(Pharmacia). The SOURCE matrix is based on rigid polystyrene/divinyl benzene beads and 
the functional charged group is –CH2SO3- (methyl sulfonate). The maximum pressure for this 
column is 3.0 MPa and the flow rate limit is 6.0 ml/min. The Column Volume (CV) is 10.053 
ml and the typical loading range is 10–25 mg of peptide.  
 
Calculation of the pI value: 
To calculate the isoelectric point (pI) value of the peptides used for cation exchange 
chromatography, the http://workbench.sdsc.edu/ webpage was used. Here, the net charge of 
the peptide is determined according to the amino acids in the sequence.  
 
Instrument: 
The instrument used to perform the cation exchange chromatography was an AKTA fast 
protein liquid chromatography (FPLC) and the software for analyzing the run was Unicorn 
version 3.2 (Amersham Pharmacia Biotech).  
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Run profile: 
Before loading the sample, the column was equilibrated with 5 CV Buffer A, 10 CV Buffer B 
and 5 CV Buffer A at a flow rate of 6 ml/min. The solubilized peptide samples were thawed 
and loaded in Buffer A using a superloop at a flow rate of 6 ml/min. Usually, 10 ml for trial 
runs and 40 ml for preparative runs were loaded. The flow rate of the run and the pressure 
limit was set to 5.0 ml/min and 3.0 MPa, respectively. To differentially elute the bound 
peptides from the column, the ionic strength of the Buffer was changed by introducing an 
increasing gradient of Buffer B to the column. To do this, Buffer A and Buffer B were mixed 
together while changing the ratio linearly. 0 % Buffer B was used as starting conditions for 3 
CV to wash out unbound sample. When doing a trial run, a gradient of 0 % to 40 % Buffer B 
over a volume of 16 CV was used for the first elution segment. The target concentration of 
the second segment was 100 % Buffer B over a volume of 4 CV. When doing a preparative 
run, the target concentration of the first segment was 8 % Buffer B over a volume of 2 CV 
and a gradient of 8 to 20 % Buffer B over a volume of 8 CV was applied for the second 
elution segment. A third elution segment was used that aimed for 100 % B over a volume of 
6 CV. The run was monitored at a wavelength of 280 nm. Protein peaks were collected and 
immediately frozen on liquid nitrogen. Following the run, remaining bound substances were 
removed by washing the column with 100 % Buffer B for 1CV.  
 
2.4.2.4 Reverse Phase chromatography 
 
RP column: 
Reverse phase chromatography was performed on a Vydac C4 reverse-phased preparative 
column (Grace Vydac). The hydrophobic (reversed) phase is attached to the silica consisting 
of butyl aliphatic groups by polyfunctional chlorobutylsilanes which results in a cross-linking 
or polymerization of the hydrophobic phase. The typical flow rate for this column is 10–30 
ml/min and the maximum pressure is 1000 psi. The CV is 95 ml and the loading range is 5–
200 mg of peptide.  
 
Instrument: 
Reverse phase chromatography was performed on a Beckman High Performance Liquid 
Chromatography (HPLC) and the software for analyzing the run was Karat32, 7.0.  
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Sample preparation: 
Captured peptides from the FPLC run were thawed and acidified with a 10 % TFA solution to 
pH 2-3. 0-6 range pH paper strips were used to determine the pH of the peptide sample. 
Before applying it to the column, the sample was filtered through a 0.2 μm Nylon filter.  
 
Run profile: 
Prior to the run, the column was equilibrated at a flow rate of 5 ml/min with 50 ml of 100 % 
Buffer B and 100 ml of 100 % Buffer A until the monitored baseline was stable. The sample 
was applied manually to the column. For trial runs, 0 % Buffer B was run through the column 
for 10 min to wash out unbound sample. Conditions were then altered so that the bound 
peptides were eluted differentially using a Buffer B gradient. To do this, a 2 %/min gradient 
from 0 %-90 % Buffer B was chosen for the first elution segment. The target concentration of 
the second elution segment was 100 % B which was reached using a 1 %/min gradient. For a 
preparative run, the starting conditions were set on 0 % Buffer B for 15 min. A 2.8 %/min 
gradient from 0 %-50 % Buffer B was then applied, followed by a 1.6 %/min gradient from 
50 %-90 % B and a 5 %/min gradient from 90 %-100 % Buffer B. The run was monitored at 
a wavelength of 210 nm and eluting peaks were collected and immediately frozen on liquid 
nitrogen. After the run, the column was washed with at least 100 ml Buffer B.  
 
2.4.2.5 Storage of purified samples 
Captured peptide from the HPLC run was lyophilized for 2–3 days and the final dried product 
was stored in an anaerobic chamber (Coy Laboratory Products) where the oxygen content 
was kept below 1 part per million.  
 
2.4.2.6 Refolding 
To refold the purified peptide (in an anaerobic chamber), the dried sample was carefully 
dissolved in water. Trial run samples were dissolved in about 50–100 μl H2O and preparative 
run samples were dissolved in about 500 μl H2O. The concentration of the peptide sample 
was calculated using Beer’s law (A = ε c l) where ε corresponds to the extinction coefficient, 
c represents the concentration of the sample, l is the path length of the cuvette and A 
corresponds to the absorbance of the sample. To determine the absorbance of the sample, the 
OD210 and OD280 were assessed. The extinction factor for OD280 was calculated using the 
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http://workbench.sdsc.edu/ webpage. The extinction factor for OD210 is 2.2 x 10-2 ml x μl-1. 
The path length for the cuvette was 1 cm. To refold the peptide, 1.5 molar equivalents of 
CoCl2 or ZnCl2 were added to the purified peptides and the pH was adjusted by slowly 
adding refolding buffer in two steps. In general the final volume of a folding reaction was 
12.5 μl.  
 
 
2.5 Techniques used for protein analysis in Drosophila melanogaster 
 
2.5.1 Materials 
 
2.5.1.1 Buffers and solutions 
• Extraction buffer: 20 mM HEPES (pH 7.5), 100 mM KCl, 5 % glycerol, 0.05 % 
NP40, 1 mM DTT, 1 x complete protease inhibitor (Roche).  
• 10 x PBS: 2.83 g of NaH2PO4·H2O, 13.74 g of Na2HPO4·2H2O and 90.0 g of NaCl. 
Distilled water was added to 1 liter.  
• 0.2 % PBT: 100 ml 10 x PBS, 2 ml Triton X-100. Distilled water was added to 1 liter. 
 
2.5.1.2 8 % Tris-glycine SDS-Polyacrylamide Gel  
 
Reagent Amount for 40 ml 
H2O 18.5 ml 
30 % Acrylamide mix 10.7 ml 
1.5 M Tris (pH 8.8) 10.0 ml 
10 % SDS 0.4 ml 
10% APS 0.4 ml 
TEMED 0.024 ml 
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2.5.1.3 Fly stocks 
 
Stock Description Reference 
y w Harbors mutation in white and yellow gene.  Lindsley and Zimm, 1992 
Ki, Δ2-3 Stock harboring dominant markers and transposase gene. Lindsley and Zimm, 1992 
y w; Bl/CyO; 
+/+ 
Stock harboring dominant markers and balancer 
chromosome. Lindsley and Zimm, 1992 
y w; +/+; 
H/TM3 
Stock harboring dominant markers and balancer 
chromosome. Lindsley and Zimm, 1992 
gmr-gal4 Eye-specific driver line that drives expression in the eye in all cells behind the morphogenetic furrow.  Freeman, 1996 
engrailed-gal4 Neuroblast specific driver line. Tabata et al., 1995 
 
2.5.2 Methods  
 
2.5.2.1 Maintaining the flies 
Flies were raised on a sucrose/cornmeal/yeast medium supplemented with the mold inhibitor 
Tegosept. Cultures were maintained in 12 hr:12 hr light-dark cycles at 25°C and 70 % relative 
humidity. 
 
2.5.2.2 Generation of germline transformants 
Stable transgenic flies were essentially generated as previously described using 
microinjections (Rubin and Spradling, 1982). 0.5-1.0 μg of midi plasmid DNA was used to 
inject dechorionized embryos collected from a cross between y w and Δ2-3 flies. The 
locations of the P-element insertions were determined genetically by performing standard 
mapping crosses of transformed flies to strains containing dominantly marked second and 
third chromosomal balancer chromosomes (Greenspan, 1997).  
 
2.5.2.3 Preparation of fly head extracts and Western blot analysis 
For each crossing, 40 heads isolated from frozen flies were placed in Eppendorf tubes and 
homogenized in 1 volume of Extraction buffer using an electronic pestle. The homogenates 
were centrifuged at full speed for 10 min and the clarified supernatant was removed to a new 
tube. Head extracts were mixed with 2 x SDS loading buffer, boiled and resolved by 
electrophoresis on a 8 % polyacrylamid SDS gel. Following electrophoresis, gels were 
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blotted onto a nitrocellulose membrane for 1 hr at 0.5 A using a semi dry blotting apparatus 
(Enprotech). Blocking, antibody incubation and washing were done as described in section 
2.1.2.12 using either anti-c-myc (Roche) or anti-HA (Covance) as primary antibodies and 
anti-mouse IgG (Amersham Biosciences) as the secondary antibody.  
 
2.5.2.4 Immunohistochemistry 
ON egg collections at 29˚C were dechorionized and stained essentially as previously 
described (Nose et al., 1992; reviewed in Patel, 1994). Briefly, embryos were dechorionized 
using 7.5 % bleach and fixed in fixative for ~ 20 min. To remove the vitelline membran the 
embryos were vortexed and washed several times in 100 % methanol. Methanol was 
subsequently removed by rinsing the embryos 5 times and washing them 3 times for 15 min 
in 1 x PBT.  
The following primary antibodies were used to stain the embryos: guinea pig anti-Hunchback 
(1:1000, J. Urban), rat anti-Zfh-2 (1:200, J. Urban) and rabbit anti-Eve (1:5000, J. Urban). 
Primary antibody incubation was performed in 1 x PBT containing 0.03 % NaAzide ON at 
4˚C. After rinsing and washing the embryos several times in 1 x PBT, the secondary 
antibodies, anti-guinea pig Cy5, anti-rat Cy3 and anti-rabbit-FITC (Dianova) were applied at 
a 1:250 dilution in 1 x PBT for 1,5 hr. The embryos were rinsed and washed again several 
times in 1 x PBT. Flat preparations of embryos were mounted in Vectashield mounting 
medium (Vector Laboratories) and analyzed with a confocal laser scanning microscope (Leica 
TCS SPII). Scanning images were processed with Adobe Photoshop and show projections of 
multiple focal planes. 
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Chapter 3. Synthetic protein-protein interaction domains created 
by shuffling C2H2 ZFs. 
 
3.1 Introduction 
 
The ability to construct complex synthetic cellular networks provides a strategy for biological 
engineering. Such artificial systems have applications in basic science for understanding 
natural phenomena as well as in biotechnology or medicine. However, in order to built these 
synthetic systems one requires a large set of macromolecular components including DNA-
binding proteins and protein interaction domains. These “parts” have to be modular and must 
act independently without disturbing other cellular functions (reviewed in Sprinzak and 
Elowitz, 2005; Endy, 2005). Natural regulatory networks in living cells extensively use C2H2 
ZFs as such “parts” and the C2H2 ZF motif has emerged as the most abundant molecular 
recognition domain in the human genome (Pellegrino and Berg, 1991; Venter et al., 2001; 
Lander et al., 2001). While C2H2 ZFs are best known for their ability to bind to DNA, they 
can also interact with RNA and other proteins, demonstrating their versatility. Because of its 
prevalence and functional diversity this motif was hypothesized to be a well suited scaffold 
for constructing artificial DNA-binding domains (DBD) with desired specificities. The 
simple modular structure of DNA-binding C2H2 ZFs, which use individual fingers to bind to 
individual “subsites” in the DNA sequence, has proven to be advantageous and prompted 
researchers to design single C2H2 ZFs capable of binding to desired subsites. Synthetic 
C2H2 ZFs and/or naturally occurring C2H2 ZFs can then be “mixed and matched” to create 
DBDs that possess novel binding specificities. These artificial DBDs can be fused to 
regulatory or effector domains for a wide variety of applications in biological research, 
systems biology, synthetic biology, and gene therapy (Klug, 1999; reviewed in Falke and 
Juliano, 2003; reviewed in Jamieson et al., 2003, reviewed in Lee et al., 2003; Blancaford et 
al., 2004, reviewed in Jantz et al., 2004). Expanding the current strategies for designing 
desired interaction specificities using these domains is still the focus of on-going research.  
Although C2H2 ZFs can also interact with a variety of different protein partners, little is 
understood about the versatility of the C2H2 zinc finger domain for mediating protein-protein 
interactions and general strategies for designing novel interaction specificities have not been 
applied to construct artificial protein-protein interactions. To address these deficits, we 
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sought to investigate whether individual protein-interacting C2H2 ZFs units can be used to 
construct finger “arrays” with novel protein binding specificities by shuffling them in a 
manner similar to the DNA-binding C2H2 ZFs. For these studies, we chose to use C2H2 ZFs 
from the dimerisation zinc finger (DZF) domains of various proteins including members of 
the mammalian Ikaros family of transcription factors, the Drosophila melanogaster 
Hunchback protein, and the human TRPS1 protein. DZF domains are defined as two C2H2 
ZFs connected by a short linker (Figure 3.1) that are sufficient to mediate homo- and hetero-
typic interactions (see section 1.3.4 for details). Previously, a functional chimeric protein 
containing portions of the human Ikaros and Drosophila Hunchback DZFs has been 
described. This synthetic hybrid DZF can mediate homo-dimerization but does not interact 
with either the wild-type Ikaros or wild-type Hunchback DZF domain (McCarty et al., 2003; 
see section 1.3.4.3). The ability of this hybrid protein to homodimerize together with the 
observation that Ikaros and Hunchback do not interact with each other suggested a “parallel” 
interaction mode with the N-terminal finger of one DZF contacting the N-terminal finger of 
the other DZF. In addition, since this protein can not interact with the wild-type DZFs, this 
result suggested that shuffling of DZF-derived C2H2 ZF domains can yield synthetic DZFs 
exhibiting novel protein-binding specificities.  
This chapter describes the construction of synthetic DZF domains with novel protein-protein 
interaction specificities that were used to design artificial transcriptional activators which are 
functional in human cells. By linking these domains together to create synthetic arrays 
consisting of four fingers, we were also able to design extended protein-interaction surfaces. 
Analysis of these two and four finger arrays led to the proposal of an alternative anti-parallel 
interaction mode for DZF domains.  
 
 
3.2 Analysis of DZF domains using the bacterial two-hybrid system 
 
3.2.1 Sequence comparison of different DZF domains 
 
Amino acid alignments of the human Ikaros family members Ikaros, Helios, Aiolos, Eos and 
Pegasus (Figure 3.1) demonstrate a high degree of sequence identity in the DZF domain. 
Ikaros, Eos, Helios and Aiolos are almost identical throughout the DZF domain whereas 
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Pegasus exhibits regions with a few distinct amino acids. Including the DZF domain of 
human TRPS1 in the alignment shows that it exhibits a considerable sequence homology with 
the Ikaros family members. Interestingly, the C-terminal zinc finger organization found in the 
various Ikaros like proteins also exists within the Hunchback protein of Drosophila 
melanogaster. This suggests that Ikaros evolved from a more ancient family of transcription 
factors and that additional Hunchback related proteins may exist in other insects. To identify 
novel DZF domains we searched the genome database for potential DZF domains in proteins 
from different organism using either the Ikaros or Hunchback DZF domain as a template. We 
found several Ikaros-like DZF domains from various vertebrate species which have already 
been shown to be highly conserved (Cupit et al., 2003; Haire et al., 2000). In addition, we 
were able to pull out several novel potential DZF domains present in various Hunchback 
proteins of different invertebrate species. Figure 3.1 shows some of the amino acid sequences 
we found and demonstrates sequence homology with the Hunchback DZF domain from 
Drosophila.  
 
Thus, we were interested in testing if these novel domains also support dimerization. The 
DZF domains we chose for this analysis are human Ikaros, Eos, Helios, Aiolos, Pegasus, 
TRPS1 and Hunchback from Drosophila melanogaster (D.m.), Locusta migratoria (L.m.) 
(Patel et al., 2001), Helobdella triserialis (H.t.) (Savage and Shankland, 1996) and 
N-terminal finger Linker C-terminal finger
N C
β-sheets β-sheetsα-helix α-helix 
human Ikaros:  YKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEH 
human Helios:  FKCEHCRVLFLDHVMYTIHMGCHGYRDPLECNICGYRSQDRYEFSSHIVRGEH 
human Aiolos:  YRCDHCRVLFLDYVMFTIHMGCHGFRDPFECNMCGDRSHDRYEFSSHIARGEH 
human Eos:   FKCEHCRILFLDHVMFTIHMGCHGFRDPFECNICGYHSQDRYEFSSHIVRGEH 
human Pegasus:  HHCQHCDMYFADNILYTIHMGCHGYENPFQCNICGCKCKNKYDFACHFARG-H 
Hunchback (D.m.): YECKYCDIFFKDAVLYTIHMGYHSCDDVFKCNMCGEKCDGPVGLFVHMARNAH 
Hunchback (L.m.): FYCEHCEITFRDVVMYSLHKGYHGLKNPFTCNACGKETADRVEFFVHIARSPH 
Hunchback (H.t.): HICRHCEMAFADQMTHRLHMGYHGYFNPFQCNGCGEKCVDAFDFMLHLMSKAH 
Hunchback (C.e.): FTCDHCKIPFDTQQVLDSHMRFHTPGNPFMCSDCQYQAFNELSFALHMYQARH 
human TRPS1:   TKCVHCGIVFLDEVMYALHMSCHGDSGPFQCSICQHLCTDKYDFTTHIQRGLH  
 
Figure 3.1 Alignment of DZF domains from various transcription factors. The top of the Figure 
shows a schematic of a DZF domain represented as double ovals that are connected by a bar. The bottom 
of the Figure presents an amino acid sequence alignment of DZFs from proteins indicated to the left. 
Organisms from which these proteins derive are also indicated. D.m. = Drosophila melanogaster, L.m. = 
Locusta migratoria, H.t. = Helobdella triserialis and C.e. = Caenorhabditis elegans. Secondary 
structures as defined for DNA binding C2H2 ZFs are shown on top of the amino acid sequence. 
Conserved cysteines and histidines are highlighted in blue. Positions showing 80% or greater 
conservation among the ten DZF domains are highlighted in yellow. This Figure was taken from 
Giesecke et al., (2006). 
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Caenorhabditis elegans (C.e.) (Fay et al., 1999). Each domain possesses different amino acid 
sequences and we were therefore interested in determining which of these domains can 
mediate homo- and/or heterotypic interactions.  
 
3.2.2 The bacterial two-hybrid system 
 
In analogy to the Yeast two-hybrid (Y2H) system, a Bacterial two-hybrid (B2H) system was 
recently developed as a convenient method to identify and analyze protein-protein 
interactions (Dove et al., 1997; for comprehensive reviews see: Hu, et al., 2000; Ladant and 
Karimova, 2000; Joung, 2001; Hu, 2001; Dove and Hochschild, 2004). This system is based 
on transcriptional activation of a reporter gene mediated by a protein-protein (or protein-
DNA interaction).  
 
As shown in Figure 3.2, transcriptional activation can be achieved by recruiting the RNA 
polymerase (RNAP) to the promoter of a reporter gene(s) via the interaction between two 
proteins of interest. To accomplish this, two hybrid proteins are co-expressed in an E. coli 
cell: Protein X is linked to a DNA-binding domain (DBD), which binds to an engineered 
DNA-binding site (DBS) in the promoter region of the reporter gene and protein Y is 
connected to a subunit (e.g. the alpha subunit) of the RNAP. If protein X and Y interact, 
RNAP is recruited to the promoter, resulting in activation of the reporter gene(s).  
Figure 3.2 Schematic diagram of the 
B2H system. Proteins to be analyzed 
are represented by X and Y.  Protein X 
is fused to a DNA binding domain 
(DBD) that binds to its respective 
DNA binding site upstream of the test 
promoter. Protein Y is fused to the 
alpha-subunit of the RNA polymerase 
(RNAP). In the absence of an 
interaction between protein X and Y, 
the expression of the reporter genes 
(lacZ or his3/aadA) is low (upper 
panel). However, if Protein X and Y 
do interact, RNAP is recruited to the 
weak promoter which results in the 
activation of the reporter gene (lower 
panel). This Figure was taken and 
adapted from Giesecke and Joung, 
(2005).  
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The B2H system can be used as a reporter system for analyzing potential or known 
interactions at a molecular level by utilizing the lacZ gene (encoding β-galactosidase) as a 
reporter which can be easily quantified by performing β-galactosidase assays. Furthermore, 
the B2H system can also be used as a selection system for identifying interacting proteins 
from recombinant DNA libraries. Here, the reporter genes used are the yeast his3 and the 
bacterial aadA genes. By using E. coli cells that are auxotrophic for histidine one can select 
for expression of HIS3 by growing these cells in the absence of this amino acid. The aadA 
gene confers resistance to streptomycin and is expressed co-cistronically with his3. Thus, by 
growing the E. coli cells in the presence of streptomycin the stringency of the selection can 
be increased (Joung et al., 2000; reviewed in Joung, 2001; Hurt et al., 2003; Giesecke and 
Joung, 2005). The crucial advantage of this bacterial based system compared with the yeast 
two hybrid method is the capability to screen very large libraries (>109) of interaction 
candidates (Joung et al., 2000). Additional advantages address its usability due to the fast 
growth and high transformation efficiency obtained in bacteria and the lack of requirement 
for nuclear localization of the hybrid proteins involved (for reviews see e.g. Hu, et al., 2000; 
Ladant and Karimova, 2000; Joung, 2001; Hu, 2001).  
 
3.2.3 DZF interactions can be detected using the B2H system 
 
To initially test whether the B2H system can be applied for studying DZF domain 
interactions, plasmids encoding fusion proteins for the B2H system setup were constructed. 
To do this, the Ikaros DZF domain was fused to the Zif268 DNA binding domain and to the 
RNAP α-subunit were constructed (Figure 3.3A, experiments performed by R. Fang). To test 
for interaction, plasmids encoding these hybrid proteins were transformed into the B2H 
reporter strain and β-galactosidase assays were performed (as described in section 2.2.2.2). 
(Note that this reporter strain bears the Zif 268 binding site at position -65 relative to the 
promoter of the reporter gene. The transcription startpoint of the reporter gene is defined as 
position +1 and the DBS is therefore placed 65 nucleotides upstream of the startpoint, see 
also Appendix A3). It was found that transcription of the lacZ reporter gene is elevated in 
cells expressing both the IkDZF-Zif268 and the RNAP α-IkDZF hybrid proteins suggesting 
that the Ikaros DZF domain mediates interactions between these proteins (Figure 3.3B, R. 
Fang). In contrast, control experiments expressing either the Zif268-hybrid or the α-hybrid 
protein alone did not show increased activation of lacZ indicating that both hybrid DZF 
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proteins must be present to activate the expression of the lacZ reporter gene (data not shown). 
Two mutations, D18Q and R47P (note that mutations are abbreviated following the pattern: 
wild-type amino acid, residue position, mutant amino acid), have been shown to disrupt 
homodimerization of the Ikaros DZF domain (McCarty et al., 2003) and were subsequently 
introduced into the two fusion proteins. Both mutations decreased lacZ expression indicating 
that interaction between the Ikaros DZFs mediates activation of lacZ (Figure 3.3B, Rui Fang). 
These preliminary data demonstrated that DZF domain interactions can be studied in the B2H 
reporter system.  
 
 
3.2.4 Interaction specificity profiles of wild-type DZFs determined using the B2H system 
 
The interaction specificities of DZF domains were examined by testing all pairwise 
interactions of ten different wild-type DZF domains using the B2H system to determine 
which of these domains can mediate homo- and/or heterotypic interactions. We constructed 
plasmids encoding fusions of each of these ten DZFs to the Zif268 DBD and to the RNAP α 
subunit and transformed pairwise plasmid combinations into a B2H reporter strain. β-
galactosidase assays were performed to assess the potential interactions of all ten DZFs. The 
results of this assay confirmed all previously described DZF interactions identified by 
Figure 3.3 Analysis of dimerization mediated by 
the Ikaros DZF domain in the B2H system. (A) 
Adaptation of the B2H system to study DZF 
domain mediated interactions. The DBD of Zif268 
(three blue circles) was applied to tether DZF1 to 
the weak lacZ promoter containing a Zif268 DBS 
(three blue boxes). DZF2 is fused to the RNAP α-
subunit and interaction of the two DZF domains 
(indicated by green double ovals) will recruit the 
RNAP to the promoter and activate transcription of 
the reporter gene. Note that although two α-DZF 
fusions are present which could theoretically homo-
dimerize, the DZF1-DZF2 interaction is dominant 
and can therefore be detected. This Figure was 
kindly provided by K. Joung (B) Pairwise 
combinations of plasmids encoding the DZF 
domain from wild-type (wtIk) and mutant (D18Q, 
R47P) Ikaros fused to both the Zif268 and the 
RNAP α-subunit were transformed into the B2H 
reporter strain and lacZ expression was measured 
by performing β-galactosidase assays (work 
performed by R. Fang).  
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biochemical or genetic methods except the homo-dimerization mediated by Aiolos (Figure 
3.4A).  
 
The reason for this discrepancy is unknown but we suggest that it may be due to a stability 
problem of the Zif268-Aiolos hybrid protein since this protein generally displays lower 
activity when tested in combination with other α-hybrid proteins (e.g. Ikaros). However, this 
further validates the use of the B2H system as a rapid method to assay DZF domain 
interactions. In addition, this experiment discovered novel homo- and heterotypic interactions 
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Figure 3.4 Dimerization specificities of wild-type DZFs determined using the B2H system. (A) 
Pairwise combinations of plasmids encoding ten wild-type DZFs were transformed into the B2H reporter 
strain and β-galactosidase activity was assessed. Values represent mean-fold activation of three individual 
experiments. Standard errors of the means are also shown. Interactions resulting in a >2.5-fold activation 
of lacZ expression were defined as positive and are highlighted in bold red text. This cutoff was chosen 
because the highest fold-activation obtained for a known non-interacting DZF pair (Ikaros and TRPS1; 
McCarty et al., 2003) was 2.5. Ik = human Ikaros, He = human Helios, Ai = human Aiolos, Eo = human 
Eos, Pe = human Pegasus, Tr = human TRPS1, Hd = Drosophila melanogaster Hunchback, Hl = Locusta 
migratoria Hunchback, Hh = Helobdella triserialis Hunchback and Hc = Caenorhabditis elegans 
Hunchback. (B) A summary of interaction specificity profiles for the ten DZF domains is shown. Lines 
indicate significant interactions between two domains as determined in A. Black lines indicate interactions 
between DZF domains that have also been observed with other methods and green lines indicate novel 
interactions that have not been previously described. This Figure was taken and adapted from Giesecke et 
al., (2006). 
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among these DZF domains. Examples for new homotypic interactions are Hunchback L.m. 
and Hunchback H.t. which are both able to mediate homodimerization. Interestingly, this 
result shows that Pegasus can interact with both Ikaros and Hunchback D.m. while these two 
do not interact with each other (Figure 3.4, McCarty et al., 2003). Hunchback D.m. on the 
other hand can mediate interactions with both Pegasus and Hunchback L.m. which also do not 
interact with each other (Figure 3.4). Although these interactions mediated by domains from 
different species do not occur in nature, they constitute further evidence for the complex 
interaction specificities of DZF domain mediated dimerization. In addition, these preliminary 
results suggest that new interaction specificities might be identified using the B2H system.  
 
 
3.3 Identification of interacting synthetic DZFs using B2H selections  
 
Since the result of our interaction profile experiment clearly demonstrates that DZF domains 
are very diverse in their interaction specificities, we were interested in exploring whether 
shuffling C2H2 ZFs from different DZFs might generate synthetic DZFs with novel 
interaction specificities. This would suggest that protein-interacting ZFs, like their DNA-
binding counterparts, can function in a modular fashion. To do this, libraries consisting of 
combinations of shuffled C2H2 ZFs derived from various wild-type DZFs were constructed 
and interacting pairs of synthetic DZFs from these libraries were identified using a B2H 
selection system.  
 
3.3.1 Overview of selections 
 
3.3.1.1 Construction of “shuffled” C2H2 ZF libraries 
To create libraries of synthetic DZF domains we shuffled C2H2 ZFs derived from eight wild-
type DZFs characterized in the B2H system (note that DZF domains from Aiolos and Helios 
were not included in this experiment since they are almost 100 % homologous to the Ikaros 
DZF). Two different shuffling approaches were used to create two pools of variant DZF 
domains: in one approach the inter-finger linker remained associated with the N-terminal 
finger whereas in the other approach the linker remained associated with the C-terminal 
finger. To create these pools of variant shuffled DZF domains, DNA fragments encoding 
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both the N-terminal C2H2 ZF and the C-terminal C2H2 ZF of defined DZF domains were 
amplified by PCR. All subdomains were reassembled using blunt end ligation in which the 
reassembly of non chimeric subdomains (which would result in wild-type proteins) was 
precluded. Each of the two reassembled pools represents one library and was then separately 
cloned into two different expression vectors that express the DZFs as fusions to the Zif268 
DBD or the RNAP α-subunit. This strategy results in a “set” of four different plasmid 
libraries that can be subsequently applied to perform selections in the B2H system (Figure 
3.5).  
 
3.3.1.2 Bacterial two-hybrid selections 
Four separate selection experiments were performed in which all possible pairwise 
combinations of the four libraries were screened for potential interactions. To perform 
selections, libraries pairs (i.e. one Zif268 library and one RNAP library) were introduced into 
B2H selection strains harboring the selectable, co-cistronic his3 and aadA genes as reporters 
(Joung et al., 2000; Hurt et al., 2003). Cells expressing DZF-Zif268 and α-DZF hybrid 
proteins that interact with each other should activate transcription of the His3 and aadA 
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Figure 3.5 Schematic overview of 
shuffled DZF library construction 
and B2H selections to identify 
interacting synthetic DZFs. DZFs 
are represented as in Figure 3.1. Note 
that this approach results in a total set 
of four different plasmid libraries by 
combining two strategies for 
shuffling and reassembling the 
subdomains with the construction of 
two libraries (one Zif268 and one 
RNAP α-subunit library). See text for 
additional details. This Figure was 
taken from Giesecke et al., (2006). 
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genes, thereby permitting them to grow on selective media (Figure 3.5). Cells that were able 
to form colonies were picked from each selection plate and plasmids encoding the pairs of 
shuffled DZF domains were isolated. To verify that a survival phenotype is genuinely linked 
to the plasmid encoding the pair of selected DZF variants, the purified plasmids were 
transformed into a B2H reporter strain and β-galactosidase assays were performed 
(phenotype-, plasmid-linkage). Plasmid pairs that resulted in elevated level of β-galactosidase 
expression were then sequenced to determine the identities of N-terminal ZF, linker and C-
terminal ZF present in the interacting pairs. Additional fragment linkage analyses were 
performed to confirm that activation in the B2H system was linked to specific chimeric DZF 
fragments isolated from the library. To do this, fragments encoding the different DZF 
variants were re-cloned into the B2H plasmids and were re-tested for their ability to activate 
reporter gene expression by performing β-galactosidase assays.  
 
3.3.2 Individual selection experiments 
 
Three different “sets” of libraries (A, B, and C) were constructed by shuffling combinations 
of C2H2 ZFs derived from various subsets of different wild-type DZFs (Table 3.1). Three 
independent selections were then performed, each using one of the three library “sets” (A, B, 
and C). For each of these three selections, all possible pairwise combinations of the four 
libraries in a “set” were analyzed for potential interactions.  
 
3.3.2.1 Libraries 
For constructing library set A we decided to use six subdomains derived from the human 
Ikaros, human Eos, human Pegasus, Hunchback D.m., Hunchback L.m., and Hunchback H.t. 
DZFs. Various subdomains from DZFs which are all know to interact with each other (e.g. 
Ikaros and Eos) were used as internal positive controls to test if it is generally possible to 
create chimeric DZFs that can mediate interaction. The expectation was to re-isolate several 
shuffled combinations of these domains.  
Since the initial characterization of the ten DZF domains showed interesting specificity 
patterns for Pegasus, Hunchback D.m. and Hunchback L.m. (Hunchback D.m. can interact 
with both Pegasus and Hunchback L.m. while these two do not interact with each other) 
another library set B was constructed consisting of shuffled combinations of these three 
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DZFs. We were interested in testing if we could enrich for chimeric proteins containing these 
subdomains.  
To create chimeric DZF domains with additional novel interaction specificities, a third library 
that only contained DZF domains that do not interact with each other was designed. We 
reasoned that chimeric proteins consisting of these subdomains would be more likely to 
possess novel specificities. Therefore DZF domains from human Eos, human TRPS1, 
Hunchback D.m., Hunchback H.t. and Hunchback C.e. were applied to create shuffled library 
set C.  
 
3.3.2.2 Selections 
For library set A each pool of DNA fragments encoded 30 different shuffled DZF domains 
since reassembly of wild-type DZFs was precluded (6 x 6 = 36 - 6). Note that for each 
library, the number of transformants (103-104) exceeded the theoretical number of shuffled 
DZFs by ~100-fold. The potential number of possible pairwise combinations of shuffled 
DZFs for each selection experiment is 30 x 30 = 900. ~106 transformants were plated which 
outnumbered the theoretical number of potential combinations by at least 1000-fold (Table 
3.1). Interestingly, a large number (~1000) of surviving colonies were obtained for each 
selection experiment.  
 
 
Theoretical # of 
potential DZFs 
in each library 
Actual # of 
transformants 
for each 
library 
Theoretical # of  
combinations for 
each selection 
(library x library) 
Actual # of 
combinations 
tested for each 
selection 
(library x library) 
Set A:  
Ik, Eo, Pe, Hd, 
Hl, Hh 
30 103-104 900 ~ 106 
Set B:  
Pe, Hd, Hl 
 
6 104-105 36 ~ 5 x 106 
Set C:  
Eo, Tr, Hl, Hh, 
Hc 
20 103-104 400 ~ 106 
 
Table 3.1 Library sizes and B2H selection statistics. Data in columns 1 and 2 describe the theoretical and 
actual sizes of each library in “Sets” A, B, and C. Data in columns 3 and 4 describe the theoretical and actual 
number (#) of combinations tested in each selection performed for “sets” A, B, and C. Each “set” consists of 
four libraries (two Zif268 fusion libraries and two RNAP alpha-subunit fusion libraries, depicted in Figure 3.5) 
which are used to perform a corresponding “set” of four selections that tested all pairwise combinations of the 
four libraries. Abbreviations are as in Figure 3.4. See text for details.  
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In library set B each pool of DNA fragments encoded six shuffled DZF domains precluding 
the reformation of the wild-type DZFs (3 x 3 = 9 – 3). The number of transformants for each 
library was 104-105 which exceeded the theoretical number by ~1000-fold. We plated ~106 
transformants, outnumbering the potential number of combinations (36) by at least 10000-
fold (Table 3.1). A large number of colonies (~1000) survived the selections. 
For library set C each fragment pool contained 20 (5 x 5 = 25 – 5) shuffled DZFs, again 
precluding the reassembly of wild-type domains. The number of transformants (103-104) for 
these libraries outnumbered the theoretical number of shuffled DZFs by about 100-fold. ~106 
transformants were plated which exceeded the theoretical number of potential combinations 
(400) by at least 1000-fold (Table 3.1). Interestingly, less surviving colonies (~100) 
compared to the other selection sets were obtained suggesting that this selection yields only a 
couple of interacting DZF domains.  
 
3.3.2.3 Plasmid linkage  
For all three independent selection sets (A, B and C) 2 to 12 colonies were picked from each 
of the four selection plates. Plasmids encoding the interacting pairs of DZF variants were 
then isolated from these colonies.  
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Figure 3.6 Plasmid linkage analysis for selected interacting pairs. Plasmids isolated from colonies 
that survived the selection were transformed into the B2H reporter strain and β-galactosidase assays 
were performed. Each graph corresponds to one selection “set” (selection A, B and C) which consists of 
4 individual selection experiments (S1-S4, S5-S8, S9-S12). Note that each bar shown for an individual 
selection in a particular “set” corresponds to one colony picked from the respective selection plate.  
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For plasmid linkage analysis, each of these pairs of plasmids was transformed into the B2H 
reporter strain and β-galactosidase assays were performed. The result (Figure 3.6) of these 
assays demonstrated that for each selection experiment most (average of ~ 85 %) of the 
selected pairs were able to activate transcription in the B2H system. This confirms that the 
survival phenotype of the cells on the selection plates is linked to their ability to activate 
expression of the selection gene. The activation obtained for most of the selected pairs of 
DZF domains is similar to the activation for the wild-type DZFs. Interestingly, some of the 
novel DZF variants displayed higher β-galactosidase units than the wild-type proteins, 
implying that these novel pairs might interact more strongly than wild-type DZF domains 
(Figure 3.6 and data not shown).  
 
3.3.2.4 Sequencing 
Plasmid pairs that resulted in elevated level of β-galactosidase expression were sequenced to 
determine the identities of the individual C2H2 ZFs and linkers encoded. Sequencing 
revealed that the selection identified several novel heterodimeric pairs of interacting DZF 
domains which represent combinations of C2H2 ZFs from the parental DZFs used to 
construct the libraries (Table 3.2). Many of the interacting pairs contain C2H2 ZFs derived 
from wild-type DZFs which are known to interact with each other. For example, the majority 
of selected DZFs from library A are various shuffled combinations of the subdomains from 
Ikaros, Eos and Pegasus. It seemed likely that these shuffled DZFs would all interact with the 
parental DZF domains from which they are derived and would therefore not exhibit novel 
interaction specificities. Similarly, library B only harbored shuffled ZF combinations 
consisting of subdomains from either Pegasus and Hunchback D.m. or from Hunchback D.m. 
and Hunchback L.m.. We were not able to pull out chimeric proteins containing ZFs from 
Pegasus and Hunchback L.m. together in a single DZF domain. However, three of the 
identified pairs from Selection A consisted of DZF domains composed of subdomains from 
parental DZFs that do not interact with each other. Interestingly, selection C harbored only 
one pair of interacting DZF variants also composed of C2H2 ZF subdomains from wild-type 
DZFs which do not interact with each other (Table 3.2). These four pairs are likely to 
represent DZF domains with potentially novel specificities and were therefore chosen for 
additional analysis (see below). 
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3.3.2.5 Linkage analysis 
To further confirm that activation of reporter gene expression in the B2H system is linked to 
the presence of various shuffled DZF fragments that were isolated from the different 
selections, fragment analysis was performed. Thus, fragments encoding selected DZF 
variants were re-cloned into fresh B2H plasmids and were re-tested for their ability to 
activate reporter gene expression by performing β-galactosidase assays. It was found that all 
of the shuffled DZFs tested mediated interaction with their selected partner indicating that the 
activation phenotype in the B2H system is linked to the specific DZF domain (data not 
shown).  
 
 
Table 3.2 Interacting pairs of 
synthetic shuffled DZF domains 
identified by genetic selection. 
Identities of the subdomains 
present in the synthetic DZF 
domains are shown. Subdomains 
are defined as N-terminal ZF, 
linker, and the C-terminal ZF 
(shown from left to right). The 
Selection “set” (A, B and C) from 
which these pairs were identified 
as well as the number of times 
each pair was identified are also 
indicated. Abbreviations for the 
subdomains are as defined in the 
legend to Figure 3.4. Location of 
the synthetic DZF on the Zif268 
or RNAP a-subunit is shown on 
top of the table. Interacting pairs 
chosen for further characterization 
are marked in bold red text.  
Library Set A
Library Set B
Library Set C 3Eo-Eo-HdTr-Eo-Eo
6Hd-Hd-PePe-Pe-Hd
1Hd-Hd-HlPe-Hd-Hd
4Hd-Pe-PePe-Pe-Hd
2Hl-Hl-HdPe-Pe-Hd
2Hl-Hd-HdPe-Hd-Hd
1Hd-Hl-HlHd-Hl-Hl
2Hl-Hd-HdHl-Hd-Hd
1Pe-Pe-EoIk-Ik-Hd
2Eo-Eo-HdPe-Pe-Eo
1Pe-Pe-EoIk-Ik-Hd
1Hl-Eo-EoPe-Hd-Hd
4Hd-Hd-PePe-Pe-Hd
3Ik-Ik-EoPe-Eo-Eo
1Eo-Pe-PeIk-Eo-Eo
1Pe-Eo-EoIk-Eo-Eo
1Pe-Ik-IkIk-Ik-Eo
2Pe-Eo-EoIk-Ik-Eo
1Ik-Eo-EoIk-Ik-Eo
1Ik-Ik-EoIk-Ik-Eo
3Eo-Eo-IkIk-Ik-Eo
2Eo-Ik-IkIk-Ik-Eo
1Ik-Ik-EoIk-Eo-Eo
4Ik-Eo-EoIk-Eo-Eo
1Eo-Eo-IkIk-Eo-Eo
2Eo-Ik-IkIk-Eo-Eo
Zif268 hybrids RNAP α hybrids Frequency
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3.4 Analysis of synthetic DZF domains using the B2H system 
 
3.4.1 Interaction specificities of selected synthetic DZFs 
 
To further analyze the specificity of the synthetic DZF variants, we decided to focus on four 
interacting pairs we identified in which at least one of the DZF variants contains subdomains 
derived from wild-type DZFs that do not interact with each other (Table 3.2, highlighted in 
red; note that these four pairs comprise a total of 6 different DZF domains). The specificity 
profiles of the DZF domains in these four pairs were examined using the B2H system as a 
reporter.  
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Figure 3.7 Interaction specificities of synthetic DZFs analyzed in the B2H system. DZFs from four 
pairs (A, B, C and D, respectively) were tested for hetero- (blue bars) and homo-typic (green bars) 
interaction as well as their ability to interact with the parental wild-type DZFs from which they were 
derived (orange bars). Assays were performed using the B2H system. Control experiments expressing 
combinations of the synthetic DZFs with either the Zif268 or the α-subunit protein with no DZF fused 
(indicated as ‘----’) are also shown (purple bars). Bars shown represent mean fold-activations of 
transcription in the B2H system calculated from three independent experiments. Standard error of the mean 
is indicated by the error bars. Abbreviations for identities of the synthetic DZFs are defined in Figure 3.4. 
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We assayed the ability of each of the six DZF domains in the various pairs to mediate hetero- 
and homo-typic interactions and also assessed their interactions with the wild-type DZFs 
from which they derived. It was found that for all four heterodimeric pairs, one DZF domain 
in the pair is not able to interact with itself (homotypic interaction) nor does it interact with 
its parental wild-type DZFs, while the second domain does both interact with itself and with 
its parental DZFs (Figure 3.7). The latter DZF domain is the one consisting of subdomains 
from wild-type DZFs which are known to interact with each other. Closer inspection of the 
activity profile suggest that three of the four DZF pairs tested prefer to hetero-dimerize, 
although one DZF domain in each pair can still mediate homodimerization. The fourth pair 
contained one DZF domain (Pe-Hd-Hd) that mediates both homo- and hetero-typic 
interactions equally well while the other pair (Hl-Eo-Eo) mediated only heterotypic 
interaction. 
 
To further analyze the specificity of these six synthetic DZF domains, we tested for potential 
cross-interactions among them using the B2H system. The result of this experiment is 
summarized in Table 3.3 and indicates that all six DZF domains interact most strongly with 
the partners they were selected with, although some DZF domains also exhibit some cross-
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Table 3.3 Analysis of cross-interactions among the six synthetic DZFs in the B2H system. Pairs of 
plasmids encoding the six synthetic DZFs fused to either the Zif268 DBD or the RNAP α-subunit were co-
transformed into the B2H reporter strain harboring the lacZ gene and reporter gene expression was 
assessed by performing β-galactosidase assays. Each combination was tested in triplicates with averages 
and standard errors of the mean shown. Positive interactions (as defined in Figure 3.4) are marked in 
colored text. Bold red text indicates hetero-typic interactions between DZFs that were selected with each 
other and red text depicts homo-typic interactions between these DZFs. Blue bold text indicates cross-
reactivity between DZFs that were identified in different selection sets. Identities of subdomains in the 
synthetic DZFs are abbreviated as in Figure 3.4.
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reactivity and bind to at least one other synthetic DZF. Note that these DZFs were obtained 
from different selection sets and could not have been selected in these combinations.  
Control experiments expressing either the Zif-hybrid or the α-hybrid protein alone did not 
show increased β-galactosidase Units (Figure 3.7). Furthermore, the previously described 
D18Q mutation was introduced into both the synthetic and the wild-type DZFs. This mutation 
has been shown to disrupt homodimerization of the Ikaros and Hunchback DZF domain 
(McCarty et al., 2003). All DZF domains with the exception of wild-type Pegasus were 
affected by this mutation in their ability to mediate homo- and heterotypic interaction (data 
not shown). This indicates that both interacting DZFs have to be intact and present to activate 
the expression of the lacZ reporter gene.  
 
3.4.2 Anti-parallel interaction mode for synthetic DZFs 
 
Analysis of the identities and homo- and heterotypic interaction specificities of the synthetic 
DZFs suggests that these domains interact in an anti-parallel fashion (i.e. the N-terminal 
finger of one monomer interacts with the C-terminal finger in the other monomer and vice 
versa). As mentioned in Chapter 1 (section 1.3.4.3), previous studies suggested that DZFs 
dimerize in a parallel mode (i.e. the N-terminal C2H2 ZFs in each monomer interact with 
each other and C-terminal C2H2 ZFs in each monomer interact with each other) (McCarty et 
al., 2003). This conclusion was based on the observation that a synthetic Ikaros-Hunchback 
hybrid DZF could efficiently homo-dimerize and on the assumption that the individual C2H2 
ZFs in this synthetic hybrid display the same interaction specificities then the parental DZFs 
from which they were constructed (McCarty et al., 2003). This analysis was applied to the 
various DZFs identified in the selections. Six pairs of synthetic DZF domains are composed 
of subdomains that indicate a specific orientation: five pairs suggest an anti-parallel 
orientation while one pair is more consistent with a parallel interaction mode (Figure 3.8 and 
Table 3.2). The remaining pairs of chimeric DZFs contain subdomains that do not provide 
information in terms of an interaction mode since they can interact using either a parallel or 
an anti-parallel mode (Table 3.2). 
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However, additional confirmation of an anti-parallel interaction mode is provided by the 
specificity profiles of the four synthetic pairs. As mentioned above three of the four pairs 
prefer to interact in a heterotypic fashion and one DZF domain in each pair is not able to 
homodimerize at all which also rules out a strictly parallel interaction. For example, Ik-Ik-Hd 
and Pe-Pe-Eo can mediate robust heterodimerization but each individual DZF in this pair 
interacts less (Pe-Pe-Eo) or not at all (Ik-Ik-Hd) with itself.  
 
3.4.3 Prediction and design of interactions between DZF domains 
 
Since preliminary results demonstrated that shuffling of DZF-derived C2H2 ZFs can yield 
synthetic DZFs with new specificities we were also interested in creating new DZF domains 
by mixing certain ZFs of interest together. We decided to test whether the anti-parallel 
interaction mode could be used as a general rule for engineering DZF-mediated interactions. 
To do this, all combinations of C2H2 ZFs and linkers from the Ikaros and Drosophila 
Hunchback DZFs were systematically synthesized applying the same approach used to 
construct our libraries. Connecting these Ikaros-Hunchback chimeras to both the Zif268 as 
well as the α-subunit of the RNAP resulted in eight different fusion proteins that were tested 
for their ability to interact with each other using the B2H system as a reporter. It was found 
that none of them showed a significant interaction (data not shown). On the contrary, a 
functional chimeric protein containing portions of the human Ikaros and Drosophila 
Hunchback DZFs has been described recently (McCarty et al., 2003; see also section 1.3.4.3). 
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Figure 3.8 Schematic indicating how 
interaction specificities of synthetic 
DZF domains suggest an anti-parallel 
interaction mode. Wild-type DZF 
domains used to construct the synthetic 
DZFs and their interaction specificity are 
shown on top of the Figure. Interaction 
specificity of a pair of synthetic DZFs is 
shown on the bottom (left side). Occurring 
interaction suggests an antiparallel 
interaction mode for the interaction 
mediated by the two synthetic DZFs. 
Interactions are indicated by an arrow 
while red X’s indicate that no interaction 
was obtained. Note that in this 
presentation the linker region was 
assigned to a certain finger but can also 
occur in the opposite constellation. See 
text for details.  
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The reason for this discrepancy remains unknown but in the approach of McCarty and 
coworkers (2003) the breakpoint for separating the protein into two subdomains was defined 
differently. Thus, residues from the respective other subdomain were included into their 
chimera which were not included in our chimeric peptides. It is also important to note, that 
we tested this chimeric protein in the B2H system and found that it interacted only weakly as 
judged by our assay.  
One possible explanation for these findings is that DZF-derived C2H2 ZFs can not be 
considered as completely modular since not all combinations of fingers can produce 
functional interaction domains (see also section 3.8.1 below). This rules out that interactions 
between DZF domains can be consistently predicted and therefore deliberately designed and 
further emphasizes that methods such as selections currently provide the only way to obtain 
such synthetic interacting DZF pairs.  
 
 
3.5 Analysis of DZF domains in mammalian cells 
 
3.5.1 Synthetic DZF domains are functional in the nucleus of mammalian cells 
 
3.5.1.1 Assay for DZF interactions 
To further test whether interacting DZFs can mediate protein-protein interactions in the 
nucleus of a mammalian cell we developed an “activator reconstitution” assay using a 
previously described artificial transcriptional activator of the endogenous human VEGF-A 
gene. This activator protein consists of a synthetic DNA-binding domain that binds within a 
region of accessible chromatin in the human VEGF-A promoter (originally termed 
“VZ+434b”, hereafter termed DBD) (Liu et al., 2001) and a NF-κB p65 transcriptional 
activation domain (termed “p65”). We divided this synthetic activator in its two domains and 
fused individual DZFs to each of the two fragments. Dimerization mediated by the DZF 
domains should then reconstitute this bi-partite transcriptional activator and therefore lead to 
an activation of the endogenous VEGF-A gene (Figure 3.9A, Pollock et al., 2002). 
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To test whether expression of various DBD-DZF and p65-DZF fusion proteins could promote 
a dimerization dependent activation of VEGF-A, plasmids encoding these hybrid proteins 
were introduced into Flp-In TRex HEK293 cells using transient transfection. Transfected 
cells were induced after 24h by adding IPTG (see section 2.3.2.1), and the level of VEGF-A 
expression was measured by ELISA (Liu et al., 2001). 
 
3.5.1.2 Synthetic DZFs can mediate assembly of heterologous protein domains in 
mammalian cells 
Using the activator reconstitution assay, we initially assessed whether various wild-type DZF 
pairs could mediate reconstitution of this bi-partite transcriptional activator in the nucleus of 
a human cell. As shown in Figure 3.9B, all tested wild-type DZFs were able to mediate 
efficient activation of VEGF-A expression in this assay. In contrast, transfection of either 
hybrid protein alone did not activate VEGF-A expression indicating that activation depends 
on the presence of an interacting DZF domain on both hybrid proteins (data not shown). This 
suggests that the artificial bi-partite activator was reconstituted at the VEGF-A locus by the 
DZF domain interaction and could therefore mediate activation of the VEGF-A gene. 
Figure 3.9 DZFs can be used to assemble an 
artificial bi-partite transcriptional activator 
in human cells. (A) A Schematic overview of 
the mammalian cell-based “activator 
reconstitution” assay for testing DZF 
interactions is presented. The originally 
described artificial transcriptional activator of 
the endogenous human VEGF-A gene is shown 
on top (Liu et al., 2001). By splitting this zinc 
finger protein (ZFP) into its DBD and its 
transcriptional activation domain (p65) and 
attaching DZF domains to these fragments, this 
setup can be used to test if two DZF domains 
can mediate interaction. Interactions of DZFs 
(green and dark blue ovals) should mediate 
reconstitution of this synthetic activator protein 
which should result in an activation of VEGF-
A expression (bottom panel). (B) Interactions 
mediated by wild-type DZFs were assessed 
using the activator reconstitution assay. Fold-
activation of VEGF-A protein expression was 
calculated by measuring the VEGF-A contents 
in the culture medium using ELISA. Bars 
shown represent mean fold-activations of 
VEGF-A expression determined from three 
independent experiments and error bars 
indicate standard errors of the mean.
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We further tested whether the four chimeric DZF pairs we identified and characterized in the 
B2H system would also be able to mediate activation of VEGF-A. As shown in Figure 3.10, 
all four synthetic pairs could mediate activation of VEGF-A expression as measured by 
ELISA indicating that they were able to interact with each other. Control experiments 
expressing either the DBD-hybrid or the p65-hybrid protein alone did not show increased 
activation of VEGF-A expression demonstrating that both interacting DZFs have to be 
present to reconstitute the synthetic activator (Figure 3.10). In addition, we confirmed that the 
D18Q mutation which disrupted DZF mediated dimerization in the B2H system also affected 
dimerization of the various DZFs in the mammalian “reconstitution assay” (data not shown).  
Next, the ability of the six individual DZFs to mediate homodimerization was examined and 
these results show that all DZF domains failed to interact with themselves and were only able 
to mediate heterotypic interactions (Figure 3.10). This result is different from previous 
experiments performed using the B2H reporter system where at least one of the DZFs in each 
pair could still mediate self interaction. It is unclear why the mammalian “activator 
reconstitution” assay does not detect self-interaction of the DZFs but one explanation could 
be that homodimeric interactions (as in the case for wild-type DZFs, Figure 3.9B) generally 
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Figure 3.10 Analysis of homo- and hetero-typic interaction of synthetic DZFs using the activator 
reconstitution assay. DZFs derived from four pairs were tested for their ability to mediate hetero- (blue 
bars) and homo-typic (green bars) interactions. Control experiments expressing combinations of the 
synthetic DZFs with either the DBD or p65 with no DZF fused (indicated as ‘----’) are also shown 
(purple bars). Each experiment was performed at least three times. Bars shown represent mean fold-
activations of VEGF-A expression determined from three independent assays. Standard error of the mean 
is represented as error bars. Identities of subdomains present in the synthetic DZFs are abbreviated as in 
Figure 3.4. 
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do not mediate VEGF-A activation as sufficiently as heterodimeric interactions (e.g. as 
mediated by the synthetic DZFs, see Figure 3.10, see also section 4.8.3 below).  
In summary, these results demonstrate that the synthetic DZF pairs are able to mediate 
heterotypic dimerization in this assay and therefore function in the context of a mammalian 
cell. In addition, these data show that DZF domains can be used to assemble an artificial 
bipartite activator at the endogenous human VEGF-A gene locus resulting in activation of 
VEGF-A.  
 
3.5.1.3 Interactions are specific and do not depend on overexpression 
To further test the applicability of these synthetic domains as protein-interaction modules, the 
expression levels were analyzed. These domains might also interact with certain endogenous 
proteins (e.g., other DZF-containing proteins) and the observed activity and specificity might 
depend on overexpressing them. Thus, experiments were performed to rule out the possibility 
that the interactions of synthetic DZFs are dependent on overexpression. FLAG epitope-
tagged versions of DZF-DBD and DZF-p65 fusion proteins were constructed, whose 
expression could be quantified by Western blotting using an anti-FLAG monoclonal 
antibody. To test, whether the interaction of the synthetic DZFs depends on their over-
expression, the expression level of the DZF-p65 fusion proteins in VEGF-A activator 
reconstitution experiments was lowered by decreasing the amount of DZF-p65-encoding 
plasmid used to transfect the cells. Western blot analysis demonstrated that for three of the 
four synthetic DZF pairs, the level of p65-DZF was decreased by 7-fold or more without 
affecting DZF-DBD expression levels (Figure 3.11A). Although the amount of p65 was 
significantly reduced, these proteins were still able to mediate robust activation of VEGF-A 
(Figure 3.11B). In the case of the Ik-Ik-Hd and Pe-Pe-Eo DZFs, the level of Pe-Pe-Eo DZF-
p65 fusion protein could not be decreased even when the amount of plasmid encoding this 
protein was reduced by 10-fold. Further reduction of the plasmid amount resulted in an 
impaired VEGF-A activation (data not shown). Thus, three of our four synthetic DZF pairs 
were able to mediate interaction even when the expression level of one member of the pair 
was reduced by >7-fold suggesting that overexpression of our synthetic DZF domains is not 
required to achieve interaction.  
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An additional set of experiments was performed to test, if the specificities of DZFs can be 
maintained even when they and their potential competitive interaction partners are both 
overexpressed. It was found that each of the four synthetic DBD-DZF hybrids interacts 
specifically with a DZF-p65 fusion harboring its synthetic interacting partner DZF but fails to 
interact with DZF-p65 fusions harboring either a synthetic non-interacting DZF or the wild-
type TRPS1 DZF (Figure 3.12A). Importantly, Western blot analysis of cells expressing these 
proteins revealed that within each set of experiments each DZF-DBD fusion protein and its 
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Figure 3.11 Synthetic DZF-DZF interactions do not critically depend upon protein over-
expression. (A) Western blot analysis of human cells transfected with various amounts of DZF-encoding 
plasmids. Western blots were performed on 293 cells transfected with combinations of FLAG-tagged 
DBD-DZF and p65-DZF hybrid proteins using an anti-FLAG monoclonal antibody. For each pair of 
DZF hybrid, two different amounts of DZF-p65-encoding plasmid were used (“hi” = 0.25 ug DNA, 
“low” = 0.06 ug DNA). The amount of cell lysate loaded in each lane was normalized to the number of 
viable cells determined by WST1 assay (see section 2.3.2.3). Band intensities were quantified using 
BioRad Quantity One software and a BioRad Fluor-S MultiImager instrument. The relative intensities of 
each DZF-p65 band are shown above each lane and represent the average of band intensities from two 
assays. Relative values were calculated by normalizing the intensity of each DZF-p65 band to the 
associated DZF-DBD band. (B) VEGF-A assays were performed simultaneously on culture supernatants 
of cells used for the Western blot analysis. Fold-stimulation of VEGF-A protein expression was 
calculated by measuring the VEGF-A contents in the culture medium using ELISA. Bars shown 
represent mean fold-activations of VEGF-A expression determined from two independent experiments 
and error bars indicate standard errors of the mean. Identities of subdomains in the synthetic DZFs are 
abbreviated as in Figure 3.4. This Figure was taken from Giesecke et al. (2006). 
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three corresponding p65-DZF fusions (harboring an interacting synthetic DZF, a non-
interacting synthetic DZF and the DZF from wild-type TRPS1) were expressed at similar 
levels (Figure 3.12B). This suggested that the specificities of DZF interactions are maintained 
even when the DZF hybrid proteins are overexpressed. Furthermore, since TRPS1 is widely 
expressed in many different human cell types (Momeni et al., 2000) these results also suggest 
that most of the synthetic DZFs do not effectively interact with potential endogenous 
competitors, even when these are very abundant.  
 
 
0 5 10 15 20
1
DBD hybrid p65 hybrid 
Tr-Eo-Eo +  Eo-Eo-Hd
Ik-Ik-Hd +  Pe-Pe-Eo
Tr-Eo-Eo +  Pe-Hd-Hd
Hl-Eo-Eo +  Eo-Eo-Hd
Pe-Pe-Eo +  Eo-Eo-Hd
Tr-Tr-Tr +  Tr-Tr-Tr
Hl-Eo-Eo +  Pe-Hd-Hd
Tr-Eo-Eo +  Tr-Tr-Tr
Hl-Eo-Eo +  Tr-Tr-Tr
Ik-Ik-Hd +  Eo-Eo-Hd
Ik-Ik-Hd +  Tr-Tr-Tr
Pe-Pe-Eo +  Pe-Hd-Hd
Pe-Pe-Eo +  Tr-Tr-Tr
Fold-activation of VEGF-A protein expression
321 4 5 6 7 108 9 11 12 13
p65 hybrid
DBD hybrid
DBD hybrid    p65 fusion
Key:
1 = Tr-Eo-Eo +  Eo-Eo-Hd
7 = Ik-Ik-Hd +  Pe-Pe-Eo
2 = Tr-Eo-Eo +  Pe-Hd-Hd
5 = Hl-Eo-Eo +  Eo-Eo-Hd
10 = Pe-Pe-Eo +  Eo-Eo-Hd
13 = Tr-Tr-Tr +  Tr-Tr-Tr
6 = Hl-Eo-Eo +  Tr-Tr-Tr
8 = Ik-Ik-Hd +  Eo-Eo-Hd
9 = Ik-Ik-Hd +  Tr-Tr-Tr
11 = Pe-Pe-Eo +  Pe-Hd-Hd
12 = Pe-Pe-Eo +  Tr-Tr-Tr
3 = Hl-Eo-Eo +  Tr-Tr-Tr
4 = Hl-Eo-Eo +  Pe-Hd-Hd
B
A
 
 
Figure 3.12 Overexpression of non-interacting synthetic DZFs does not result in an activation 
of VEGF-A. (A) Expression of VEGF-A from human 293 cells transfected with plasmids expressing 
various combinations of interacting and non-interacting DBD-DZF and p65-DZF hybrid proteins. 
Fold-stimulation of VEGF-A protein expression was calculated as described in Figure 3.11. Identities 
of subdomains present in the synthetic DZFs are abbreviated as in Figure 3.4. (B) Western blots of 
whole cell lysates prepared from the transfected cells used for ELISA assays in (A) are shown. Blots 
were performed as described in Figure 3.11. This Figure was taken from Giesecke et al., (2006). 
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3.5.2 Synthetic DZF domains are functional in the cytoplasm of mammalian cells 
 
To determine whether our synthetic DZF pairs can also mediate protein-protein interactions 
in the cytoplasm of a human cell, co-immunoprecipitation assays were performed. For these 
experiments a previously developed co-immunoprecipitation method to assess DZF 
interactions was used. In this assay, the different synthetic DZFs were co-expressed in HEK 
293 cells as two fusion proteins of different molecular weights (Figure 3.13).  
 
The larger size protein represents the Ikaros isoform I (Ik-1, see section 1.3.1.2) containing a 
replacement of the C-terminal fingers with various DZFs. The smaller size protein consists of 
only 79 amino acids from the N-terminus of Ik-I fused directly to the various synthetic DZFs 
and harbors a FLAG epitope tag (McCarty et al., 2003). None of the DZF fusion proteins 
used in this assay harbors a nuclear localization signal. To test for interaction, cytoplasmic 
cell lysates were analyzed by immunoprecipitation using an anti-FLAG antibody followed by 
extensive washing. The precipitated DZF fusion proteins were then visualized by Western 
blot analysis using Ikaros antibodies that recognize the common N-terminal domain present 
in both fusions.  
As shown in Figure 3.14, it was found that the various tagged proteins efficiently co-
immunoprecipitated the corresponding untagged fusion proteins suggesting that the synthetic 
DZF pairs can mediate interaction in this assay. Control experiments expressing only the 
untagged DZF fusion peptides demonstrated that these peptides did not bind to the anti-
FLAG antibody in a nonspecific manner, indicating that the precipitation is due to the 
interaction between the different DZF domains (data not shown).  
Figure 3.13 Scheme of the co-immunoprecipitation 
assay for analyzing DZF domain mediated 
interactions. FLAG tagged DZF proteins consisting of 
the Ikaros N-terminal sequence (NTS), the DZF domain 
(light blue ovals) and a N-terminal FLAG tag were co-
expressed with untagged full-length Ikaros isoform I 
(Ik-I) consisting of NTS, C-terminal sequence (CTS) 
and the DZF domain (dark blue ovals) in HEK 293 
cells. Cell lysates containing both FLAG-tagged and 
untagged DZFs were incubated with anti-FLAG-
agarose beads. Proteins bound to these beads were 
visualized by Western Blot using antibodies that 
recognize the NTS. Detection of two bands indicates 
the interaction between the two DZFs since untagged 
fusion proteins (upper band) can only be pulled down 
by binding to FLAG-tagged proteins (lower band) 
(McCarty et al., 2003).  
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Thus, the results of this assay together with the results of the “activator reconstitution” 
experiments show that the synthetic DZF pairs are functional in the complex protein 
environment of a human cell and can interact in both the nucleus and the cytoplasm.  
 
 
3.6 Engineering of more extended C2H2 ZF-mediated protein-protein 
interfaces 
 
3.6.1 Design of extended interaction surfaces 
 
In previous studies various groups have attempted to create high-affinity binding peptides by 
multimerizing two or three C2H2 DNA-binding ZFs (see section 1.2.5). Different strategies 
were used to create these longer arrays of ZFs capable of recognizing extended DNA 
sequences. For example, four- and six-finger peptides have been created by joining together 
units consisting of two ZFs with different types of linker. These tandem arrays of ZFs were 
capable of binding 12 and 18 base pair DNA sequences with high affinities and specificities 
(Moore et al., 2001; Tan et al., 2003; Urnov et al., 2005). We were therefore interested in 
testing whether it would also be possible to design extended protein-protein interfaces by 
linking together DZF domains. The goal was to connect two synthetic DZFs to create double-
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Figure 3.14 Synthetic DZF interactions analyzed using the coimmunoprecipitation assay. 
Mammalian cell extracts were co-transfected with plasmids encoding combinations of tagged and 
untagged DZFs (defined in the Key) and immunoprecipitated using an anti-FLAG antibody. The 
“input” represents fusion protein samples before incubating them with anti-FLAG antibody and the 
“output” shows proteins after the immunoprecipitation step. Western blots were performed with an 
antibody that recognizes the Ikaros NTS sequence. Controls testing the homotypic interaction of wild-
type Hunchback (positive control) and the interaction between Ikaros DZF and Hunchback DZF 
domains (negative control) are also shown. Identities of subdomains in the synthetic DZFs are 
abbreviated as in Figure 3.4. 
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DZFs (dDZFs) consisting of four ZFs which are expected to mediate protein-protein 
interactions with higher affinity than the single DZF domains. Figure 3.15B shows the two 
pairs of synthetic DZFs that were chosen for designing the double-DZFs. The individual 
DZFs in these pairs prefer to heterodimerize with their respective partner and the interaction 
is very specific such that individual DZFs in each pair do not bind to DZFs present in the 
other pair (Figure 3.15A). Choosing these DZFs has the advantage that interactions occurring 
between the individual DZFs in these double-DZFs can be controlled and unwanted inter- 
and intra-molecular interactions can therefore be avoided.  
Eight double-DZFs were designed by varying the linear order of the synthetic DZFs and 
using two kinds of linkers between them (Figure 3.15C). For one set of constructs the 
synthetic DZFs were connected with a linker consisting of the amino acids GEKP after the 
residue following the last histidine of their natural linker sequence. In a second set of 
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Figure 3.15 Construction of synthetic double-DZFs. (A) Pairwise interactions between four synthetic 
DZFs were tested using the mammalian cell-based activator reconstitution assay. Fold-stimulation of 
VEGF-A protein expression was calculated using ELISA measurements of secreted VEGF-A that were 
performed at least three times. Bars shown represent mean fold-activations of VEGF-A expression and 
error bars indicate standard errors of the mean. (B) Summary of interaction specificities of synthetic 
DZFs used to construct double-DZFs. Interaction specificities shown (arrows) were determined using the 
B2H system (Table 3.3) and the mammalian cell-based “activator reconstitution” assay (A). Red X’s 
indicate that no interaction was detected. (C) Schematic of synthetic double-DZFs. Inter-DZF linkers are 
shown as black lines. Short lines represent the GEKP linker while long lines indicated the hinge linker 
(see main text for details). Double-DZFs 1-4 were connected to the DBD and double-DZFs 5-8 were 
fused to p65. This Figure was taken and adapted from Giesecke et al., (2006). 
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constructs a flexible hinge peptide (EFPKPSTPPGSSGGAP) was used as the linker region, 
which is derived from the murine IgG3 hinge region (Pluckthun and Pack, 1997; Deyev et al. 
2003). 
 
3.6.2 Characterization of various double-DZFs 
 
To initially test whether double-DZFs could mediate specific interactions, the mammalian 
cell-based activator reconstitution assay was used. As shown in Figure 3.16, only double-
DZF1/double-DZF5 and double-DZF4/double-DZF7 pairs were able to mediate robust 
activation of VEGF-A expression.  
 
By contrast, testing different combinations of the same double-DZFs (double-DZF1/double-
DZF7 and double-DZF4/double-DZF5) resulted in a lower VEGF-A expression level similar 
to the one obtained with single DZFs. Interestingly, these pairs of double-DZFs only differed 
in the linear order of their constituent synthetic DZFs. The remaining double-DZFs exhibited 
a lower level of VEGF-A activation. Surprisingly, the only difference between some of these 
double-DZFs is the linker region between the single DZFs pairs. For example double-DZF1 
and double-DZF5 mediated efficient activation of VEGF-A expression. The single DZFs in 
these two double-DZFs are linked by the amino acids GEKP. In double-DZF2 and double-
DZF6 the same single DZFs were fused in the same linear order using the hinge linker and 
the activation of VEGF-A mediated by these two double-DZFs was less efficient. A simple 
explanation of these results is that the linker may play a role in orientating the two single 
DZFs in the double-DZFs and is therefore important for the ability of the double-DZFs to 
interact with another double-DZF. It can certainly be ruled out that the linker is part of the 
Figure 3.16 Synthetic double-DZFs 
interact in mammalian cells. Pairwise 
combinations of plasmids encoding 
double-DZFs (dDZF) were co-
transformed into HEK293 cells and 
interactions of these pairs were assessed 
using the mammalian cell-based activator 
reconstitution assay. VEGF-A protein 
expression levels were calculated as 
absolute values using ELISA 
measurements of secreted VEGF-A that 
was performed two times. Identities of 
dDZF domains as indicated in Figure 
4.15C.  
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interacting surface because both double-DZF1/double-DZF7 and double-DZF4/double-DZF5 
pairs were not able to mediate a robust activation of VEGF-A, although they harbor the same 
linker region as double-DZF1/double-DZF5 and double-DZF4/double-DZF7 pairs which 
were able to active VEGF-A very efficiently.  
 
We were interested in comparing the interaction strength of the double-DZFs with the level 
of interaction observed with the single DZF pairs that we used to construct these double-
DZFs. As shown in Figure 3.17, both double-DZF pairs (double-DZF1/double-DZF5 and 
double-DZF4/double-DZF7) mediated very robust activation of VEGF-A expression, greater 
than the activation observed with the single DZF pairs from which they were constructed. 
The level of activation achieved by the double-DZFs is similar to that obtained with the 
originally described artificial VEGF-A activator (SpI-p65 in Figure 3.17; Liu et al., 2001). 
Control experiments demonstrated that the expression of neither the DBD-double-DZF 
protein nor the p65- double-DZF protein alone activated VEGF-A expression. Interactions of 
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Figure 3.17 Analysis of the interactions mediated by double-DZFs in mammalian cells. The strength 
and mode of interactions mediated by the double-DZF1/double-DZF5 and double-DZF4/double-DZF7 
pairs was assessed using the mammalian cell-based activator reconstitution assay. dDZFs were tested for 
their interaction with each other and with the single DZFs from which they were derived. Controls testing 
the interaction of single DZF pairs and of the intact synthetic VEGF-A activator SpI-p65 (consisting of the 
DBD that binds the VEGF-A promoter covalently fused to the p65 activation domain) are also shown. 
Fold-stimulation of VEGF-A protein expression was calculated by measuring the VEGF-A contents in the 
culture medium using ELISA. Bars shown represent mean fold-activations of VEGF-A expression 
calculated from three independent assays and error bars indicate standard errors of the mean. Identities of 
the synthetic DZFs are abbreviated as in Figure 3.4, and identities of dDZF domains are as indicated in 
Figure 3.15C.  
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the double-DZFs with the individual single DZFs which they consist of caused a reduced 
activation of VEGF-A compared to the activation obtained with the double-DZFs. In 
addition, when the linear order of the synthetic DZFs was reversed, both double-DZF pairs 
(double-DZF1/double-DZF7 and double-DZF4/double-DZF5) stimulated VEGF-A 
expression less efficiently. This suggests that double-DZF-1/double-DZF-5 and double-DZF-
4/double-DZF-7 interact stronger because they are able to utilize both single DZFs whereas 
double-DZF-1/double-DZF-7 and double-DZF-4/double-DZF-5 interact less strongly because 
they use only one of the two DZFs for mediating the interaction.  
 
To further confirm this, another set of double-DZFs was designed where each of the single 
DZFs in every double-DZF construct was individually mutated by introducing the D18Q 
mutation. A double-DZF construct that harbors such a mutation in one of its DZFs was then 
tested for its ability to interact with another double-DZF construct, which harbors a mutation 
in the corresponding interacting DZF domain (i.e., two single DZF domains that usually 
interact with each other). Both of the double-DZF pairs were impaired in their ability to 
activated VEGF-A expression when they harbored mutations in interacting single DZFs. The 
activation level was similar to that observed with the single DZF pairs suggesting that only 
the wild-type DZFs in the double-DZF constructs mediated the interaction (Figure 3.18). This 
confirms that the two wild-type double-DZF pairs are able to mediate a very robust activation 
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Figure 3.18 Analysis of the effect of the D18Q mutation introduced into the single DZFs present 
in the double-DZFs. The D18Q mutation was introduced into one of the single DZFs present in the 
DBD-dDZF hybrid and into the corresponding single DZF present in the p65-dDZF hybrid. One star 
(*) indicates that the mutation was introduced into the single DZFs Hl-Eo-Eo and Pe-Hd-Hd present in 
each of the dDZF domains, while two stars (**) indicate that the mutation was introduced into the Tr-
Eo-Eo / Eo-Eo-Hd DZF domains. Note that all dDZFs consist of combinations and different 
arrangements of these single DZFs (see Figure 3.15C). Controls testing the interaction of the intact 
dDZFs and the single DZF pairs are also shown. Fold-stimulation of VEGF-A protein expression was 
calculated from three independent assays and error bars indicate standard errors of the mean.  
Chapter 3. Synthetic protein-interacting zinc finger domains. 
 88
of VEGF-A by using both single DZFs for the interaction, thus displaying an extended 
interaction surface.  
 
3.6.3 Double-DZF interaction confirms anti-parallel interaction mode for DZF domains 
 
Analysis of the affinities of the various double-DZFs and the linear order of the single 
synthetic DZFs in these double-DZFs confirms an anti-parallel interaction mode for DZF 
domains (Figure 3.19). Assuming that the DZFs within the double-DZF interact in an anti-
parallel fashion, double-DZF1/double-DZF5 and double-DZF4/double-DZF7 pairs would be 
expected to interact more strongly because they would be able to utilize both DZFs at the 
same time. On the other hand, the double-DZF1/double-DZF7 and double-DZF4/double-
DZF5 pairs would not be able to use both DZF domains and are therefore expected to interact 
more weakly (Figure 3.19). Thus, the relative affinities of the different double-DZF pairs 
provided additional evidence for an anti-parallel interaction mode of the DZF domains.  
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Figure 3.19 Potential interaction modes for synthetic double-DZFs. Possible anti-parallel and 
parallel interation modes applied to the individual DZFs within the double-DZFs result in various 
models for the interaction of the double-DZFs. Identities of double-DZFs and the single DZFs from 
which they were constructed are color-coded as in Figure 3.15B and C. This Figure was taken from 
Giesecke et al., (2006). 
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3.6.4 Scaffold 
 
We were interested in exploring whether it is possible to engineer synthetic “scaffolds” or 
“adaptors” (Ferrell, 2000; reviewed in Pawson and Scott, 1997) which can be used to tether 
various proteins that are linked to DZF domains. Initially we planed to design a 
transcriptional scaffold in which two transcriptional activators (input) are integrated into one 
output represented by activation of the VEGF-A expression. This should result in a synergetic 
transcriptional activation which is described as the process where several activators work 
together and support each other in activating the respective target gene. Synergetic activation 
generally results in a substantial increase of transcriptional activation. This level of activation 
is higher compared to a situation where the effect of two independent activators is purely 
additive (reviewed in Ptashne and Gann, 1997; Jackson et al., 1998; Zhu et al., 2000; Cassel 
et al., 2002; reviewed in Remenyi et al., 2004). Thus, the idea was to design constructs where 
two activation domains (p65 and VP16) are each fused to different synthetic DZF domains 
which both can interact with one of the single synthetic DZFs present in a double-DZF 
domain. Applying double-DZF domains fused to SpI should permit an assembling of two 
activation domains at the promoter which in turn should lead to a synergetic activation of 
VEGF-A (Figure 3.20).  
 
For an initial set of constructs double-DZF1 and double-DZF4 were used since both worked 
well for designing an extended interaction surface. The two corresponding single partner 
DZFs were separately fused to the p65 and the VP16 activation domains. These constructs 
were introduced into our mammalian cell-based assay and tested for their ability to mediate 
activation of VEGF-A. As shown in Figure 3.21, the interaction between the double-DZF 
domains and both single synthetic DZFs fused to the activation domains was low and the 
activation of VEGF-A expression was not very efficient.  
Figure 3.20 Schematic overview of a 
transcriptional scaffold. Interactions 
between the dDZF (light red and blue 
double ovals connected by a line) fused 
to a synthetic DBD that binds to a DBS 
in the VEGF-A promoter and two 
single DZFs (dark red and blue double 
ovals) fused to the p65 and the VP16 
transcriptional activation domains 
should stimulate VEGF-A expression 
stronger than interactions with either 
p65 or VP16 DZF fusions alone. 
RNA Pol II
HIGH??
VEGF
???p65
VP16
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Control experiments showed that neither interactions of the double-DZFs with the individual 
single DZFs nor the double-DZF protein alone activated VEGF-A expression. In all cases the 
activation is clearly lower than that obtained with the single DZF pairs from which they were 
constructed. Interestingly, a significant difference in the level of VEGF-A expression was 
detected for the single DZF pairs depending on which activation domain was used for the 
activation. Fusing one of the DZFs to VP16 did not yield the same amount of VEGF-A 
activation as fusing the same DZF to p65 (data not shown). This suggested that the activation 
mediated by VP16 is generally lower then that mediated by p65 which could be one reason 
why the scaffold was not able to mediate robust activation of VEGF-A. In addition, we 
suspected that the double-DZF construct was not accessible and did not provide the right 
geometry for the two DZFs fused to the activation domains to achieve an optimal binding.  
Therefore we decided to optimize the double-DZF construct by introducing different linkers 
in between the two synthetic DZFs. A very long and flexible linker consisting of the amino 
acids FHMSGGGGSGGGGS and a shorter FHMS linker were designed. Unfortunately, these 
new constructs did not improve the level of VEGF-A activation suggesting that the linker is 
either not important for the scaffold setup or does still not provide the right geometry. 
Interestingly, adding another p65 activation domain instead of using VP16 and therefore 
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Fold-activation of VEGF-A protein expression  
 
 
Figure 3.21 Interactions of double-DZFs with single DZFs fused to different activation domains 
(AD). dDZFs 1 and 4 are connected to the DBD (left column) while single DZFs are either fused to p65 
or VP16 (AD1 or AD2, middle and right column). Various combinations of plasmids encoding these 
fusions (see columns) were transfected into HEK293 cells and interactions were assessed using the 
mammalian cell based activator reconstitution assay. Fold-stimulation of VEGF-A protein expression 
was calculated using ELISA measurements of secreted VEGF-A that were performed three times. Bars 
shown represent mean fold-activations of VEGF-A expression and error bars indicate standard errors of 
the mean. Identities of the synthetic DZFs are abbreviated as in Figure 3.4, identities of dDZF domains 
are as indicated in Figure 3.15C.  
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recruiting two p65 peptides to the promoter caused an increased but still weak activation of 
VEGF-A expression (data not shown). Thus, we further tried to optimize the geometry of the 
scaffold using two p65 activation domains. We tested another scaffold setup where one of the 
p65 domains is fused to the N-terminus while the other p65 domain is fused to the C-terminus 
of the respective synthetic DZF domain. For this experiment double-DZF1 and double-DZF4 
were used to recruit the two DZF-linked p65s. Unfortunately, this setup still did not lead to an 
increased level of VEGF-A activation (data not shown).  
 
 
3.7 Using DZF domains to dimerize DNA-binding zinc-fingers 
 
3.7.1 Overview 
 
Previous studies have shown that DNA-binding C2H2 ZFs can be linked together into 
tandem arrays capable of binding to extended DNA sequences with increased affinity and 
specificity. However, only limited numbers of fingers can be linked together in order to 
create a functional protein. Several synthetic peptides consisting of more then three ZFs have 
been characterized but these peptides displayed only little enhancements in their DNA-
binding affinity (reviewed in Wolfe et al., 2000; reviewed in Pabo et al., 2001; see also 
section 1.2.5). These limitations are likely to be due to structural or energetical problems that 
emerge when more then three fingers are present. To avoid this problem, alternative 
approaches were taken to design DNA-binding proteins with higher and more specific DNA 
binding affinity. One successful strategy involved the attachment of a dimerization domain to 
DNA-binding ZFs which enables these ZF to bind DNA in a cooperative manner. Different 
dimerization systems have been described which assemble DNA-binding ZFs on the DNA 
and enhance their specificities and affinities (Pomerantz et al., 1998; Wang and Pabo, 1999; 
Wolfe et al., 2000; Wolfe et al., 2003). Thus, we were interested in testing if DZF domains 
can also be used as modules that could be applied to dimerize DNA binding C2H2 ZFs.  
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3.7.2 Setup 
 
As an initial test of whether DZF domains can be used as dimerization elements we applied 
these domains to cooperatively assemble DNA-binding ZFs on the DNA. For some of the 
DZF domains (e.g. - Ikaros family of transcription factors) it has been shown that they 
mediate dimerization of their N-terminal DNA-binding zinc finger domain (Sun et al., 1996; 
Morgan et al., 1997; Kelley et al., 1998). Thus, we hypothesized that these domains should 
be able to mediate dimerization of heterologous DNA-binding C2H2 ZFs as well. To begin 
exploring the possibility of dimerizing DNA-binding ZFs using DZF domains, the B2H 
system was adapted so that it could be used as a reporter system for detecting protein-DNA 
interactions mediated by dimerization.  
 
The idea was to construct a fusion of finger 2 and 3 from Zif268 (ZF23) to the DZF domain 
of Ikaros. Finger 2 and 3 from Zif268 were chosen because previous studies have shown that 
these two fingers are not able to bind tightly to their specific DNA site due to low binding 
affinities. However, attaching a dimerization domain can mediate the cooperative binding of 
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Figure 3.22 Schematic overview of the B2H system for testing if DZF domains can dimerize DNA-
binding ZFs. (A) DNA-binding domains consisting of F2 and F3 of Zif268 but lacking F1 (numbered blue 
circles) fail to bind to their specific DBS (left side of Figure). Attachment of a dimerization element 
represented by the DZF domain (green double ovals) should mediate dimerization of the two DNA-binding 
ZFs, thus permitting them to bind to their composite DBS (right side of Figure). (B) The B2H system was 
used to detect cooperative binding of DZF-ZF23 fusion proteins to a composite DBS. In this setup Gal11P 
(dark pink) was fused to the C-terminus of F3 from Zif268 and its interacting partner Gal4 (light pink) was 
fused to the RNAP α-subunit. Assembling of the DNA-binding ZFs (numbered blue circles) on the 
composite DBS placed upstream of the lacZ reporter gene by DZF mediated dimerization should recruit the 
RNAP to the promoter via the interaction between Gal11P and Gal4, which should result in an activation 
of lacZ transcription. This Figure was kindly provided by K. Joung. 
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these two fingers to a composite DNA side consisting of two specific “half-sites” (Figure 
3.22A, Wolfe et al., 2000). To detect the protein-DNA interactions, a B2H reporter strain 
must be used which bears a composite DNA-binding side consisting of two “half-sites” 
known to be bound by ZF23 in the promoter region of the lacZ reporter gene. Furthermore, a 
fragment of the yeast Gal11P protein (GP) was connected to the C-terminus of the DZF-ZF23 
fusion protein which will allow detection of DNA binding through its interaction with the 
yeast protein Gal4 (Joung et al., 2000; Hurt et al., 2003). To initiate activation of the lacZ 
reporter gene, the B2H reporter strain has to co-express Gal4 fused to the RNAP α-subunit 
with the DZF-Zif23-GP fusion protein. Cooperative binding of two DZF-Z23-GP fusion 
proteins to their composite DNA-binding site should then enable GP to recruit the RNAP to 
the promoter via its interaction with Gal4, which should in turn activate the expression of 
lacZ (Figure 3.22B).  
 
3.7.3 Characterization of Ik-Zif268-Gal11P and Ik-Z23-Gal11P in the B2H system 
 
Initial experiments to determine whether the Ik-Z23-GP fusion protein can be studied using 
this B2H setup were performed. First, we tested if the GP fragment is functional in the 
context of our Ikaros-Zif268 hybrid protein. Thus, the Ik-Zif268 fragment (containing all 
three DNA-binding ZFs) was fused to a fragment of the yeast GP protein using a flexible 
linker of the sequence GGGGS to create the Ik-Zif268-GP fusion. A C-terminal FLAG tag 
epitope was also added for Western blot analysis. Plasmids encoding the Ik-Zif268-GP fusion 
and the α-Gal4 hybrid protein were then introduced in the B2H strain harboring one Zif268 
binding side and β-galactosidase assays were performed to assess the binding of this fusion 
protein to its DNA side. As shown in Figure 3.23, the Ik-Zif268-GP fusion protein can bind 
to its specific DNA site and efficiently activates transcription of the lacZ reporter gene 
compared with the Ik-Zif268 only control. This suggests that the GP protein is functional in 
the context of our fusion protein and can generally be used to detect DNA-binding through its 
interaction with the yeast protein Gal4.  
F1 of the Zif268 protein was then deleted by PCR to create the Ik-Z23-GP hybrid protein. As 
expected, in contrast to the Ik-Zif268-GP, Ik-Z23-GP was not able to mediate activation of 
lacZ in the B2H system (Figure 3.23) suggesting that Finger 2 and 3 of Zif268 were not able 
to bind to the promoter consisting of one Zif268 DBS. 
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To further test whether the Ik-Z23-GP protein is stably expressed, Western blot analysis was 
performed. This should rule out that the abolished activation of lacZ is due to a lack of 
protein. Thus, whole cell lysates from the cultures used for the β-galactosidase assays were 
resolved by SDS-polyacrylamide gel electrophoresis. Western blot analysis was performed to 
visualize the hybrid proteins using an anti-FLAG antibody that recognizes the C-terminal 
FLAG tag epitope. We found that the Ik-Z23-GP protein is stably expressed (data not shown) 
and concluded that Ik-Z23-GP could not bind with high affinity to the Zif268 binding side 
because it contained only two DNA-binding ZFs.  
 
3.7.4 Dimerization of Ik-Z23-GP using the DZF domain 
 
We next wanted to determine whether the attached DZF domains can be used to mediate 
cooperative binding of two 2-Finger Zif268 domains to a composite DNA side composed of 
two half-sites. To assess cooperative DNA-binding by the Ik-Z23-GP protein, appropriate 
B2H reporter strains were constructed that harbor composite DNA-binding sites in the 
promoter region of the lacZ reporter gene. In these strains the six-base-pair binding sites 
(“half-site”) for each Ik-Z23-GP monomer are arranged in an inverted orientation. A series of 
B2H reporters were generated containing various spacings of the half-sites (Table 3.4) to find 
an arrangement optimal for DNA-binding (termed as 0, 1, 3 ... sites). To test whether Ik-Z23-
GP can dimerize and subsequently bind to the inverted half-sites, plasmids expressing Ik-
Z23-GP together with a plasmid encoding the α-GAL4 were introduced into each of the B2H 
reporter strains to assess β-galactosidase activities. It was found that none of the reporters 
exhibited high activation of the lacZ gene indicating that Ik-Z23-GP was not able to bind 
cooperatively as a dimer. Increasing the concentration of IPTG to produce more protein did 
Figure 3.23 The B2H system can be used to 
study DZF mediated dimerization of DNA-
binding ZFs. Plasmids encoding fusions between 
the Ik DZF domain, Gal11P (GP) and either 
Zif268 (Ik-Zif268-GP) or the Zif268 protein with a 
deleted F1 (Ik-Z23-GP) were co-transformed with 
the RNAP α-Gal4 plasmid into the reporter strain 
harboring only one Zif268 DBS and β-
galactosidase assays were performed to assess the 
activity of these constructs. A control expressing 
the Ik DZF domain fused to Zif268 lacking the GP 
protein (Ik-Zif268) is also shown. 
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not improve the ability of Ik-Z23-GP to activate lacZ (data not shown).  
 
Spacing (bp) Binding site 
0 5’ – GCGTGGCCACGC – 3’ 
1 5’ - GCGTGGCCCACGC – 3’ 
3 5’ - GCGTGGGTCCCACGC – 3’ 
5 5’ - GCGTGGGTGGCCCACGC – 3’ 
7 5’ - GCGTGGGTGTAGCCCACGC – 3’ 
9 5’ - GCGTGGGTGGGTAGCCCACGC – 3’ 
11 5’ - GCGTGGGTGGGCTTAGCCCACGC – 3’ 
13 5’ - GCGTGGGTGGGCGATTAGCCCACGC – 3’ 
16 5’ - GCGTGGGTGGGCGACTATTAGCCCACGC – 3’ 
22 5’ - GCGTGGGTGGGCGACGCACAGTATTAGCCCACGC – 3’ 
 
Table 3.4 Composite DBSs for cooperative binding of F2 and F3 of Z23. The sequences of the different 
DBSs used to construct B2H reporter strains are given in the right column. The six base-pair binding sites (half-
sites, 5’ – GCGTGG – 3’) recognized by the ZFs in each Ik-Z23-GP monomer are highlighted in red and green 
where the red triplet is recognized by F2 and the green triplet is recognized by F3 of Z23. The spacing between 
two half-sites is shown in the left column (indicated as numbers of base-pairs present in between the two half-
sites). Note that only one DNA strand is shown and the second half-site is actually on the other strand (indicated 
by a reverse complement display of the actual half-site).  
 
 
We suspected that our setup configuration might not provide the right geometry for the Ik-
Z23 to bind cooperatively. Thus, we decided to adjust the configuration of the Ik-Z23 protein 
by optimizing the linker region between the Ikaros DZF domain and the Z23 DNA-binding 
domain. Different linkers of various length and flexibility (Table 3.5) were introduced since 
the geometry of our dimeric DNA-binding complex was unknown.  
 
Linker name Linker sequence 
L1 RFHMSGGSRVRTGSKTPPHERP 
L2 AAA 
L3 GGGGS 
L4 RFHMS 
L5 RFHMSGGGGS 
L6 TGEKP 
 
Table 3.5 Linkers used to connect the Ikaros DZF domain to the Z23. The right column shows the amino-
acid sequences of the various linkers. Residues that represent the authentic C-terminal end of the Ikaros protein 
are highlighted in red and were only present in L1, L4 and L5. L2, L3 and L6 were directly fused to the final 
zinc-binding histidine of the DZF domain.  
 
 
Plasmids encoding the different linker constructs were introduced into each of the B2H 
reporter strains and β-galactosidase activities were assessed. None of the various proteins in 
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combination with the different binding sites we tested was able to activate lacZ (data not 
shown). However, linker L6 (canonical TGEKP-type linker) improved the ability of Ik-Z23-
GP to bind to the 0 site which stimulated transcription of lacZ gene nearly two-fold (Figure 
3.24). Again, this effect could not be improved by adding more IPTG (thereby increasing the 
amount of protein, data not shown).  
 
To further verify that this increased activation of lacZ depends on a cooperative binding of 
Ik-Z23-GP mediated by dimerization, the D18Q mutation was introduced into the attached 
DZF domain. The effect of this mutation was assessed in the 0 site reporter using various 
concentrations of IPTG. As shown in Figure 3.24, D18Q completely abolished the ability of 
Ik-Z23-GP to activate lacZ. This suggested that the DZF domain mediated a cooperative 
binding of Ik-Z23 to the two half-sites by dimerizing two Ik-Z23 molecules. We concluded 
that it was in principle possible to use the DZF domains as a dimerization element to 
assemble DNA-binding ZFs on specific DNA-sites although the cooperative binding of Ik-
Z23 was not very strong. This again demonstrated the versatility of the C2H2 ZF motif.  
 
 
3.8 Discussion 
 
3.8.1 DZF-derived C2H2 ZFs can be “mixed and matched” 
 
The principal goal of DNA-binding ZF design was to engineer ZFs that can bind any DNA 
site of interest. To achieve this, different groups took advantage of the simple modular 
structure of DNA-binding ZFs and applied various methods including modeling, sequence 
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Figure 3.24 Analysis of DZF mediated 
dimerization of DNA-binding ZFs. 
Plasmids encoding Z23-GP fused to either 
the wild-type Ik DZF domain (blue bars) 
or the Ik DZF domain harboring the D18Q 
mutation (purple bars) together with the 
RNAP α-Gal4 expression plasmid were 
introduced into the 0-site B2H reporter 
strain harboring a composite DBS (see 
Table 3.4) and activity of these constructs 
was assessed over a range of IPTG 
concentrations.  
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comparison and selections to alter the specificity of individual fingers within a multifinger 
protein. These fingers together with naturally occurring ZFs can then be combined by 
“mixing and matching” to create designer ZFs capable of recognizing novel DNA sequences. 
In addition, various ZFs can be linked together into tandem arrays that are capable of 
recognizing extended DNA sequences. Before this study, it was not known whether protein-
binding ZFs could be mixed and matched as well in order to create synthetic proteins with 
novel interaction specificities. It has previously been shown that the two ZFs in the Pegasus 
and Eos DZF domain are separable and capable of folding independently of each other 
(Westman et al., 2004). These data suggested that ZFs in the DZF domain may behave in a 
modular manner. In addition, a functional hybrid DZF domain consisting of two individual 
ZFs derived from different wild-type proteins has been described (McCarty et al., 2003). 
Thus, we decided to systematically investigate whether C2H2 ZFs and DZFs could be “mixed 
and matched” to create domains with novel interaction specificities. Our results showed that 
shuffling of DZF-derived C2H2 ZFs can yield synthetic DZFs with new specificities that can 
then be linked together into more extended interaction interfaces. Interestingly, only a small 
number (less then 0.5%, 26 selected DZF pairs/5344 total potential pairs) of the potential 
combinations of DZFs were identified as positive for interactions. Since the theoretical 
number of combinations in all libraries was completely over sampled, and because our 
sequencing results revealed that we identified many of the interacting pairs multiple times, 
we are confident that we identified nearly all interacting DZFs. In addition, attempts to create 
synthetic DZFs without using the B2H selection strategy by simply constructing all possible 
combinations of C2H2 ZFs and linkers from the Ikaros and Drosophila Hunchback DZFs 
were unsuccessful and none of these synthetic domains could mediate interaction with each 
other. Thus, we conclude that individual fingers in the DZF domain do not always operate as 
completely modular units and, as is the case for DNA-binding C2H2 ZFs (Isalan et al., 1997; 
Isalan et al., 1998; Wolfe et al., 1999; Hurt et al., 2003; see also section 1.2.5), context-
dependent interactions are important for the binding affinity. This also emphasizes the 
importance and necessity of using selection methods to identify synthetic DZF pairs that are 
fully optimized for protein-binding. 
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3.8.2 Anti-parallel interaction mode 
 
Analysis of the interaction specificities of the synthetic DZFs revealed a novel antiparallel 
interaction geometry for DZF domains. Previous studies suggested that DZF domains interact 
in a parallel fashion based on the interaction specificity of an engineered chimeric 
Ikaros/Hunchback DZF (McCarty et al., 2003). However, the identities of our selected 
synthetic DZFs together with their homo- and heterotypic interaction specificities indicated 
that these domains interact in an anti-parallel manner. Furthermore, the relative interaction 
affinities of the double-DZFs are most consistent with a model in which the component 
synthetic DZFs interact in an anti-parallel fashion. It is noteworthy that our selections also 
identified a synthetic DZF pair that suggests a parallel interaction mode (Pe-Hd-Hd 
interacting with Hd-Hd-Hl). Thus, both parallel and anti-parallel interaction geometries seem 
to exist for synthetic DZFs which further highlight the functional versatility of C2H2 ZFs. It 
is worth noting that these interaction modes were defined for synthetic isolated DZFs and 
may not reflect the geometry of naturally occurring DZFs in the context of a full-length 
protein.  
 
3.8.3 Applications of synthetic DZFs  
 
Our synthetic DZF domains have proven to be efficient in mediating assembly of a bi-partite 
transcriptional activator capable of stimulating expression of the endogenous VEGF-A gene 
in human cells. This represents an example of synthetic control as we managed to by-pass the 
normal regulatory signals such as hypoxia to activate VEGF-A. Furthermore, because this 
activation depends upon the presence of two DZF-linked proteins, it provides a mechanism 
for making VEGF-A expression dependent on two inputs (as in an ‘AND’ gate circuit, 
Kramer et al., 2004). These synthetic DZF domains can also be used to activate expression of 
a specific gene in a bacterial cell suggesting that they may also have implications for 
constructing synthetic circuits in bacteria.  
The fact that our synthetic DZF domains mediate preferentially heterotypic interactions 
provides important advantages compared to naturally occurring wild-type DZFs. Heterotypic 
interactions may be particularly useful for applications requiring asymmetric complex 
assembly. In fact, these synthetic DZFs are more efficient in mediating assembly of a bi-
partite transcription factor in our “activator reconstitution” assay than for example naturally 
Chapter 3. Synthetic protein-interacting zinc finger domains. 
 99
occurring homotypic DZFs. On explanation for this observation could be that the formation 
of unwanted homodimers of DNA-binding domain fusions (or activation domain fusions) is 
less likely to occur since our domains prefer heterotypic interactions. These undesired 
homodimers could compete with the formation of the wanted DNA-binding 
domain/activation domain heterodimer and would thereby impair the ability of the DZF 
domains to mediate activation of VEGF-A. 
Furthermore, our synthetic DZF domains demonstrated a high level of specificity which may 
have helped avoiding any unwanted cross-interactions with endogenous competitors. In fact, 
our synthetic DZFs were functional in three cellular compartments (i.e. the cytoplasm of 
bacterial and mammalian cells and the nucleus of mammalian cells) indicating that none of 
the potential competitors present in these cellular contexts was able to interfere with the 
interactions. Moreover, the specificity did not depend on over-expression of the synthetic 
DZF domains since both lowering the expression levels of these DZFs and over-expression of 
potential interfering proteins did not impair the ability to interact with defined partners in 
human cells.  
Another notable feature of our synthetic DZF domains is that they can be linked together into 
more extended arrays. This suggests that DZF domains can be used as modules to create 
synthetic multi-DZF ‘scaffold’ or ‘adaptors’ upon which various DZF-linked proteins might 
be assembled. Our initial attempts to design a transcriptional scaffold consisting of two 
transcriptional activators has proven to be challenging and the obtained activation of the 
VEGF-A expression was very weak. It will be interesting to explore whether it is possible to 
engineer a scaffold in the cytoplasm of a human cell by applying our synthetic DZF domains. 
Such a scaffold could be used to create novel synthetic signaling pathways by simple 
tethering defined signaling molecules of interest (Park et al., 2003; Harris et al., 2001).  
 
3.8.4 Future directions 
 
Finally, these findings have important implications for future prospects to design C2H2 ZFs 
capable of interacting with any target protein of interest. The versatility and modularity of the 
DZF domain suggest potential strategies for re-engineering zinc finger protein-protein 
interfaces. Thus, like for their DNA-binding counterparts, it may be possible to randomize 
residues within the DZF domain that are known to be important for mediating protein-protein 
interactions (see Chapter 4) to create C2H2 ZFs with completely novel specificities. Such an 
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approach depends on a precise structural and biochemical information about the interaction 
surface. Mutagenesis as well as structural analysis of DZF domains is necessary and will help 
narrow down the choice of residues feasible for randomization (see Chapters 4 and 5). 
Resulting re-engineered ZFs in combination with naturally occurring ZFs could then be 
shuffled and linked together to create finger arrays with novel interaction specificities.  
In the long-term, the capability to engineer synthetic C2H2 ZFs with desired protein-protein 
interaction specificities, together with existing strategies for engineering designer C2H2 ZF 
DNA-binding proteins, should yield a powerful toolbox useful to construct artificial cellular 
networks. Hence, the development of these technologies should have significant applications 
in synthetic biology as well as biomedical research.  
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Chapter 4. Genetic analysis of various DZF domains using 
mutagenesis. 
 
4.1 Introduction 
 
Despite the functional importance of the DZF as a novel protein recognition domain, 
relatively little is currently known about how this domain mediates protein-protein 
interactions. DZFs exist in several proteins which all display substantial sequence homologies 
at the amino acid level. This suggests that the DZF domain exhibits a uniform fold on which 
the dimerization presumably is based. Despite the high degree of homology, studies have 
shown that the interaction mediated by distinct DZF domains have differences in 
specificities. Recent studies by McCarty and coworkers (2003) have provided initial 
molecular determinants of the DZF domain interactions. The results of these studies 
demonstrated that dimerization mediated by the DZF domain of Ikaros and Hunchback is 
highly specific since both domains showed homodimerization but were not able to 
heterodimerize with each other. Furthermore, by analyzing a series of Ikaros-Hunchback 
DZF chimeras for their abilities to interact with either wild-type Hunchback or wild-type 
Ikaros, McCarty and co-workers (2003) defined the boundaries of specificity determining 
residues (see section 1.3.4.3 and Figure 1.6 for details). To localize “specificity determinants” 
on the interaction surface of the Ikaros DZF domain, McCarty and coworkers constructed 
several double or single “swap residue” mutants based on the amino-acid sequence of the 
Hunchback DZF domain. Residues that are different in Hunchback were introduced into the 
Ikaros DZF at the corresponding position. The ability of these “swap” mutants to interact 
with the wild-type Ikaros DZF were tested using co-immunoprecipitations. Mutants identified 
in this initial screen were then assessed for homo-dimerization using chemical crosslinking 
assays. This experiment identified eight residues that seemed to be important for Ikaros 
mediated dimerization (McCarty et al., 2003; see also section 1.3.4.3 and Figure 1.6). 
Although this study provided some insights into the molecular mechanism through which 
DZF domains mediate specific protein-interactions, additional studies of the protein interface 
are required to define and distinguish residues responsible for both specificity and affinity on 
the uniform defined fold likely to be present in all DZF domains. 
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To begin to address these points, a detailed mutational analysis of the Ikaros, Pegasus and 
Hunchback Drosophila DZF domain interfaces was performed. We chose these three DZFs 
because a comparison of the amino acid sequences of these domains reveals both similarities 
and differences (Figure 4.1). In addition, they display very selective interaction profiles: 
Although all three DZF domains can mediate homodimerization, Hunchback and Ikaros fail 
to heterodimerize with each other. Pegasus on the other hand can interact with both Ikaros 
and Hunchback (see section 3.2.4 for details). We reasoned that detailed analysis of these 
three domains should help define the nature of specific homo- and hetero-typic interactions at 
the interface. 
 
To investigate systematically which amino acids are critical for dimerization, the DZF 
domains of Ikaros, Hunchback and Pegasus were studied using alanine scanning mutagenesis. 
In general, this approach is used to identify functionally important residues of a protein by 
sequentially substituting each residue with an alanine and assessing the effect of this 
replacement. Substitution of the DZF domain residues by alanine may identify contact sites 
for homodimerization because protein-protein interaction surfaces are known to be 
accomplished by side-chain interactions between certain amino-acids (Ashkenazi et al., 
1990). Since alanine only has a CH3 group instead of a longer side chain it does not alter the 
main-chain conformation. Moreover, alanine is the most prevalent amino acid found at 
positions buried inside the protein as well as at exposed positions of the protein structure. 
Thus, alanine is not expected to destroy the overall structural features of the protein, and 
VYKCEHCRVLFLDHVMYTIHMGCHGFRDPFECNMCGYHSQDRYEFSSHITRGEH 
LHHCQHCDMYFADNILYTIHMGCHGYENPFQCNICGCKCKNKYDFACHFARG-H 
IYECKYCDIFFKDAVLYTIHMGYHSCDDVFKCNMCGEKCDGPVGLFVHMARNAH 
 
 
F/Y-X-C-X2-5-C-X3-F/Y-X5-Ψ-X2-H-X3-5-H 
 
 
Ik
Pe
Hd
cZF
β-sheets β-sheets α-helix α-helix 
 
 
Figure 4.1 Comparison of the amino acid sequences of the DZF domain from Ikaros (Ik), Pegasus 
(Pe) and Hunchback Drosophila (Hd). Conserved cysteines and histidines involved in zinc binding are 
highlighted in blue. Residues that are in positions that are normally highly conserved in classical C2H2 
ZFs are highlighted in yellow (Phe/Tyr) and pink (Ψ, hydrophobic residues). The consensus sequence 
motif of a classical DNA binding C2H2 ZF (cZF) is presented below the DZF sequences for comparison. 
Deviations from the consensus sequences are indicated by boxes. Secondary structures defining the DNA 
binding C2H2 ZFs are indicated on top of the amino acid sequences. 
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therefore provides an ideal replacement residue (Cunningham and Wells, 1989; Thukral et 
al., 1991).  
In another set of experiments, a similar strategy as previously described was applied by 
constructing several “swap” mutants for the Ikaros and Hunchback DZF domains (McCarty 
et al., 2003). Since Ikaros and Hunchback DZFs do not heterodimerize with each other, we 
reasoned that swapping a residue important for making contact in one DZF with the 
corresponding residue in the other DZF domain is likely to disrupt this specific contact and 
thereby the ability to dimerize. Our hope was that this approach would help identifying 
specific residues that are important for the dimerization of e.g. the Ikaros DZF but not for 
Hunchback and vise versa. Thus, this approach in combination with the alanine scanning 
mutagenesis should help determining residue positions that are necessary for specific DZF 
mediated interactions.  
 
 
4.2 DZF domain mediated homodimerization can be studied in the 
Bacterial one-hybrid system  
 
4.2.1 The Bacterial one-hybrid (B1H) system 
 
In addition to the B2H system a B1H system has been described which can be used to study 
and identify dimeric proteins (Hu et al., 1990). This system is based on the observation that 
the N-terminal DNA binding domain (NTD) of the bacteriophage lambda repressor (λcI) 
requires a dimerization domain in order to bind efficiently to its specific DNA site, the λ 
operator. Thus, fusing a domain of interest (X) to the λcI NTD will permit the λcI-X fusion 
protein to bind to the λ operator as long as X can mediate dimerization. The dimerization can 
be detected by using an appropriate E. coli reporter strain. As shown in Figure 4.2, in this 
strain, the λ operator is placed in between the -10 and -35 region of a strong promoter and 
binding of the λcI-X fusion protein to its site will repress the promoter by blocking binding of 
the RNAP. By using lacZ as the reporter gene, repression of the promoter can be easily 
assessed performing quantitative β-galactosidase assays.  
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4.2.2 Validation of the B1H system for studying homodimeric DZF domain interactions 
 
To initially test whether homodimeric interactions of the DZF domain can be detected in the 
B1H system, we generated plasmids encoding the DZF domains from Ikaros (work 
performed by R. Fang), Pegasus and Drosophila Hunchback fused to the C-terminus of the 
λcI DBD (consisting of the NTD and the linker that connects the NTD with the naturally C-
terminal domain of λcI). Each of these plasmids (encoding the λcI-DZF fusion proteins) was 
transformed into a B1H reporter strain containing a λcI operator positioned between the -35 
and -10 hexamers of the lac UV5 promoter. To test for homodimerization and DNA-binding 
mediated by these different DZF domains, β-galactosidase assays were performed. As 
expected, it was found that cells which expressed the λcI NTD+linker alone (lacking the C-
terminal λ dimerization domain) showed high levels of transcription of the lacZ reporter 
gene. In contrast, transcription of lacZ was repressed in cells expressing the λcI-DZF fusion 
proteins suggesting that all three DZF domains mediate efficient homodimerization of the 
chimeric protein (Figure 4.3A).  
λ operator
X X
X X
Dimeric
Protein X
Y
Y
Non-dimeric
Protein Y λ operator
Y
Y
lacZ 
or
his3/aadA
-35  λ operator  -10
low
X X
lacZ 
or
his3/aadA
-35  λ operator  -10
HIGH
RNAPα
α
Y Y
RNAPα
α
 
 
 
Figure 4.2 Schematic of the Bacterial one-hybrid (B1H) system. A dimeric protein X can mediate 
dimerization of the N-terminal DBD of λcI (λcI-NTD, blue circles) resulting in the binding of the λcI-X 
fusion protein to the λ operator site (lower panel, left side). In an appropriate B1H reporter strain the λ 
operator is placed between the -10 and -35 sequences. Thus, binding of the dimeric λcI-X fusion protein 
competes with binding of the RNAP which results in a repression of the reporter gene expression (lower 
panel, right side). In contrast, non-dimeric proteins fused to λcI-NTD will abolish the ability of λcI to bind 
to the λ operator site, thus resulting in an activation of reporter gene expression (upper panel). This figure 
was kindly provided by K. Joung. 
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To further test, if the repression of lacZ is dependent on the expression of the different λcI-
DZF fusion proteins, an IPTG titration experiment was performed where the expression of 
the proteins was induced using various amounts of IPTG.  
 
As shown in Figure 4.3B, repression of lacZ was directly related to the protein expression 
level as long as the IPTG concentration stayed below a certain threshold. Interestingly, the 
effect of increased IPTG concentration was different for the individual fusion proteins. The 
Pegasus DZF domain reached a maximum level of repression at an IPTG concentration of 
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Figure 4.3 Analysis of the Ikaros, Pegasus and Hunchback Drosophila DZF domains in the B1H 
system. (A) B1H reporter strains expressing the three DZF domains fused to λcI were assayed for β-
galactosidase activity. A control expressing the λcI-NTD protein is also shown. In this assay an IPTG 
concentration of 50 μM was used for inducing the expression of the fusion proteins. (B, C, D and E) The 
activity of these wild-type constructs together with constructs harboring the D18Q mutation in the DZF 
domains were assessed using increasing concentrations of IPTG. The three wild-type proteins (B), wild-
type and D18Q Ikaros (C), wild-type and D18Q Pegasus (D) as well as wild-type and D18Q Hunchback 
(E) were group wise compared to each other. 
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100 μM, whereas for the Ikaros DZF domain the repression level increased linearly with the 
IPTG concentration even up to high levels of IPTG (Figure 4.3B and data not shown, R. 
Fang). Overexpression of the Hunchback DZF domain was toxic to the bacterial strains and 
the fusion protein could not mediate repression when the IPTG concentration went above 25 
μM. The toxicity may have forced the bacterial cells to select for a Hunchback mutant in 
order to survive and grow. This would explain why these cells did not repress lacZ when high 
levels of proteins were present. On the other hand, these hybrid proteins might have 
dimerized detached from the DNA and were therefore not able to mediate transcriptional 
repression at the promoter. 
To further validate the B1H system as a genetic method to study DZF mediated 
homodimerization an additional series of constructs was designed where the previously 
described D18Q mutation (McCarty et al., 2003) was introduced into the DZF domains. 
Plasmids encoding this mutation were transformed into the B1H reporter strain and β-
galactosidase assays were performed using cultures grown in various concentrations of IPTG. 
It was found that the three proteins showed a different response to the D18Q mutation at 
various concentrations of IPTG. For the Ikaros DZF domain, the ability of the protein to 
repress lacZ was completely abolished by the D18Q mutation even at very high levels of 
IPTG (Figure 4.3C, R. Fang). In contrast, overexpression of the mutated Hunchback DZF 
domain abolished repression only at IPTG concentrations below 10 μM, indicating that the 
effect of the mutation is very sensitive to the amount of expressed protein (Figure 4.3E). In 
the case of the Pegasus DZF domain, the D18Q mutation resulted in a small reduction of 
repression (Figure 4.3D) which is consistent with the data obtained in the B2H system (see 
section 3.4.1 and data not shown).  
In summary, the results of these assays demonstrated that the repression observed in the B1H 
assay is due to expression of the different domains since the level of repression depends on 
the amount of protein expressed in the cell. Furthermore, the D18Q mutation affected 
dimerization of Ikaros and Hunchback but not of Pegasus which was also found when this 
mutation was tested in the B2H system (see section 3.4.1). These results confirm the validity 
of using the B1H system to analyze dimerization mediated by the DZF domain.  
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4.3 Analysis of the Ikaros DZF domain 
 
4.3.1 Alanine scanning mutagenesis  
 
To investigate systematically which amino acids of Ikaros are critical for dimerization, the 
Ikaros DZF domain was studied using alanine-scanning mutagenesis (work performed by R. 
Fang). This approach should reveal residue positions that contribute to dimerization. 
To perform an alanine-scan of the Ikaros DZF domain a set of plasmids encoding mutant 
proteins was generated and assayed using the B1H system. PCR-mediated mutagenesis was 
used to introduce individual alanine substitutions at 47 different residue positions within the 
Ikaros DZF domain except at conserved positions that mediate zinc binding (cysteines and 
histidines). To analyze the effects of these mutations on homodimerization, plasmids were 
constructed encoding each of these 47 different mutants fused to λcI and introduced into the 
reporter strain to measure their β-galactosidase activity (R. Fang).  
Figure 4.4 shows the results of the alanine-scan. The cutoff for defining a dimer-defective 
mutant was set to >1.5 fold the β-galactosidase activity obtained with wild-type Ikaros DZF 
domain. This cutoff was chosen to include the standard error of these experiments which is 
typically about 10%. Thus, mutants displaying β-galactosidase units 1.5-fold higher than 
wild-type were considered to possess a significant dimerization defect. Mutations in 21 of the 
47 positions tested displayed β-galactosidase units comparable to that of the wild type (<1.5 
fold activation), suggesting that those residues are not directly involved in dimerization. 10 of 
these alanine substitution mutants exhibited slightly higher dimerization activity. Alanine 
substitutions in the remaining 26 positions tested significantly affected dimerization. The 
nature and importance of the various residue positions are described in more detail below.  
 
Predicted conserved hydrophobic residues: 
Alanine substituted mutants Y07A, F16A, Y22A, F35A and F50A affected residues which 
are likely to form the hydrophobic core of the C2H2 ZF since these residue positions are 
defined as conserved in the typical C2H2 ZF motif (Figure 4.1, see also section 1.2.3). These 
mutants were all severely defective in dimerization. It is noteworthy that residue position 44 
is also defined as highly conserved in the classical DNA binding C2H2 ZF and is typically a 
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phenylalanine. Interestingly, this residue is substituted by a serine in the Ikaros DZF domain 
and was not affected by an alanine mutation (see also section 4.7.3 below).  
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Figure 4.4 Alanine scan analysis of the Ikaros DZF domain in the B1H system. (A) Ikaros DZF 
mutants were tested for their ability to mediate homodimerization in the B1H system by performing β-
galactosidase assays. The cutoff for defining dimer-defective mutants was set to >1.5-fold the β-
galactosidase activity of wild-type Ikaros and is indicated by the red line. This cutoff was chosen to take 
account of the standard error of these experiments which is typically about 10%. Residues replaced by an 
alanine are shown below the graph and each substitution corresponds to the respective bar. Note that 
conserved cysteines and histidines are also shown but were not mutated. Residues were numbered 
according to McCarty et al., 2003 where the conserved tyrosine 2 residues before the first Zinc-ligating 
cysteine is defined as residue position 7. Controls expressing λcI and wild-type Ikaros are also shown. 
Regions defining the N-terminal ZF, linker and C-terminal ZF are indicated on the bottom of the residue 
sequence. Values are presented as the mean calculated from three independent experiments. (B) Summary 
of residues that were affected by an Alanine-substitution. Zinc ligating cysteines and histidines are 
highlighted in blue and conserved residues are highlighted in yellow (Phe/Tyr) and pink (hydrophobic 
residues). Residues that abolished dimerization when mutated are boxed. Typical secondary structures are 
indicated above the amino-acid sequence. Figure 4.4A was kindly provided by K. Joung. 
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Predicted β-sheets: 
Mutants E10A, H11A, V14A, L15A, L17A and D18A lie in the predicted ββ-sheet region of 
the first C2H2 ZF motif and were all dimerization defective, whereas mutants K08A and 
R13A did not affect dimerization. The ββ-sheet region in the second ZF contained five more 
residue positions that were affected by an alanine substitution (E36A, M39A, G41A, Y42A 
and D46A). Although we can not rule out that G41 participates in the interaction, we suspect 
that because of its features this residue is likely to play a structural role by for example 
providing flexibility in the β-sheet region of the second ZF. Mutations in the other residues in 
this region (N38A, H43A, S44A and Q45A) did not affect dimerization.  
 
Predicted α-helices: 
Residues 19-29 and 47-59 in fingers 1 and 2, respectively, are predicted to form the α-helix. 
Mutants M21A, I24A, M26A, I54A and R56A in these regions significantly disrupt the 
dimerization while mutations in the other residues of the α-helices (H19A, V20A, T23A, 
G27A, C28A, R47A, S51A, S52A, T55A, G57A and E58A) did not affect dimerization.  
 
Inter-finger linker: 
The region between the two individual C2H2 zinc fingers is termed the linker region and 
contains a highly diverse sequence throughout the different DZF domains. Mutations in three 
of these residues G30A, D33A and P34A, disrupted dimerization whereas mutations F31A 
and R32A had no effect.  
 
Overall, this preliminary study of the Ikaros DZF domain identified several residue positions 
that may contribute to dimerization. Theses residues are spread out throughout the whole 
DZF domain and could be directly involved in the interaction but could also affect the 
affinity indirectly, by for example changing the confirmation or stability of Ikaros. In fact, 
Western Blot analysis of the expression level of these mutated peptides in E. coli indicated 
that many of the mutants that are severely impaired in their ability to dimerize, are expressed 
at lower levels compared to the wild-type Ikaros DZF domain (R. Fang, personal 
communication). 
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4.3.2 Residue “swap” scanning mutagenesis 
 
To further narrow down specific residue positions in Ikaros important for dimerization, a 
similar strategy already described by McCarty and co-workers (2003) was taken. In this 
study, proteins harboring either single or double mutation were tested for their ability to 
heterodimerize with wild-type Ikaros using co-immunoprecipitation assays. In contrast, we 
decided to systematically analyze DZFs harboring single “swap” mutations for their ability to 
homodimerize, which is expected to be more stringent then examining heterodimerization 
with the wild-type protein (note that McCarty and co-workers further analyzed their 
identified mutants for homo-dimerization using chemical crosslinking assays which is a less 
stringent than e.g. co-immunoprecipitation). To do this, we constructed a large series of 32 
Ikaros “swap” mutants in which single residues in the Ikaros DZF domain were replaced with 
residues that correspond to the same position in the Hunchback DZF domain (residue “swap” 
mutants, Figure 4.5A). All mutants were expressed as a fusion to λcI in the appropriate 
reporter strain and assessed for their capability to homodimerize by performing β-
galactosidase assays (Figure 4.5B, work performed by R. Fang).  
The results are summarized in Figure 4.5C and agreed well with the previously described 
result. Mutations in 18 of the 32 positions tested displayed β-galactosidase units comparable 
to that of the wild type (<1.5 fold activation), suggesting that these positions are not 
important for dimerization. Swap mutations in the other 13 positions tested abolished 
dimerization. Interestingly, five of these mutants (Q45D, D46G, R47P, Y48V and E49G) are 
adjacent to one another and seem to form a patch in the second ZF. Q45D lies at the end of 
the predicted ββ-sheet, while the remaining residues (D46G, R47P, Y48V and E49G) are part 
of the predicted α-helix (with residue D46G representing position -1 of the α-helix). Note that 
position F50 is also affected by the swap mutation but is defined as conserved in the typical 
C2H2 ZF motif and is therefore likely to play a structural role in the C2H2 ZF fold. The 
remaining eight defective mutations are distributed throughout the DZF domain with 
mutations E10K, L17K and Y42E affecting residues lying in the predicted ββ-sheets, while 
mutations M21L, C28Y, G30S and G57N destroy residues that are part of the predicted α-
helices. Only one residue position in the linker region was found to be impaired by a 
mutation (P34V). In summary, this study of the Ikaros DZF domain exhibits additional 
insights into residues important for dimerization.  
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Figure 4.5 “Swap” scan analysis of the Ikaros DZF domain in the B1H system. (A) Sequence 
alignment of the Ikaros and Hunchback DZF domain. Residues that are different in both DZFs are 
highlighted in green and were used to construct “swap” mutants. See text for details. (B) “Residue swap” 
mutants were tested for their ability to abolish dimerization by introducing them into the B1H reporter 
strain and assessing their β-galactosidase activities. The cutoff for defining dimer-defective mutants is as 
defined in Figure 4.4 indicated by a red line. “Swap” mutations are indicated below the graph. Values 
represent the mean of three assays. (C) Summary of residues that were affected by a “swap” mutation. 
Zinc ligating cysteines and histidines together with conserved residues are highlighted in blue, yellow, and 
pink. Residue positions that were affected by a “swap” mutation are boxed. Predicted secondary structures 
are indicated above the amino-acid sequence and individual ZF are shown below. Figure 4.5B was kindly 
provided by K. Joung. 
Chapter 4. Mutational analysis of various DZF domains. 
 112
4.3.3 Comparison of mutants identified by alanine scan and “swap” scan analysis  
 
32 of the 47 alanine scan mutants bore substitutions at residue positions also tested in the 
swap mutation experiment described above. Comparison of the ability to dimerize for these 
32 pairs of mutants reveals that 23 pairs show the same dimerization phenotype (Figure 4.6). 
Substitutions in 13 of these residue positions consistently showed no effect on dimerization 
and are certainly not part of the interaction surface whereas mutations in the remaining ten 
positions significantly affected the ability to dimerize. However, nine residue positions 
yielded different results depending on which amino acids were used for substitution. For 
example, five positions were only impaired by an alanine replacement whereas for the other 
four positions only the “swap” mutation had an impact on dimerization. This suggested that 
in some cases the nature of the substituted side chain has to be considered since it may have 
an effect on the confirmation or the chemical properties of the whole protein.  
 
The remaining 15 of the alanine-scan mutants introduced substitutions at residue positions 
that are the same in both the Ikaros and Hunchback DZF domains and were therefore not 
tested in the residue “swap” experiments. 11 of these residue positions (Y7, F16, D18, Y22, 
I24, M26, D33, F35, M39, G41, and R56) were strongly affected by a mutation. These 
residues may participate in contacts at the dimer interface but could also destabilize the 
protein and therefore its ability to dimerize.  
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Figure 4.6 Comparison of the residues identified by alanine scan and “swap” scan analysis as 
important for dimerization of the Ikaros DZF domain. The results are projected on the amino acid 
sequence of the Ikaros DZF domain which is shown three times. Residues identified by alanine scan (A-
scan) analysis are highlighted in yellow and residues identified by “swap”-scan (S-scan) analysis are 
highlighted in green. A merge of both results is shown below, where residues identified as important in 
both scans are highlighted in turquoise while residues that consistently showed no effect are highlighted in 
grey. Blue asterisks mark residue positions that were analyzed by both scans. Bold letters indicated 
conserved residues. Numbering of residues is shown as defined in Figure 4.4. Individual fingers and 
secondary structures are also shown.  
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4.4 Analysis of the Hunchback DZF domain 
 
4.4.1 Alanine scanning mutagenesis 
 
An alanine scan was also performed with the DZF domain of Drosophila Hunchback PCR-
mediated mutagenesis was applied to introduce individual alanine substitutions at 49 different 
residue positions within the DZF domain except at positions occupied by the conserved 
cysteines and histidines. This set of mutant proteins was then assayed using the B1H system. 
As demonstrated in Figure 4.7, mutations in 18 of the 49 positions tested displayed β-
galactosidase units comparable to that of wild-type, suggesting that those residues are not 
directly involved in dimerization. Three of these alanine substitution mutants exhibited 
slightly higher dimerization activity. Alanine substitutions in the remaining 31 positions 
tested impaired dimerization.  
 
Predicted conserved hydrophobic residues: 
Mutations in the conserved hydrophobic residues (Y07A, F16A, Y22A, F35A and L50A) all 
severely affected the dimerization as was the case for Ikaros. Interestingly, residue C44 was 
also impaired by an alanine. As mentioned above, this residue position is normally conserved 
in the C2H2 ZF motif (and is typically a phenylalanine) but no effect was detected for the 
Ikaros DZF domain when this residue was mutated.  
 
Predicted β-sheets: 
Seven mutations (K10A, Y11A, C12A, I14A, F16A, K17A and D18A) in the predicted ββ-
sheet of the N-terminal finger and 5 mutations (K36A, C40A, G41A, D45A and G46A) in the 
ββ-sheet of the C-terminal finger disrupted dimerization whereas the remaining residue 
positions (E08, D13, N38, E42 and K43) in this region in both C2H2 ZFs seemed not to be 
impaired by alanine substitutions.  
 
Predicted α-helices: 
Affected residue positions in the predicted α-helices are L21, Y22, I24, M26, G27, Y28, V48, 
V52, M54, A55, R56 and A58 while the remaining positions (A19. V20, T23, S30, P47, G49, 
F51 and N57) in this secondary structure were not affected by alanine substitutions. 
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Inter-finger linker: 
The linker region between the N-terminal and the C-terminal finger contained 2 additional 
mutations D32A and D33A that displayed severe dimerization defects.  
Thus, this study identified several residue positions that may contribute to dimerization 
mediated by the Hunchback DZF domain. These residues could be directly involved in 
making contacts but could also be important for stability of the protein. Although some of 
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Figure 4.7 Alanine scan analysis of the Hunchback DZF domain in the B1H system. (A) Hunchback 
DZF mutations were tested for their ability to abolish homodimerization in the B1H system by performing 
β-galactosidase assays. The cutoff is indicated by the red line and defined as in Figure 4.4. Residues 
replaced by an alanine are shown below the graph. Note that alanine residues in the original DZF domain 
were always replaced by a glycine. Zinc binding cysteines and histidines are also shown but were not 
mutated. Residues are numbered as in Figure 4.4. Controls expressing λcI and wild-type Hunchback are 
also shown. Values represent the mean calculated from three independent assays. (B) Summary of residues 
that were affected by an alanine-substitution. Conserved residues are highlighted in blue, yellow and pink as 
described in Figure 4.1. Residues that effected dimerization when mutated are boxed. Predicted secondary 
structures and individual ZF with linker region are also indicated. 
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these residues are adjacent to one another, overall they are spread out throughout the whole 
domain.  
 
4.4.2 Residue “swap” scanning mutagenesis  
 
To further investigate dimerization mediated by the DZF domain “swap” mutation analysis 
was also applied to the Drosophila Hunchback DZF.  
 
To do this, 32 Hunchback “swap” mutants in which single residues were replaced with the 
corresponding residues from the Ikaros DZF domain were constructed. As described for the 
Ikaros DZF domain, we used PCR mutagenesis to individually introduce these mutations 
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Figure 4.8 “Swap” scan analysis of the Hunchback DZF domain in the B1H system. (A) “Residue 
swap” mutants are defined as in Figure 4.5A and were tested for their ability to abolish dimerization by 
performing β-galactosidase assays. The cutoff for “dimerization defective” is indicated by a red line and 
defined in Figure 4.4. “Swap” mutations are indicated below the X-axis. Values represent the mean of 
three experiments. (B) Summary of residues that were affected by a “swap” mutation depicted on the 
amino acid sequence of the Hunchback DZF domain. Conserved residues are marked in blue, yellow and 
purple and residue positions that were impaired by a mutation are indicated by boxes. Predicted secondary 
structures and individual ZFs are also shown.  
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within the Hunchback DZF domain and subsequently assessed the ability of each of these 
swap mutants to homodimerize using the B1H system. It was found that 18 mutants yielded 
β-galactosidase activity <1.5 fold of the wild-type activity, suggesting that they did not affect 
dimerization of Hunchback (Figure 4.8). Mutations in the remaining 14 residue positions 
weakened or abolished the interaction (Figure 4.8). Some of the disruptive “swap” 
substitutions occurred within the inter linker region (S30G, C31F and D32R) and at the 
predicted transition between the second β-sheet and the α-helix of the C-terminal finger 
(C44S, D45Q, P47R and V48Y). The remaining seven defective mutations (D13R, I14V, 
K17L, K36E, E42Y, F51S and V52S) are distributed throughout the DZF domain. Overall, 
these 14 residues may participate in contacts at the dimerization interface that are responsible 
for specificity of the Hunchback DZF domain.  
 
4.4.3 Comparison of mutants identified by alanine scan and “swap” scan analysis  
 
32 of the 49 residue positions differ in both Ikaros and Hunchback and were tested in both the 
alanine scan as well as in the residue swap experiments. Comparing the dimerization 
phenotype for these 32 pairs demonstrated that 18 pairs behaved the same in their ability to 
dimerize. Mutations in eight of the positions caused dimerization defects whereas mutations 
in the remaining ten positions did not affect dimerization. However, substitutions in 14 
residue positions displayed different effects when replaced with alanine or swapped with the 
corresponding Ikaros amino acid. Eight of these residue positions were affected by an alanine 
but not by a swap substitution, whereas six positions were only impaired by the “swap” 
substitution.  
The remaining 17 alanine mutations are at residue positions that are the same in both the 
Hunchback and Ikaros DZF domains and were therefore not tested in the residue swap 
experiments. 11 of these mutations (Y7A, F16A, D18A, L21A, I24A, M26A, G27A, D33A, 
F35A, G41A and R56A) possessed significant dimerization defects and may provide 
additional information about residues involved in contacts at the dimer interface. 
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4.5 Analysis of the Pegasus DZF domain by alanine scanning mutagenesis 
 
To perform an alanine scan of the Pegasus DZF domain, plasmids encoding 47 mutant 
proteins were generated as described for Ikaros and Hunchback. As before, this set of mutants 
was subsequently assayed using the B1H system.  
As shown in Figure 4.10, three types of mutants emerged from the alanine-scan. Mutations in 
22 of the 47 positions tested were silent having no effect on dimerization. Ten of the alanine 
substitution mutants exhibited higher dimerization activity and seemed to stabilize the protein 
or the interaction. Alanine substitutions in the other 15 positions tested weakened or 
abolished dimerization. The most disruptive alanine substitutions affected the conserved 
hydrophobic residues (H07A, F16A, Y22A, F35A, C44A and F50A). Since these residue 
positions define the predicted hydrophobic core it is likely that mutations in those amino 
acids destabilize the protein and therefore indirectly affect dimerization. Another severe 
mutation affected position N46, the last residue in the predicted second β-sheet of the C-
terminal ZF. The remaining 9 alanine substitutions only weakened the dimerization. Mutants 
H08A, H11A, D13A, M14A, Y15A and D18A are present in the predicted ββ-sheet region of 
the first zinc finger motif and mutant K43A lies in the ββ-sheet of the second zinc finger. An 
additional mutation at position L6 which is the first amino acid of the DZF domain abolished 
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Figure 4.9 Comparison of the residues identified by alanine scan and “swap” scan analysis as 
important for dimerization of the Hunchback DZF domain. The results are summarized on the amino 
acid sequence of the Hunchback DZF domain. Residues identified by A-scan analysis are highlighted in 
yellow in the first sequence and residues identified by S-scan analysis are highlighted in green in the 
second sequence. A merge of both results is shown below, where residues identified as important in both 
scans are highlighted in turquoise while residues that consistently showed no effect are highlighted in grey. 
Blue asterisks mark residue positions that were analyzed in both scans. Conserved residues are marked in 
bold letters. Numbering of residues is shown as defined in Figure 4.4. Individual fingers and typical 
secondary structures are also shown.  
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dimerization. Neither any residue positions in the α-helices nor in the inter-finger linker were 
affected by an alanine substitution.  
 
Overall, the alanine scan mutagenesis for the Pegasus DZF domain revealed only a few 
important amino acids which most likely are structural residues. Individual point mutations 
seemed not to be effective enough to disrupt dimerization of the Pegasus DZF domain. Note 
that the Pegasus DZF domain was not further analyzed by “swap” scan analysis. Since it 
appears that the interaction mediated by Pegasus is not selectively specific towards 
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Figure 4.10 Alanine scan analysis of the Pegasus DZF domain in the B1H system. (A) Pegasus DZF 
mutations indicated below the graph were tested for their ability to abolish homodimerization in the B1H 
system by assessing their β-galactosidase activities. The cutoff is indicated by the red line and defined as 
in Figure 4.4. Note that alanine residues in the original DZF domain were replaced by a glycine. Zinc 
binding cysteines and histidines were not mutated. Residues were numbered as in Figure 4.4. Controls 
expressing λcI and wild-type Pegasus are also shown. Values represent the mean determined from three 
independent assays. (B) Summary of residues that were affected by an alanine-substitution depicted on the 
amino acid sequence of the Pegasus DZF domain. Conserved residues are highlighted in blue, yellow and 
pink as described in Figure 4.1. Residues that abolished dimerization when mutated are boxed. Secondary 
structures and individual ZFs with linker region are also indicated. 
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Hunchback and Ikaros (Pegasus can mediate interaction with both Hunchback and Ikaros), 
swapping in residues from these two proteins will not offer new information about the 
specificity of this DZF domain-mediated interaction.  
 
4.6 Comparison of results obtained for different DZF domains 
 
4.6.1 Alanine scan mutagenesis for Ikaros, Hunchback and Pegasus 
 
Comparison of the alanine scan results for the Ikaros and Hunchback DZF domains reveals 
partially overlapping but also distinct sets of residues important for homodimerization 
(Figure 4.11A). Besides the predicted conserved structural residue positions (Y7, F16, Y22, 
F35 and F/L50, bold in Figure 4.11A) there are several residue positions (10, 11, 14, 17, 18, 
21, 24, 26, 33, 36, 41, 46, 48, 55 and 56) in both DZF domains that are affected by an alanine 
substitution. These residues are spread out across the DZF domain and are found in the 
predicted β-sheets, α-helices and the inter-finger linker region. Four mutations at residues 10, 
11, 17 and 18 are adjacent to one another and lie on the β-sheets of the C-terminal zinc finger. 
However, 14 alanine-scan mutants yielded different results for the Ikaros and Hunchback 
DZF domain. Of the 14 positions, six (15, 30, 34, 39, 42 and 49) were only affected in the 
Ikaros DZF domain whereas eight positions (27, 28, 32, 44, 45, 52, 55 and 58) had the 
reverse phenotype and were only impaired in the Hunchback DZF domain. These residues 
may define positions that are specifically important for the respective DZF. 
Including Pegasus in this comparison adds some supplementary information for 
understanding dimerization. In general the Pegasus DZF domain was only weakly affected by 
the alanine substitutions. Besides mutations in the conserved hydrophobic residue positions 
there were some additional mutations (L6, H8, D13 and K43) localized in the predicted ββ-
sheet region of the first and second zinc finger motif that disrupted dimerization. 
Interestingly, these positions were affected in neither the Ikaros nor the Hunchback DZF 
domain, suggesting these residues are specifically important for dimerization mediated by the 
Pegasus DZF domain. Otherwise, the result obtained with the alanine scan mutant at position 
14 was consistent with the result obtained in Ikaros while the effect of alanine at conserved 
position 44 was consistent with the effect this mutation caused in Hunchback. Substitutions in 
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the remaining four residue positions (11, 14, 18 and 46) disrupted dimerization which was 
also the case for Ikaros and Hunchback.  
 
4.6.2 Residue “swap” scan mutagenesis for Ikaros and Hunchback 
 
Comparison of the swap mutant results for the Ikaros and Hunchback DZF domains reveals 
some insights in how these DZF domains mediate dimerization (Figure 4.11B). Mutations in 
six of these residue positions (17, 30, 42, 45, 47 and 48) disrupted dimerization of both the 
Ikaros and the Hunchback DZF domain. Positions 10, 15, 21, 28, 34, 46, 49 and 57 were 
affected by a mutation only in the Ikaros DZF domain while positions 13, 14, 31, 32, 36, 44, 
51 and 52 showed the reverse result and were only affected by mutations in the Hunchback 
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Figure 4.11 Residues identified as important for dimerization for the Ikaros DZF domain compared 
to residues identified for the Hunchback DZF domain. The results are summarized and projected on the 
amino acid sequence of the Ikaros and Hunchback DZF domain. Conserved residues are marked in bold 
letters. Numbering of residues is shown as defined in Figure 4.4. Individual fingers and typical secondary 
structures are also shown. (A) Residues identified by A-scan analysis are highlighted in yellow. Identified 
residue positions found in both DZF domains are highlighted in red in the numerical identifier below. (B) 
Residues identified by “swap” scan analysis are highlighted in green and residue positions identified in 
both DZF domains are summarized in blue below.  
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DZF domain. Four Ikaros residues (Q45, D46, R47, Y48 and E49) which seemed to be very 
important for selectively were adjacent to one another and formed a patch on the predicted α-
helix of the C-terminal finger. A similar patch of residues (C44 D45 P47 and V48) was found 
in Hunchback. Here, additional residues (S30, C31 and D32) were present at the inter linker 
region which were not present in the Ikaros DZF domain. The rest of the affected residues 
were spread out for both DZF domains. Overall, this result confirmed the result of the 
alanine-scan and emphasizes that these two DZF domains share partially overlapping regions 
but use different specificity determinants.  
 
4.6.3 Comparison with result previously obtained for different DZF domains 
 
Other groups have identified residues in the DZF domains from Ikaros and Eos that are 
important for dimerization and the results of these studies compared to our findings will be 
discussed below (Sun et al., 1996; McCarty et al., 2003; Westman et al., 2004). As 
mentioned above, McCarty and co-workers performed a “swap” mutation analysis for the 
Ikaros DZF domain using mammalian-cell based chemical crosslinking or co-
immunoprecipitation assays to analyze the effect of these mutations. Sun and co-workers 
replaced 12 single residue positions in the Ikaros DZF domain with glycine (C9, C12, D18, 
H25, H29, C37, C40, D46 and E49), proline (V20 and M21) and histidine (G57) and used 
Y2H assays for analyzing these mutants. The last group (Westman et al., 2004) introduced 
pairwise alanine substitutions into all residues in the Eos DZF domain with the exception of 
defined structural amino acids and used Y2H assays to test for the abrogation of homo-
dimerization.  
Generally, our results for Ikaros matched well with those from McCarty and co-workers, 
although we found one mutation, D46Q that significantly abolished homodimerization in our 
system that was not detected in the previous study using co-immunoprecipitation. This 
divergent result may be due to the different methods used for analyzing the mutants. For 
example, the B2H system may generally be more sensitive for detecting dimerization defects. 
On the other hand, this mutant may have been expressed at lower levels in E. coli which 
resulted in an abrogation of homo-dimerization. Discrepancies are definitely present in the 
study of Sun and co-workers since none of their mutations (except in the structural residues) 
seemed to have an effect on dimerization. We obtained a similar result for the Pegasus DZF 
domain where, besides the structural amino acids, only few other residues were identified as 
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important. Consistent with Ikaros, important residues identified for Eos concern mainly the α-
helix in the first ZF, although additional residues were found that were not important for 
Ikaros dimerization (Westman et al., 2004). On the other hand, almost none of the residues in 
the second ZF were identified as important for Eos which is clearly different from the result 
obtained with Hunchback and Ikaros. Thus, differences appear for the various DZF domains 
and discrepancies occur when different methods are used (see also section 4.7.6).  
 
 
4.7 Discussion  
 
4.7.1 Overall fold of the DZF domain is expected to be similar to that of the classical 
C2H2 ZFs 
 
The work in this chapter was aimed at identifying residues important for affinity and 
specificity of DZF domain mediated homodimerization. The DZF domains from Ikaros, 
Pegasus and Hunchback were chosen because they interact in very specific and distinctive 
patterns despite a high degree of homology in their amino acid sequences. Despite their 
functions as mediators of protein-protein interactions (instead of DNA binding) both fingers 
in all three DZF domains match the conserved motif of classical C2H2 zinc fingers. 
Exceptions are the missing Phe/Tyr residue in the second finger (four positions after the 
second C, Figure 4.1) which is part of the predicted hydrophobic core and the linker between 
the two fingers, which differs from the highly conserved linker that usually connects DNA-
binding ZFs. Although these variations exist, studies of the individual C-terminal fingers 
from Eos and Pegasus using Circular Dichroism (CD), UV-Vis and NMR have shown that 
both domains individually fold in a manner similar to that of the classical C2H2 ZFs 
(Westman et al., 2004). In addition, the structure of the second finger in Eos was determined 
by NMR spectroscopy and revealed that the overall fold is similar to the typical ββα structure 
of other C2H2 ZFs although some significant differences exist (Westman et al., 2004; see 
also section 1.2.7.2). For example, the structure displays some conformational flexibility 
which could result in a rearrangement of the backbone and thereby of the zinc ligating 
residues. However, this finger contains a well organized hydrophobic core which is believed 
to stabilize the overall ββα-structure of classical C2H2 ZFs. This is somehow surprising 
given the fact that the invariant phenylalanine (four positions after the second C) of the 
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classical C2H2 ZF motif is missing (Westman et al., 2004). Closer examination of the 
hydrophobic core suggested that the loss of this bulky hydrophobic side-chain is partly 
compensated by the side-chains of a tyrosine (two positions after the second zinc ligating 
cysteine) and the invariant phenylalanine (2 positions before the first zinc ligating cysteines) 
as well as by the presence of a phenylalanine three residue positions before the first zinc 
ligating histidine (note that this residue position is defined as an invariant hydrophobic 
position in the classical C2H2 ZF motif). These three residues are positioned closer to the 
center of the hydrophobic core and may help maintaining the overall structural integrity of 
this C2H2 ZF (Westman et al., 2004). Because of the high sequence homology between the 
various DZF domains (see section 3.2.1) it may be reasonable to assume that the overall fold 
of the DZF domain is constant for the different proteins and represents a scaffold upon which 
the residues important for contacting other proteins in a specific manner are displayed. 
 
4.7.2 Mutational analysis narrowed down residue positions that might be important for 
dimerization  
 
To identify residues that are important for dimerization affinity, a mutational analysis of the 
DZF domains from Ikaros, Pegasus and Hunchback was performed using alanine and “swap” 
mutation scans. Note that the Pegasus DZF domain was only analyzed by alanine scan 
mutagenesis and only a few residue positions were found to be affected by such a mutation. 
Individual point mutations seemed not to be effective enough to disrupt dimerization. A 
possible reason for this could be that the binding energy of this interaction is generally higher 
compared to Ikaros and Hunchback. However, since we can not rule out that the introduced 
mutations affected stability of the protein, this may just indicate that Pegasus is more stable 
and the structure of the peptide can be maintained despite the presence of mutations.  
For Ikaros and Hunchback, several residues could be identified that were affected in their 
ability to mediate homodimerization when replaced by a different amino acid. Mutations at 
these positions may disrupt specific contacts at the dimerization surface, indicating that these 
positions are essential for dimerization, but we can not rule out that these positions were 
simply important for stability of the structure or rather solubility of the protein. In addition, 
some mutated proteins might have been toxic to the cells and were not expressed at high 
levels which would also result in a diminished ability of the domain to dimerize. In any case, 
several residues were not defective in their ability to homodimerize when replaced by a 
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mutant and are therefore unlikely to contribute substantially to the interaction surface (see 
Figures 4.6 and 4.9). 
 
4.7.3 Results of alanine scan and “swap” scan analysis are generally consistent 
 
The DZF domains of Ikaros and Hunchback were analyzed by both alanine scans and “swap” 
scans. Although the results of these two scans were generally very consistent for each DZF 
domain, there are some residue positions where only one of the two introduced mutations 
showed an effect on dimerization. For example, in both DZF domains several positions were 
only affected by an alanine and not by the corresponding swap residue. Introducing “swap” 
residues that are not directly involved in mediating contacts may be less severe since these 
residues supposedly help maintaining the structural integrity of another (either Ikaros or 
Hunchback) DZF.  
At other positions the opposite phenotype was observed and only the swap mutation had an 
effect on dimerization. For example, in the Ikaros DZF domain positions 45 and 47 are both 
affected by the respective swap mutation, suggesting that they are important for the 
interaction. In addition, both positions are adjacent to other residues identified as important 
for dimerization. However, introducing an alanine at these positions did not cause a 
dimerization defect. An explanation for this phenomenon could be that in these cases the 
swap residue may have had an effect on neighboring amino acid residues by, for example, 
changing the arrangement of these residues, which in turn caused changes in the orientation 
of the interaction surface. A similar argument can be made for residues 47 and 51 in the 
Hunchback DZF domain, which are only affected by the corresponding swap mutation. Both 
positions are close to other residues defined as important and mutations at these positions 
may act on nearby essential residue positions.  
Thus, it is noteworthy that in some cases the nature of the substituted side chain has to be 
considered since it may have an effect on the confirmation or the chemical properties of the 
whole protein. Some of the side chains in the “swap” mutations may have been inappropriate 
for testing the potential function and importance of the original side chain present in the wild-
type protein. Thus, results from both scans have to be considered and compared before one 
can make conclusions about potential important residue positions. Although it is difficult to 
define residue positions that make contacts at the interaction interface, those amino acids 
Chapter 4. Mutational analysis of various DZF domains. 
 125
which were not defective in dimerization when replaced by an alanine or “swap” residue are 
definitely not important for dimerization. 
 
4.7.4 Several structural and hydrophobic residue positions were affected by a mutation 
 
Residues identified by alanine scan and “swap” analysis were generally distributed 
throughout the whole domain except for Pegasus where most of the residues were found in 
the predicted β-sheets of the N-terminal ZF. Many of them are defined as likely structural 
amino acids important for maintaining the ββα structure (e.g. positions 07, 16, 22, 35 and 50). 
Position 44 is a phenylalanine in the classical C2H2 ZF motif and is believed to be involved 
in maintaining the hydrophobic core of the ββα fold. Interestingly, as described for Eos, this 
residue is substituted by a serine in the Ikaros DZF domain and was not affected by a 
mutation. On the other hand, residue positions 35, 42 and 48 were impaired by a mutation 
and these residues are believed to be involved in maintaining the hydrophobic core in the Eos 
C-terminal C2H2 ZF (see section 4.7.1). This suggests that the hydrophobic core and the 
overall structure of the C-terminal C2H2 ZF of Ikaros are similar to the corresponding Eos 
ZF. On the other hand, both Hunchback and Pegasus harbor a cysteine at position 44 and 
introducing a mutation at this position affected the ability of these proteins to dimerize. Thus, 
different residue positions may be involved in maintaining the hydrophobic core of these two 
proteins.  
Besides these defined hydrophobic and aromatic residue positions a few other hydrophobic 
amino acids were identified as important in the DZF domains, which are mainly present in 
the N-terminal C2H2 ZF. Hydrophobic residues have been found to be abundant in various 
protein-protein interaction surfaces suggesting that they are sufficient to stabilize protein 
complexes (Lo Conte et al., 1999; reviewed in Jones and Thornton, 1996). In fact, analysis of 
residue pairing preferences at protein interaction interfaces has shown that the most prevalent 
pairing involves amino acid interactions between hydrophobic residues (Glaser et al., 2001). 
Thus, hydrophobic residues identified as important for the DZF domain are likely to be 
involved in the interaction surface, possibly by providing the necessary binding energy for 
the DZF interaction in general. They could be participating in making initial contact with 
other DZF domains. Using van der Waals interactions they may stabilize this primary 
dimerization complex upon which the specific tight interactions are eventually established. 
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On the other hand, they may just contribute indirectly to the dimerization by both orientating 
and stabilizing the protein backbone in a way that the interaction surface is exposed.  
 
4.7.5 Residue positions important for specific dimerization are mainly located in the 
predicted α-helices of the DZF domains 
 
Importantly, the result of the “swap” scan analysis demonstrated that some of the identified 
residues in the Ikaros DZF domain are adjacent to one another and have been suggested to 
form clusters on the surface of the protein using homology modeling (McCarty et al., 2003). 
Most striking is the patch in the C-terminal finger formed by five adjacent residue positions 
(Q45, D46, R47, Y48 and E49) that were all affected by a mutation and are very likely to 
cluster on the surface of the domain. Within the N-terminal finger, residue positions 17, 21 
and 28 were expected to cluster as well and these three positions were all important for 
dimerization as judged by our mutational analysis. Interestingly, both regions correspond to 
the α-helix which is known to contact specific DNA sites in DNA binding ZFs (McCarty et 
al., 2003; reviewed in Wolfe et al., 2000; see also section 1.2.4). These base contacts are 
mainly made by amino acids at positions -1, 2, 3 and 6 of the α-helix, although variations of 
this pattern have been described as well. Examples are ZFs 4 and 5 from GLI that use α-helix 
residues at positions 1 and 5, respectively to contact specific DNA-sites (Pavletich and Pabo, 
1993). In addition, the residue at position 10 has been described to form important base 
contacts for ZF3 of TFIIIA (Wuttke et al., 1997). Within the C-terminal DZF finger of 
Ikaros, the cluster of residues that is suggested to contribute to selectivity lies between 
positions -2 and +4, although position 4 is occupied by a hydrophobic core residue (F50) and 
is therefore not directly involved in making protein contacts (McCarty et al., 2003). The 
candidate residues found in the predicted α-helix of the N-terminal ZF in the Ikaros DZF 
domain correspond to positions -2, +3 and +10 of the recognition helix (McCarty et al., 
2003). It is noteworthy that besides these two clusters in the predicted α-helices several other 
positions were affected which are distributed throughout the whole domain including the β-
sheets and the linker region.  
The hunchback DZF domain displays a similar but distinct group of adjacent residues (C44, 
D45, G46, P47 and V48) in the second ZF located in the predicted C-terminal end of the β-
sheet and in the predicted N-terminal α-helix. These residues correspond to positions -3 to +3 
of the recognition helix and may also form an exposed cluster on the surface of the protein 
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assuming that the overall ββα fold of this domain is similar to the one modeled for Ikaros 
(McCarty et al., 2003). There was no obvious cluster found in the α-helix of the N-terminal 
ZF which is in contrast to the result obtained for Ikaros. Rather, additional residues (S30, C31 
and D32) are present within the inter linker region and these positions were not identified as 
being important for dimerization in the Ikaros DZF domain. The remaining affected residues 
were mainly found in the predicted β-sheet region of the domain.  
 
4.7.6 A potential role for the linker in mediating specific dimerization  
 
Another notable feature of these results is the potential role of the linker region for 
dimerization specificity. In general, the linker connecting the individual fingers in the DZF 
domain motif is different from the conserved TGEKP linker that normally links DNA-
binding zinc fingers. Furthermore, three residues inclined to be important for dimerization are 
found as a cluster in the linker region of the Hunchback DZF domain although it is not clear 
if these residues are directly involved in making specific contacts with other DZF domains. 
Ikaros on the other hand contains a rigid proline residue at position 34 which appears to be 
necessary for dimerization. This residue may play a role in decreasing general flexibility of 
the protein (note that Hunchback has a valine residue at this position). Thus, it is possible that 
the linker is essential to maintain a defined orientation of the two ZFs in the DZF domain 
which in turn is important for selectivity of the interaction.  
 
4.7.7 Different DZF domains are likely to use different residue positions for mediating 
specific dimerization  
 
Comparing the results obtained for the Ikaros and Hunchback DZF domain highlights both 
similarities and differences. For instance, the result for both DZF domains suggests that the 
predicted N-terminus of the α-helix in the second C2H2 ZF is important for dimerization 
specificity (McCarty et al., 2003). On the other hand, an additional important cluster of 
residues is found in the predicted α-helix of the first ZF in the Ikaros DZF domain and this 
cluster is missing in the Hunchback protein. Thus, this cluster may be important for 
dimerization of Ikaros, but not for Hunchback. Other groups have identified residues in the 
DZF domains from Ikaros and Eos that are important for dimerization (McCarty et al., 2003; 
Westman et al., 2004). In general, our results matched well with those obtained in these 
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studies, indicating, that the predicted N-terminal end of the α-helix is generally important for 
dimerization. While Hunchback dimerization relies mainly on the predicted α-helix in the 
second finger, Eos seems to require the α-helix of the first ZF. Ikaros on the other hand seems 
to use the α-helices of both fingers. Thus, it appears that differences exist for the various DZF 
domains. Although it is difficult to interpret these variations, it may indicate that different 
molecular mechanisms are used for mediating dimerization which in turn contributes to the 
specificity of the DZF domain and might explain the various interaction specificities between 
them (see Chapter 3). Hence, DZF domains may generally share overlapping regions for 
mediating dimerization but use different specificity determinants for their interactions. It is 
important to note that recent studies by Westman and co-workers (2003) suggested that the 
Eos DZF domain mediates the formation of multimeric complexes consisting of as many as 
ten molecules. In addition, Ikaros has been reported to form a multimer as well (Trinh et al., 
2001; McCarty et al., 2003). Thus, the different interactions surfaces described for the 
various DZF domains may account for different multimerization states of the respective 
DZFs.  
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Chapter 5. Steps towards determining the structure of the DZF 
domain. 
 
5.1 Introduction 
 
Although numerous examples of protein-protein interactions mediated by C2H2 ZFs have 
been described, there is still relatively little structural information available about how C2H2 
ZFs mediate protein-protein interactions. Unfortunately, only a few structures of C2H2 ZFs 
involved in protein binding have been described (see also section 1.2.7.2). For example, the 
structure of the C-terminal C2H2 ZF of Eos which is part of the DZF domain has been solved 
using NMR spectroscopy. This structure revealed both similarities and differences to the 
typical ββα fold of the C2H2 ZFs (Westman et al., 2004; see section 1.2.7.2) but does not 
provide information about C2H2 ZF mediated dimerization. Other initial attempts to obtain 
biochemical information about C2H2 ZF mediated protein-protein interactions have been 
performed, but no structure of a C2H2 ZF interacting with another protein has been described 
to date. In contrast, much progress has been made in understanding DNA recognition 
mediated by C2H2 ZFs and structures of various DNA-binding C2H2 ZFs bound to their 
DNA sites have been described in detail (Pavletich and Pabo, 1991; Pavletich and Pabo, 
1993; Elrod-Erickson et al., 1996; Houbaviy et al., 1996; Kim and Berg, 1996; Nolte et al., 
1998; reviewed in Wolfe et al., 2001). We therefore attempted to use X-ray crystallography 
to obtain detailed structural information of a dimeric or multimeric DZF complex. This 
structure together with mutational information (see Chapter 4) should identify specific 
surfaces and residues within the C2H2 ZFs that are involved in this protein-protein 
interaction.  
To determine high-resolution crystallographic structures of DZF domains, we sought to 
purify milligrams of highly pure peptides from different DZF domains which could then be 
used for X-ray crystallography (in collaboration with Dr. Robert Grant of the X-Ray 
Crystallography Core Facility in the Department of Biology at the Massachusetts Institute of 
Technology [MIT]). We decided to follow a previously described strategy which was 
successfully used to purify various C2H2 DNA-binding ZF domains containing 2 to 5 fingers 
for crystallographic studies (Figure 5.1, Pavletich and Pabo, 1991; Pavletich and Pabo, 1993; 
Elrod-Erickson et al., 1996; Elrod-Erickson et al., 1998).  
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In this approach, ZF domains are over-expressed in E. coli and isolated from inclusion 
bodies. The presence of peptides in inclusion bodies can generally be beneficial since the 
over-expressed protein often dominates in inclusion bodies taking up > 50% of the total 
cellular protein content. In addition, they provide protection for the peptide from proteolytic 
degradation as well as for the cell against the potential toxicity of the peptide (reviewed in 
Lilie et al., 1998; Clark, 1998). ZF peptides are subsequently solubilized under denaturing 
and reducing conditions. To further purify solubilized C2H2 DNA-binding ZFs, successive 
rounds of cation exchange (using Fast Protein Liquid Chromatography [FPLC]) and reverse-
phase (using High Performance Liquid Chromatography [HPLC]) chromatography were used 
(Elrod-Erickson et al., 1998). Cation exchange chromatography was carried out under 
denaturing conditions (using a Source 15S column) and the denaturant was subsequently 
removed by reverse-phase (RP) chromatography (using a C4 column). After these various 
successive purification steps, the biological activity of the peptide has to be recovered by 
refolding it back to its native form. Since ZF proteins are prone to oxidation, care must be 
taken to refold them under anaerobic conditions. So far, various C2H2 ZFs were successfully 
re-folded by applying different buffer-conditions (Pavletich and Pabo, 1991; Pavletich and 
Pabo, 1993; Elrod-Erickson et al., 1996; Elrod-Erickson et al., 1998). Folding reactions can 
be performed in the presence of cobalt instead of zinc. Coordinated binding of the Co2+ ion 
by the cysteines and histidines leads to the reduction of cobalt which results in a color change 
Bacterial whole cell
lysates
Isolation and Solubilization of
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Cation Exchange
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RP 
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Cation Exchange and RP
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Figure 5.1 Purification strategy for C2H2 
ZFs. This strategy was successfully applied to 
purify various DNA-binding ZFs for setting up 
crystallization trials. RP, reverse phase. See text 
for details.  
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of the sample from clear to blue. Thus, the color change can be used as a preliminary 
indicator of successful folding events (Pavletich and Pabo, 1991). Mobility shift experiments 
were performed to show, that the refolded DNA-binding C2H2 ZF was active and able to 
bind to its specific DNA binding site. To separate active peptides from inactive forms, two 
additional purification steps were performed. The folded C2H2 ZF was first purified on a 
MonoS cation exchange column with a NaCl gradient and was subsequently loaded onto a C4 
RP HPLC column to perform another round of RP chromatography. Resulting pure and 
active peptides were then used for setting up crystals (Pavletich and Pabo, 1991).  
This chapter describes the over-expression and partial purification of DZF domains from 
several Ikaros family members. It further delineates various attempts to refold these DZFs 
into stable active peptides.  
 
 
5.2 Overexpression and purification of the Pegasus DZF domain  
 
5.2.1 Overexpression of the Pegasus DZF domain  
 
Overexpression of peptides was performed in the pET E. coli expression system under the 
control of an IPTG-inducible promoter. We constructed a pET3a derived expression plasmid 
which expressed a segment encoding the DZF domain of human Pegasus under control of a 
strong T7 phage promoter. This plasmid was introduced into the E. coli strain 
BL21(DE3)pLysS, in which the T7 RNA polymerase expression is controlled by the Lac 
repressor. To test, whether this peptide can be overexpressed, IPTG was added to the E. coli 
cells to induce expression. Analysis of whole cell lysates from uninduced and IPTG induced 
cells using SDS PAGE revealed that a peptide of the predicted molecular weight of 7.14 kD 
(Table 5.1) is expressed at high levels (Figure 5.2A, lane 2). Control experiments 
demonstrated that the expression of this peptide is dependent upon induction by IPTG since 
uninduced cells did not express the peptide (Figure 5.2A, lane 1). In addition, SDS-PAGE 
analysis of soluble fractions and inclusion bodies from lysates of the induced cultures 
indicate that the Pegasus DZF peptide is primarily localized within the inclusion body 
fraction (Figure 5.2B, lane 2).  
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5.2.2 Purification of inclusion bodies and solubilization 
 
To further investigate whether the Pegasus DZF peptide can be captured by isolating 
inclusion bodies, we harvested 2 liter cultures of E. coli cells expressing the Pegasus DZF 
domain peptide. The cells were lysed using a freeze/thaw protocol and by adding detergents 
(see section 2.4.2.2). After centrifugation, the inclusion body pellet was washed with a buffer 
containing chaotropic agents and detergents. To solubilize the peptides, inclusion bodies were 
resuspended in a buffer containing a strong denaturant (urea) and a reducing agent (DTT). 
SDS-PAGE analysis of the purified and solubilized inclusion bodies demonstrated that most 
of the Pegasus peptide was soluble (Figure 5.2C lane 3) under denaturing conditions although 
some peptide was still trapped in the insoluble pellet (Figure 5.2C lane 4). Samples of the 
supernatant were taken after every wash step (pellet wash 1 and 2, see section 2.3.2.2) and 
also analyzed by SDS-PAGE (Figure 5.2 lane 1 and 2). While the supernatant of pellet wash 
1 contained some contaminants that probably absorbed onto the hydrophobic inclusion 
bodies, the supernatant of pellet wash 2 was clean. Thus, isolation of inclusion bodies can be 
used to capture the Pegasus DZF peptides from cell lysates. 
 
10 kD 10 kD
A B
10 kD
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Figure 5.2 SDS-PAGE analysis of the over-expression and purification of the Pegasus DZF. (A) 
Analysis of whole cell lysates from uninduced (lane 1) and induced (lane 2) bacterial cell cultures 
transformed with a plasmid encoding the Pegasus DZF domain. Induction was performed at 37˚C for 
three hours by adding 0.4 mM IPTG. (B) Analysis of soluble fractions (lane 1) and inclusion bodies (lane 
2) from whole cell lysates obtained in A. (C) Analysis of samples taken during the inclusion body 
purification and solubilization. Lane 1 = wash step 1, lane 2 = wash step 2. lane 3 = solubilized peptide, 
lane 4 = inclusion bodies. Red arrow indicates band which corresponds to the Pegasus DZF peptide. 
Black arrow indicates 10 kD band of Standard (Precision Plus protein standard, Biorad) which was run 
simultaneously with the samples (data not shown). See text for details.  
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5.2.3 Ion exchange chromatography 
 
To purify the solubilized Pegasus DZF peptide, cation exchange chromatography was used 
under denaturing conditions. Separation in ion exchange chromatography is based on the 
reversible binding of a charged peptide to an oppositely charged medium. Cation exchangers 
are negatively charged and have positively charged counter-ions (cations). Thus, peptides to 
be bound to the exchanger have to carry a “net” positive charge. Since most proteins are both 
positively and negatively charged the “net” surface charge of a protein is usually influenced 
by the composition of the surrounding medium. Thus, at a certain pH value termed as the 
isoelectric point (pI) a protein will have zero “net” charge. Below its pI a protein has a “net” 
positive charge and can bind to cation exchangers. To assure that Pegasus binds reliable to 
the negatively charged exchangers, we decided to initially choose a buffer which was at least 
1 pH unit below the pI of Pegasus. The estimated pI value for the Pegasus DZF peptide was 
6.7 (Table 5.1). Thus, the peptide was loaded on a Source 15S cation exchange column in a 
buffer of pH 5.0 that also provided denaturing and reducing conditions (Buffer A). 
Conditions were then altered so that the bound molecules were eluted differentially using a 
N.d.N.d.N.d.N.d.N.d.3503.2Hd C-finger
N.d.N.d.N.d.N.d.N.d.3752.5Hd N-finger
N.d.N.d.N.d.N.d.N.d.4397.1Ik C-finger
N.d.N.d.N.d.N.d.N.d.4156.2Ik N-finger
N.d.N.d.N.d.N.d.N.d.19449.2Pe-Zif268
640065 %29-31 %HEPES 7.58.518626.3Zif268-Pe
384072-76 %8-10 %MES 5.05.87066.4Tr-Eo-Eo
384068-72 %10-12 %MES 5.56.66898.1Hc
N.d.N.d.N.d.N.d.N.d.6587.0Hd
5120Not recordedNot recordedMES 5.06.77700.2Ik
256074-79 %10-12 %MES 5.06.07056.4Tr
512068-72 %12-13.5 %MES 6.06.77135.5Pe
Extinction 
coefficient at 
280 nm (units 
of M-1 cm-1)
Conc of buffer B 
required for 
eluting peptide of 
column (C4)
Conc of buffer B 
required for eluting 
peptide of column 
(source 15S)
Composition 
of buffer A 
for loading 
onto column
pI valueMolecular 
weight (kD)
Peptide
 
 
 
Table 5.1 Biochemical properties of peptides and applied buffer conditions. This table summarizes 
information about the various peptides (shown in first column) required to perform the different 
purification steps and folding reactions. Cells displaying N.d. (not determined) belong to peptides that 
were not further purified. Abbreviations are as defined in Figure 3.4 (Chapter 3). N-finger, N-terminal ZF; 
C-finger, C-terminal ZF; Conc, concentration. Source 15 S and C4 indicate the respective column (see 
section 2.4.2.3 and 2.4.2.4). See text for details.  
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NaCl gradient (Buffer B) where increasing salt concentration gradually displaced the peptide 
on the column.  
 
A trial chromatography run showed 4 peaks (2 small and 2 major peaks), which eluted at 
different concentrations of buffer B (Figure 5.3A). To find out, which peak contains the 
Pegasus peptide, the peak fractions and several fractions adjacent to the peaks were collected 
and analyzed by SDS-PAGE and subsequent silver staining. As shown in Figure 5.3B, the 
Pegasus DZF peptide eluted in a very broad range between 12-25% of buffer B, although the 
majority was located in peak C. This suggested that the peptide bound too tightly to the 
negatively charged exchangers and could therefore not be eluted efficiently in a single 
fraction. In addition, the Pegasus peptide eluted close to another protein which decreased the 
purity of the preparation.  
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Figure 5.3 Analysis of the initial ion exchange chromatography run applied to purify the Pegasus 
DZF domain. (A) Analytical FPLC trace for the DZF domain from Pegasus. Peptides were loaded onto 
the column in buffer A (pH 5.0). Bound peptides were eluted over ~40 min using a Buffer B gradient 
(shown in green). UV trace measuring the Absorbance units (mAU) is shown in blue. Peaks obtained are 
numbered A, B, C and D. (B) SDS-PAGE analysis of the FPLC run from (A). Peak fractions A-D together 
with several fractions (2-9) taken at different time points were analyzed. Lane 1 represents a sample of the 
solubilized peptide before it was loaded onto the column. Red arrow indicates Pegasus DZF domain band 
and black arrow indicates 10 kD band deduced from Standard. See text for details.  
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Therefore, we decided to increase the pH of Buffer A to 6.0 with the hope that the Pegasus 
DZF peptide would bind less tightly to the column. As shown in Figure 5.4A, under these 
conditions four well-defined peaks eluted at different concentrations of buffer B. Analysis of 
the chromatography run by SDS-PAGE and silver staining demonstrated that the Pegasus 
peptide eluted as a single peak between 12-13.5% of buffer B, although there is still some 
peptide eluting even at lower concentrations of buffer B. The captured sample contained 
mainly the Pegasus peptide as judged by silver staining (Figure 5.4B). Increasing the pH of 
Buffer A even further did not improve the elution profile and the majority of the peptide did 
not bind to the column at all (data not shown).  
 
We tested if larger amounts of the Pegasus peptide could be purified when the protein 
purification was scaled up. For this experiment, pH 6.0 for Buffer A was used and a 
shallower gradient of buffer B was used for eluting the protein. Analysis of the 
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Figure 5.4 Analysis of an ion exchange chromatography run applied to purify the Pegasus DZF 
domain. (A) Analytical FPLC trace for the DZF domain from Pegasus. Peptides were loaded onto the 
column in buffer A (pH 6.0). Bound peptides were eluted using a Buffer B gradient (shown in green). UV 
trace is shown in blue. Peaks are numbered A, B, C and D. (B) SDS-PAGE analysis of the FPLC run 
from (A). Peak fractions A-D together with several sample fractions (2-10) were analyzed. Lane 1 
represents the solubilized peptide. Red arrow indicates Pegasus DZF domain band (contained in sample 
C) and black arrow indicates 10 kD band of Standard.  
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chromatography run demonstrated that the Pegasus peptide eluted as a single peak between 
11-12% of buffer B (data not shown). The amount of protein was increased compared to the 
small scale run as judged by the absorbance units and the captured volume.  
 
5.2.4 Reverse phase chromatography 
 
To further purify the Pegasus DZF peptide, RP chromatography (using HPLC) was applied. 
Using this approach, peptides are separated based on their “hydrophobic character”. Peptides 
adsorb to the hydrophobic nonpolar surface of the column after applying them in a polar 
mobile phase by interaction of the nonpolar components of the proteins with the hydrophobic 
nonpolar stationary phase. Compounds are eluted from RP HPLC columns by decreasing the 
polarity of the mobile phase using organic solvents which results in desorption of the protein. 
To assure that separation is solely based on hydrophobicity, the effective charges of the 
peptide have to be reduced before loading it onto the column. This can be accomplished by 
reducing the pH (typically to 2) and at the same time providing an ion-pairing reagent (e.g. 
TFA) that “hides” the resulting positive charges by forming “ion pairs” with them. 
Thus, the sample was acidified with 10 % TFA to pH 2-3 to provide binding to the 
hydrophobic stationary phase of the C4 reverse phase column that is solely based on the 
hydrophobic character of the peptide. The protein was then loaded onto the column using 
nonpolar buffer conditions (Buffer A, consisting of water with 0.1 % TFA). Molecules were 
eluted differentially with an organic mobile phase (Buffer B, containing acetonitrile with 0.1 
% TFA) that was introduced gradually. As shown in Figure 5.5A, three major peaks eluted at 
different concentrations of buffer B. Several fractions together with the peaks were captured 
and analyzed by SDS-PAGE and subsequent silver staining demonstrating that the Pegasus 
DZF domain eluted as a single peak between 68-71 % of buffer B (Figure 5.5B). In addition, 
the captured sample was highly pure and contained only the Pegasus DZF domain. (Note that 
the other peaks did not contain any proteins and are likely to represent buffer and DTT 
eluting from the column). The same buffer conditions were then used to scale up the sample 
amount using a shallower gradient for eluting the peptide. As expected, this chromatography 
run yielded more protein as judged by the absorbance units and the captured volume (data not 
shown). The HPLC peak fraction corresponding to the Pegasus DZF peptide was 
subsequently lyophilized and the dried product was moved to an anaerobic chamber.  
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5.2.5 Refolding 
 
After these successful purification steps, we attempted to refold the Pegasus peptide with 
either cobalt or zinc. To do this, the dried peptide was resuspended in water (in an anaerobic 
chamber) and the protein concentration was determined (~ 25 mg/ml in this initial 
experiment). To attempt refolding the peptide in its active form, 1.5 molar equivalents of 
cobalt were added and the pH was adjusted by introducing different buffers. The solution of 
dissolved Pegasus peptide immediately turned blue after adding the buffer, suggesting that 
the peptide was coordinating the cobalt ion (data not shown). However, insoluble aggregates 
accumulated immediately following appearance of the blue color. Spinning down the sample 
demonstrated that the aggregates represented the refolded peptide since the precipitate was 
blue and the supernatant did not harbor any detectable protein as judged by UV absorbance 
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Figure 5.5 Analysis of the Reverse Phase (RP) chromatography run applied to further purify the 
Pegasus DZF. (A) Analytical HPLC trace for the DZF domain from Pegasus. Bound peptides were eluted 
over ~ 60 min using a Buffer B gradient (shown in turquoise). UV trace is shown in purple. Collected 
peaks are numbered A, B, C. (B) SDS-PAGE analysis of the HPLC run from (A). Peak fractions A-C 
together with several fractions (2-9) taken at different time points were collected and analyzed. Lane 1 
represents a sample of the acidified peptide before it was loaded onto the column. The red arrow indicates 
the Pegasus DZF domain band and the black arrow indicates where the 10 kD band of the Standard ran.  
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measurement. Using zinc instead of cobalt or performing the folding reaction on ice also 
resulted in a precipitation of protein following adjustment of the pH. 
The efficiency of refolding depends in general on the competition between correct folding 
events and aggregation (reviewed in Lilie et al., 1998). Thus, it is very important to slow 
down the aggregation process in order to obtain correct folded and biological active protein. 
There a various biochemical variables that influence the formation of properly folded protein 
which were gradually evaluated as described below.  
 
5.2.5.1 Protein concentration 
A very direct way of minimizing aggregation is by reducing the concentration of the protein, 
since aggregation usually happens at high concentrations of proteins (reviewed in Clark, 
1998). Thus, the protein concentration of the Pegasus DZF peptide was decreased stepwise 
by serially diluting purified unfolded peptide with water. The following final concentrations 
of protein were tested in this experiment: 10, 0.1, 0.05, 0.001 and 0.0001 mg/ml. We 
attempted to re-fold these diluted peptides using the method described above and the color 
change was monitored. The result of this experiment showed that reduction of the protein 
concentration still led to formation of precipitates. Going below a certain protein 
concentration (< 0.001 mg/ml) did not permit detectable levels of blue color anymore (as 
determined by eye).  
 
5.2.5.2 Folding buffer composition (pH, ionic strength) 
Other variables that influence the stability of the proper folded state are the pH and the ionic 
strength of the folding buffer (reviewed in Clark, 1998; reviewed in Lilie et al., 1998). Thus, 
different buffer conditions (pH 5.0 to pH 8.0) were used and salt was added at various 
concentrations to refold the protein. As shown in Table 5.2, the peptide folded but 
precipitated at pH 7.0 - 8.0 but then was not able to fold at pH 5.0 or pH 6.0 as judged by the 
color change or lack thereof. Adding salt at different concentrations did not prevent 
precipitation once the protein was folded (Table 5.3). Introducing salt to the folding reaction 
before adding cobalt resulted in an immediate precipitation and the color did not change, 
even after introducing cobalt.  
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Buffer, pH Folding phenotype 
0.5 M MES, pH 5.0 No change in color. No precipitation 
0.5 M MES, pH 6.0 No change in color. No precipitation 
1 M HEPES, pH 7.0 Blue precipitate 
1 M BTP, pH 7.0 Blue precipitate 
1 M HEPES, pH 7.5 Blue precipitate 
1 M BTP, pH 7.5 Blue precipitate 
1 M HEPES, pH 8.0 Blue precipitate 
1 M BTP, pH 8.0 Blue precipitate 
 
Table 5.2 Evaluation of different folding buffers with different pH values used to perform the refolding 
reaction.  
 
5.2.5.3 Urea 
Urea has been proven to inhibit aggregation by increasing the solubility of unfolded proteins 
and decreasing non-specific hydrophobic interactions which results in a general increase of 
correctly folded protein (Orsini and Goldberg, 1978). Thus, urea was added at various 
concentrations (0-2 M) to refold the protein either in combination with salt or without adding 
salt. As shown in Table 5.3, even after introduction of urea we still observed blue 
precipitates.  
 
Buffer Salt Urea Folding phenotype 
0 M 
1 M 0 mM NaCl, KCl or NH4OAc 
2 M 
Blue precipitate 
0 M 
1 M 10 mM NaCl, KCl or NH4OAc 
2 M 
Blue precipitate 
0 M 
1 M 
1 M HEPES, 
pH 7.5 
200 mM NaCl, KCl or NH4OAc 
2 M 
Precipitation before adding 
cobalt, no color change after 
adding cobalt 
 
Table 5.3 Evaluation of different folding buffer compositions (pH, ionic strength and addition of urea) 
used to perform the refolding reaction. 1 M HEPES, pH 7.5 was used for all reactions. Three different salts at 
three different concentrations (column 2) were tested either in combination with urea (used in two 
concentrations) or without adding urea.  
 
5.2.5.4 Additives 
It has been shown that the use of refolding additives can prevent aggregation by interfering 
with intermolecular hydrophobic interactions. A variety of additives have been described that 
prevent aggregation by stabilizing the proper folded state, by destabilizing incorrect folded 
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peptides, and by enhancing the solubility of either folding intermediates or unfolded peptides. 
Examples for such additives are detergents, surfactants and sugars which have proven to 
minimize aggregation and increase the yield of properly folded protein (Maeda et al., 1996; 
reviewed in Clark, 1998). Thus, we tested a large series of different additives which were 
introduced to the folding reaction in order to prevent aggregation. To do this, a commercially 
available detergent screen kit was used which provided 72 unique detergents (Hampton 
Research, detergent screen 1, 2 and 3). None of the provided detergents was able to prevent 
aggregation during the refolding step (data not shown). 
 
Since we were not able to find proper folding conditions for the Pegasus DZF peptide, we 
decided to purify the DZF domain from human Ikaros (work performed by R. Fang), human 
TRPS-1, Hunchback D.m. and Hunchback C.e., as well as the synthetic DZF domain Tr-Eo-
Eo applying the same purification strategy used for the Pegasus DZF domain. The hope was 
that using different proteins might help to solve the aggregation problems since the 
aggregation could be due to various surface-exposed hydrophobic amino acids in the Pegasus 
peptide. Another reason for the aggregation could be the formation of higher order oligomers 
as described for Eos (Westman et al., 2003) and Ikaros (McCarty et al., 2003) which in turn 
could result in a precipitation of the proteins. Thus, the DZF domain from Hunchback C.e. 
and the synthetic Tr-Eo-Eo domain were chosen because they do not mediate 
homodimerization at all or only weakly, respectively, as judged by the B2H (see Chapter 3, 
sections 3.2.4 and 3.4.1) and B1H system (data not shown).  
 
 
5.3 Overexpression and purification of various DZF domains 
 
5.3.1 Purification of the Ikaros, TRPS-1, Hunchback C.e. and Tr-Eo-Eo DZF domains 
 
Since purification of Pegasus resulted in a very clean and stable product, we applied the same 
purification approach to purify the DZF domains from Ikaros (work performed by R. Fang), 
TRPS-1, Hunchback D.m., Hunchback C.e. and the synthetic DZF Tr-Eo-Eo. pET3a derived 
expression plasmids were constructed which expressed peptides encoding these DZFs and 
were introduced into the E. coli strain BL21(DE3)pLysS. Analysis of whole cell lysates from 
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uninduced and IPTG induced cells showed that nearly all DZF domains (except Hunchback 
D.m., see below) were expressed at high levels and that expression depended upon induction 
with IPTG (data not shown). The calculated molecular weights of these peptides (Table 5.1) 
corresponded well with the relative sizes of the peptides as judged by their electrophoretic 
mobility. However, it was found that the Hunchback DZF domain from D.m. could not be 
induced at all and efforts to overcome this problem using various IPTG concentrations and 
different induction times as well as temperatures were unsuccessful (data not shown).  
As in the case of the Pegasus DZF, the remaining DZF peptides were localized in inclusion 
bodies which were isolated to capture the desired peptides. To do this, 400 ml of induced 
starter culture were used and the peptides were solubilized in 10 ml denaturing buffer (Table 
5.1). Analysis of the solubilized inclusion bodies demonstrated that for all four peptides the 
majority of the sample was soluble (data not shown). 
To further purify the peptides, cation exchange chromatography was applied using conditions 
for a trial run. The estimated pI value for the four peptides and the individual buffer 
conditions used for loading the peptides onto the Source 15S cation exchange column are 
shown in Table 5.1. The peptide samples were subsequently eluted with a NaCl gradient 
(Buffer B). Analysis of the chromatography run by SDS-PAGE and silver staining 
demonstrated that all four peptides were able to bind to the column and eluted as single peaks 
(data not shown). The captured samples were very clean consisting mainly of the desired 
peptides as judged by silver staining (data not shown). Table 5.1 summarizes the 
concentrations of Buffer B required to elute the individual peptides from the column.  
A subsequent reverse phase chromatography step was used to further purify the protein 
samples. The peptides were acidified with 10 % TFA to pH 2-3, loaded onto the column in a 
nonpolar buffer (Buffer A) and eluted differentially with a organic mobile phase (Buffer B). 
SDS-PAGE analysis of collected samples demonstrated that the peptides eluted as single 
peaks and the resulting samples were highly pure as judged by silver staining (data not 
shown). Elution conditions for the individual samples are shown in Table 5.1. HPLC peak 
fractions representing the individual peptides were dried by lyophilization and stored in an 
anaerobic chamber.  
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5.3.2 Refolding of the Ikaros, TRPS-1, Hunchback C.e. and Tr-Eo-Eo DZF domains 
 
We attempted to re-fold the various purified DZF peptides by adding 1.5 molar equivalents of 
cobalt and adjusting the pH by introducing different buffers. All peptides turned blue after 
refolding but insoluble aggregates accumulated in the resulting samples as was observed with 
the Pegasus DZF peptide. Several of the folding conditions described above (e.g. pH, urea, 
protein concentration and selected detergents) were evaluated but none of these prevented 
aggregation during the refolding step. 
Thus, the aggregation seemed to be a general issue of the DZF domain. Although we also 
analyzed DZF domains that are not able to mediate dimerization as judged by B2H and B1H 
assays, we can not rule out that the aggregation is caused by the process of dimerization 
itself. Folding reactions are generally performed at high protein concentrations and the DZFs 
may have dimerized at these high concentrations.  
 
 
5.4 Overexpression and purification of the Pegasus DZF domain linked to 
Zif268 
 
5.4.1 Inclusion body isolation and solubilization of the Zif268-Pegasus fusion peptide  
 
After these various unsuccessful attempts to avoid aggregation, we decided to link the DZF 
domain to a soluble protein, hoping that this additional protein might help prevent the DZF 
domain from aggregation. We chose to link the DZF domain of Pegasus to Zif268 which has 
been shown to be soluble after refolding and was used for X-ray crystallography before 
(Pavletich and Pabo, 1991). In addition, we know that Pegasus is active and can mediate 
dimerization when fused to Zif268 since it was used in this configuration in the B2H system 
(see Chapter 3, section 3.2.4).  
To determine whether the Pegasus DZF peptide could be purified as a fusion to the Zif268 
DNA-binding domain using the purification strategy described above, we initially 
constructed two pET3a derived expression plasmids which expressed the DZF domain from 
Pegasus as an N- or C-terminal fusion to Zif268 (Table 5.1).  
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These plasmids were introduced into the E. coli strain BL21(DE3)pLysS and IPTG was 
added to the cells to induce the expression. Analysis of whole cell lysates from uninduced 
and IPTG induced cells using SDS PAGE reveals that peptides of the expected molecular 
weights (18.6 kD for the C-terminal fusion and 19.4 kD for the N-terminal fusion, Table 5.1) 
are expressed at high levels (Figure 5.6A and data not shown).  
 
To further test whether the fusion peptides can be captured by preparing inclusion bodies, 
400 ml of induced starter culture were used to isolate inclusion bodies and the peptides were 
subsequently solubilized in 10 ml of denaturing buffer (Table 5.1). SDS-PAGE analysis of 
the solubilized inclusion bodies demonstrated that the majority of the Zif268-Pegasus fusion 
protein was soluble (Figure 5.6B). In contrast, all of the Pegasus-Zif268 fusion protein (data 
not shown) was trapped in the inclusion bodies and was therefore considered to be insoluble.  
 
5.4.2 Ion exchange chromatography 
 
We decided to continue purifying the Zif268-Pegasus peptide by cation exchange 
chromatography. The estimated pI value for the Zif268-Pegasus peptide is 8.5 and the peptide 
was loaded on the column in a buffer of pH 7.5 (Buffer A) followed by differential elution 
with a gradient of Buffer B (Table 5.1). Surprisingly, the chromatography run bore only 1 
well defined peak (Figure 5.7A).  
A
15 kD 15 kD
B
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Figure 5.6 SDS-PAGE analysis of the overexpression and purification of the Zif268-Pegasus DZF 
fusion protein. (A) Analysis of whole cell lysates from uninduced (lane 1) and induced (lane 2) cell 
cultures transformed with a plasmid encoding the Pegasus DZF domain fused to the C-terminus of Zif268. 
(B) Analysis of samples taken during the inclusion body purification and solubilization. Lane 1 = wash 
step 1, lane 2 = wash step 2. lane 3 = inclusion bodies, lane 4 = solubilized peptide. Red arrow indicates 
band which corresponds to the Zif268-Peg fusion protein. Black arrow indicates 15 kD band of the 
Standard which was run simultaneously with the samples (data not shown).  
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An aliquot of this peak and several 20 μl fractions at various steps of the run were collected 
and analyzed by SDS-PAGE and subsequent silver staining. As shown in Figure 5.7B, the 
Zif268-Pegasus peptide was only partly present in the collected peak fraction but eluted from 
the column in a very broad range between 29-31 % of buffer B without giving any FPLC 
signal. Using different loading buffers to improve the binding/elution conditions could not 
improve the elution profile and the peptide still did not elute in a defined peak. Furthermore, 
increasing the amount of loaded sample did not result in the occurrence of a clear peak 
suggesting, that the Zif268-Pegasus peptide can not be detected using a wavelength of 280 
nm.  
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Figure 5.7 Analysis of the ion exchange chromatography run to purify the Zif268-Pegasus fusion 
protein. (A) Analytical FPLC trace for the Zif268- Pegasus fusion protein. Buffer B gradient applied to 
elute bound peptides is shown in green. UV trace is shown in blue. Collected peak and two of the 
collected fractions are indicated (A, 7, and 8). (B) SDS-PAGE analysis of the FPLC run from (A). Peak 
fraction A together with several fractions (2-8) taken at different time points were collected and analyzed. 
Lane 1 represents the solubilized peptide before loading it onto the column. Red arrow indicates Pegasus 
DZF domain band and black arrow shows where the 15 kD band of the Standard ran. See text for detail.  
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5.4.3 Reverse phase chromatography 
 
Since we were able to capture some of the eluting Zif268-Pegasus peptide, we decided to 
apply it to a C4 reverse phase column in order to further purify it using RP chromatography. 
The peptide was acidified to pH 2-3, loaded onto the column in a nonpolar buffer and eluted 
differentially with a organic mobile phase. The chromatography run bore 4 very small peaks, 
which eluted at different concentrations of buffer B (Figure 5.8). Peak fractions together with 
several fractions adjacent to the peaks were captured and analyzed by SDS-PAGE and 
subsequent silver staining demonstrating that the Zif268-Pegasus peptide eluted without 
giving a clear signal. Peak C contained some of the sample but did not give a strong signal 
(data not shown). Thus, as before, the sample could not be detected although a wavelength of 
210 nm was used for monitoring the run. The HPLC fraction corresponding to the Zif268-
Pegasus peptide was subsequently lyophilized but the dried product did not contain any 
protein. 
 
 
5.5 Attempted purification of single finger domains from DZFs 
 
Since the purification of Zif268-DZF fusion proteins proved to be very challenging we took a 
different approach and decided to attempt to purify single finger domains derived from 
various DZFs for use in X-ray crystallography studies. We constructed four pET3a derived 
expression plasmids which expressed single N- or C-terminal ZFs of the Ikaros and the 
A
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Figure 5.8 Analytical RP-HPLC trace for the Zif268-Pegasus fusion protein. Bound peptides were 
eluted over a ~60 min period using a Buffer B gradient (shown in black). UV trace is shown in blue. 
Collected peaks are numbered A, B, C but did not contain the expected peptide. 
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Hunchback Drosophila DZF domains (Table 5.1). These plasmids were introduced into the 
E. coli strain BL21(DE3)pLysS. To test, whether any of these peptides could be 
overexpressed we examined whole cell lysates from uninduced and IPTG induced cells using 
SDS PAGE and found that the peptides could not be appreciably detected and are therefore 
not expressed at high levels (data not shown). Efforts to overcome this problem by using 
different concentration of IPTG, increasing and decreasing induction time or adding glucose 
were not successful and the expression level could not be improved (note that plasmids 
containing toxic target genes can be destabilized in stationary phase cultures by expression of 
the T7 RNA polymerase. This expression is initiated by cAMP mediated derepression of the 
lacUV5 promoter and can therefore be avoided by adding glucose to the media which inhibits 
cAMP production). 
 
 
5.6 Discussion 
 
In order to obtain structural information about a C2H2 ZF mediated protein-protein 
interaction, we attempted to purify the DZF domains from several Ikaros/Hunchback 
transcription factors for use in crystallographic studies. When overexpressed, these DZFs 
accumulated in inclusion bodies and could be solubilized using denaturants (urea) and 
reducing agents (DTT). Further purification was successfully achieved by ion-exchange and 
RP-HPLC chromatography and resulted in a very clean sample containing only the respective 
DZF domain as judged by silver staining. Simultaneously, the denaturant was removed 
during the HPLC run to permit subsequent refolding of the solubilized proteins. To perform 
the folding reaction, the peptides were rapidly diluted into folding buffer containing either 
cobalt or zinc. However, although highly purified peptides were successfully obtained, 
various attempts to refold these peptides into active domains resulted in the formation of 
precipitates containing the various DZFs. We can not rule out that aggregation of these DZF 
peptides is due to an unknown misfolding event but believe that these peptides may just fold 
fine (as indicated by the blue color). The correctly folded DZFs may aggregate due to the 
dimerization surface, and DZFs that are usually not able to mediate dimerization may actually 
dimerize at these high protein concentrations (that are present in the folding reactions). 
Although we do not know the precise multimerization state of the various DZF domains, 
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aggregation may just be a consequence of the formation of higher order oligomers as 
previously described for Eos (Westman et al., 2003) and Ikaros (McCarty et al., 2003).  
In general, misfolding as well as aggregation competes with the correct folding event 
resulting in a dilution of the amount of active peptides. For example, aggregation processes 
can be caused by nonspecific, hydrophobic interactions of mainly unfolded polypeptide 
chains. Moreover, correct folding of peptides also depends on correct regeneration of 
covalent disulfide bonds and it is known that the presence of free thiols can cause 
complications during the re-folding process due to oxidation problems (reviewed in Rudolph 
and Lilie, 1996). Thus, various properties of the peptide to be folded can influence the folding 
process and have to be evaluated. In fact, analysis of the amino acid sequences of the various 
DZFs that were unsuccessfully refolded indicates that they all contain a highly hydrophobic 
N-terminal finger consisting of numerous aromatic and aliphatic residues. These residues 
may have decreased the solubility of the peptides during refolding which in turn resulted in 
aggregation of folding intermediates. Introducing silent mutations into these hydrophobic 
residues may help preventing aggregation. In addition, at least one cysteine residue was 
present in these DZFs predicted not to be involved in zinc ion co-ordination. These cysteines 
provide free thiol groups that may have formed incorrect disulfide bonds resulting in 
misfolded peptide aggregates (reviewed in Rudolph and Lilie, 1996). Thus, it may be 
reasonable to silently mutate all cysteine residues that are not involved in zinc binding.  
Several attempts to address the problem of aggregation were undertaken that were all aimed 
to directly influence aggregation during the folding event. For example, because aggregation 
usually appears at high protein concentrations (reviewed in Rudolph and Lilie, 1996; 
reviewed in Rudolph et al., 1998; reviewed in Clark, 1998), renaturation was performed at 
high dilutions of the protein. Furthermore, various refolding conditions were tested including 
variables such as buffer composition (pH and ionic strength of the folding buffer) and 
temperature. Several additives know to enhance the folding process were added to the folding 
reaction as well. Examples are urea (Orsini and Goldberg, 1978; Maeda et al., 1996), ionic 
and non-ionic detergents (Tandon and Horowitz, 1987) and sugars (Maeda et al., 1996; Ahn 
et al., 1997). Although the precise mechanism of action for these additives is not known they 
are believed to prevent aggregation by either destabilizing incorrect folded intermediates or 
by stabilizing the correct folded product (reviewed in Clark, 1998). However, none of the 
tested additives in combination with several buffer conditions was able to decrease the 
amount of aggregated DZF domains. Other additives such as L-Arginine/HCl (Buchner and 
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Rudolph, 1991; Brinkmann et al., 1992) or the use of chaperones (Thomas et al., 1997; 
Altamirano et al., 1997) have also been described as enhancers of the folding reactions but 
were not tested in this study.  
However, since none of the attempts to directly influence the success of the folding reaction 
worked, it is very likely that this problem can only be solved by using a different folding 
method. Various methods for refolding of proteins have been described and may be helpful 
for future attempts to renature the DZF domain: Dialysis is probably the most common 
method to remove denaturing and reducing agents and therefore allowing the peptide to 
renature. In doing so, the concentration of the solubilizing agent decreases slowly which 
allows the protein to refold properly (reviewed in Clark, 1998; reviewed in Rudolph and 
Lilie, 1996). Another method to remove the denaturant is pulse renaturation. Here, aliquots of 
denatured protein are added to the renaturation buffer at defined time points, so that the 
concentration of unfolded protein is kept low. This strategy is based on the observation that 
during refolding only the concentration of unfolded and not that of correct folded protein is 
critical for aggregation. The process is stopped when the concentration of denaturant reagent 
introduced into the renaturation buffer reaches a critical level at which even native peptides 
tend to aggregate (reviewed in Lilie et al., 1998).  
Finally, one can try to address the solubilization problem right at the beginning by avoiding a 
situation where the DZF peptides aggregate in inclusion bodies in the first place. ZF proteins 
are generally insoluble but can be linked to a soluble peptide that forces the fusion peptide to 
stay in solution. In fact, previous studies described various DZF domains fused to the 
maltose-binding protein (MBP) which were soluble and could be used for biochemical 
analysis (Westman et al., 2003). In addition, subsequent studies done by this group using 
single C2H2 ZFs of Pegasus and Eos fused to glutathione S-transferase (GST) resulted in the 
NMR structure of the C-terminal ZF of the DZF domain from Eos (Westman et al., 2004). 
However, despite extensive efforts this group did not succeed in crystallizing the complete 
Eos DZF domain or oligomers generated by this domain. In addition, other groups reported 
similar technical difficulties including the insolubility of DZFs (Westman et al., 2004, 2003; 
McCarty et al., 2003). Thus, the crystallization of the DZF domain has proven to be very 
challenging and will remain the goal of future studies.  
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Chapter 6. Functional analysis of the Hunchback DZF domain in 
Drosophila melanogaster. 
 
6.1 Introduction 
 
The DZF domain of Ikaros family members has been shown to mediate homo- and hetero-
oligomerization and this process is believed to be important to support high affinity DNA 
binding. This domain is highly conserved among these family members but has also been 
found in the Hunchback transcription factors from various species. In order to understand the 
biological role of the Hunchback DZF domain in greater detail, we sought to perform a 
functional analysis of this domain. We decided to focus on the Hunchback transcription 
factor from Drosophila melanogaster, an organism which has proven to be an ideal model 
system for studying many biological processes.  
In addition to its important function in formation of the anterior-posterior axis in the fly 
embryo (Lehmann and Nuesslein-Volhard, 1987; Bender et al., 1988; Tautz, 1988; Wimmer 
et al., 2000; Schroeder et al., 2004), Hunchback has also been shown to be involved in 
regulating cell fates in the developing central nervous system (CNS) of the Drosophila 
embryo (Brody and Odenwald, 2000; Isshiki et al., 2001; Novotny et al., 2002; Pearson and 
Doe, 2003; reviewed in Brody and Odenwald, 2002). Development of the CNS requires the 
generation of a highly complex network of cells with divergent and well defined functions. 
The question of how one proliferating cell changes over time to generate a sequential ordered 
series of specified cell types is still one of the most challenging and interesting questions in 
developmental biology. The stem cell-like precursors of the CNS, termed neuroblasts (NBs), 
give rise to characteristic invariant cell lineages that produce a diverse population of neurons 
and glia cells (Bossing et al., 1996; Schmidt et al., 1997). NBs undergo multiple rounds of 
asymmetric cell divisions to generate a renewed NB and one ganglion mother cell (GMC) at 
each division, which subsequently produces two neurons and/or glia cells. It has been 
demonstrated, that the identity of each GMC is determined by its “birth” order within the NB 
lineage (Doe and Goodman, 1985) suggesting that a NB must constantly change its properties 
to generate different cells at each division. Recently, four transcription factors have been 
identified that are expressed in several NB lineages and the spatial and temporal expression 
pattern of these genes functions as a determinant for the temporal identity of GMC (Isshiki et 
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al., 2001; Kambadur et al., 1998). NBs sequentially express Hunchback (Hd) → Krüppel 
(Kr) → POU domain protein (Pdm) → Castor (Cas), with GMC and their progenies 
maintaining the transcription factor profile present at their birth (Figure 6.1). The precise 
timing of this sequential expression in the NB is essential for proper CNS development 
(Isshiki et al., 2001).  
 
A very well characterized NB lineage is the early forming NB 7-1 (Figure 6.2A). NB 7-1 
gives rise to more then 20 GMCs, but only the first five express the nuclear marker Even-
skipped (Eve) (Bossing et al., 1996). Each of these five Eve+ GMCs gives rise to one Eve+ 
motoneuron (U1, U2, U3, U4 and U5; note that each GMC also generates a second Eve- 
neuron which can not be tracked because no molecular marker is present). It has been 
demonstrated that the first two GMCs and their two Eve+ motoneuron progeny (U1 and U2) 
express Hunchback while later progeny do not show Hunchback expression. Hunchback 
mutants lack these two first-born Eve+ GMCs which results in a loss of Eve+ U1 and U2 
motoneurons. In contrast, over-expression of Hunchback in NB 7-1 results in an excess of 
early born GMCs at the expense of later-born GMCs and all differentiate as early-born 
U1/U2 motoneurons (Figure 6.2B; Isshiki et al., 2001). Interestingly, ectopic expression of 
Hunchback containing a point mutation in one of the zinc ligating cysteines of the DZF 
domain results in a phenotype similar to the wild-type phenotype with motoneurons U1-U5 
being generated again (personal communication J. Urban). Thus, Hunchback is necessary for 
CPKH NB
progeny
 
 
 
Figure 6.1 Sequential transition in NB gene expression. NBs transiently express Hd → Kr → Pdm → 
Cas, but their progeny maintain expressing the same transcription factor present during their birth. Cells 
that express Hunchback (dark blue) are pushed into deeper layers of the developing CNS upon birth of 
subsequent progeny (Isshiki et al., 2001). The expression pattern of these genes is believed to act as a 
competence factor, determining the ability of the NB to generate progeny with distinct functions (e.g. 
neurite projection pattern). Hunchback (H) expressing cells are shown in dark blue, Krueppel (K) 
expressing cells are shown in green, POU domain protein (P) expressing cells are yellow and Castor (C) 
expressing cells are orange. White cell indicates that the expressed transcription factor is unknown. This 
figure was adapted from Brody and Odenwald (2002).  
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specifying early-born cell fates and the C-terminal DZF domain in Hunchback seems to be 
important for maintaining this function. However, despite the importance of the DZF domain, 
remarkably little is know about the mechanism involved.  
 
 
The experiments of this chapter are aimed at exploring if Hunchback uses its DZF to 
dimerize in Drosophila melanogaster and if this dimerization is essential for the function of 
the protein. Thus, constructs encoding Hunchback with various natural and modified DZF 
domains were generated. Both, DZF domains that mediate homodimerization as well as DZFs 
that can only heterodimerize were used and transgenic flies containing these constructs were 
established. Over-expression of these constructs in NB 7-1 was then used as an assay to 
analyze whether swapping the natural Hunckback C-terminus with DZFs that either can or 
can not dimerize will restore the function of the wild-type protein. Furthermore, Hunchback 
variants that prefer to heterodimerize are expected to cause a mutant phenotype when 
expressed individually but should be able to rescue the wild-type function of Hunchback 
upon co-expressing them simultaneously. With this approach we sought to answer the 
question if DZF mediated homodimerization of the Hunchback protein is important for its 
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Figure 6.2 Characteristic transcription factor expression pattern of the early NB 7-1 lineage. (A) In 
wild-type embryos, the NB 7-1 initially performs five cell divisions resulting in five GMCs and each of 
these GMCs give rise to one motoneuron (U1-U5). The expression pattern present in the NB is retained in 
the motoneuron (as indicated by the colors) and determines the identity of the respective motoneuron. 
Note that in order to simplify matters, the GMCs are not shown. Each dividing GMC produces two 
siblings but only one can be identified and is therefore shown (U1-U5, respectively). Big letters indicate 
high expression level of the respective transcription factor and small letters indicate low levels of 
expression. Abbreviations are as defined in Figure 6.1. (B) Ectopic expression of Hunchback throughout 
the NB 7-1 results in an over-production of early born motoneurons (U1 and U2, indicated in blue) at the 
cost of later born neurons.  
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biological function. In addition, transgenic flies expressing tagged versions of the various 
constructs were generated to eventually investigate whether Hunchback homodimers could be 
identified in the fly.  
 
 
6.2 Generating transgenic flies 
 
6.2.1 Overview: The GAL4-UAS system 
 
The GAL4-UAS system was used to express Hunchback in a cell- and tissue specific pattern. 
The principle of this system is demonstrated in Figure 6.3 and described below. 
 
 
This bipartite ectopic expression system utilizes the yeast transcription factor GAL4 which 
binds to its target DNA sequence, the upstream activation sequence (UAS), thereby activating 
gene transcription. GAL4 can be expressed in a cell specific pattern by placing it under the 
control of various Drosophila melanogaster promoter (or enhancer) sequences. Subsequently, 
GAL4 activates transcription of the GAL4-responsive (UAS) target gene in an identical set of 
cells. The GAL4 gene and the UAS-target gene are maintained in two distinct transgenic 
Hd cDNAs
Figure 6.3 The GAL4/UAS system. The 
GAL4-line expresses the GAL4 activator 
under the control of a cell- or tissue 
specific promoter (left) while the UAS-
line (right) harbors the target gene (e.g. 
Hunchback) downstream of the upstream 
activation sequence (UAS). Crossing 
these two transgenic lines together 
generates progeny which carry both 
elements (GAL4 and the UAS controlled 
target gene). In these flies, the cell-
specific promoter drives expression of 
GAL4 which in turn activates the 
transcription of the target gene (e.g. 
Hunchback) in the same set of cells. This 
Figure was taken and adapted from Phelps 
and Brand (1998).  
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lines. Thus, the GAL4 activator protein is inactive in one line (GAL4-line) while the target-
gene is not expressed in the other line (UAS-line) because GAL4 is missing. After crossing 
the GAL4 line to the UAS-line the target gene is turned on in the resulting progeny (Brand 
and Perrimon, 1993; Phelps and Brand, 1998).  
 
6.2.2 Description of pUAST-Hunchback constructs 
 
In order to characterize the function of the DZF domain in Drosophila melanogaster, 
constructs encoding full-length Hunchback proteins with either natural or synthetic DZF 
domains at the C-terminus were constructed. The DZF domain from wild-type Ikaros and two 
synthetic DZFs (Tr-Eo-Eo and Eo-Hd-Hd) were used to replace the Hunchback DZF domain 
in the wild-type full-length protein. While the Ikaros DZF domain can mediate homo-
dimerization, Tr-Eo-Eo and Eo-Hd-Hd prefer to hetero-dimerize and interact either only 
weak or not at all with themselves (see chapter 3, section 3.4.1). Care was taken to keep the 
introduced DZF domains as small as possible so that they all started with the conserved 
Tyr/Phe two residues N-terminal of the first zinc-ligating Cys (see Figure 3.1, chapter 3). All 
fragments continued to the authentic C-terminus of the respective DZFs (as defined in 
Chapter 3) terminating 1-5 residues after the final zinc-binding histidine. For each fragment, 
additional versions containing either a myc- or a HA-tag were designed by fusing these tags 
to the C-terminus of the DZF domains using a GEKP linker.  
 
For expression in the GAL4-UAS system, the resulting 10 fragments (Figure 6.4 and not 
shown) were fused to the N-terminal domain of wild-type Hunchback and cloned into the 
Ik
TrEoEo
EoEoHd
N-
N-
N-
DZF
Hd
N- -C
N-terminal ZF
-C
-C
-C
Figure 6.4 List of full-length Hunchback 
germ-line transformation constructs 
containing swapped DZF domains. The DZF 
domain from Hunchback (green ovals) was 
replaced with the DZF domain from wild-type 
Ikaros (pink ovals) as well as with the 
synthetic DZFs Tr-Eo-Eo (purple-blue ovals) 
and Eo-Eo-Hd (blue-green ovals). Note that 
tagged versions of wild-type Hunchback (myc 
and HA tag), Hunchback Ik (myc and HA tag), 
Hunchback TrEoEo (myc tag) and Hunchback 
EoEoHd (HA tag) were also generated. 
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pUAST plasmid placing them under the control of the UAS promoter (Brand and Perrimon, 
1993; see section 6.2.1).  
 
6.2.3 P-element transformation 
 
P-element transformation was performed to introduce the various Hunchback constructs into 
flies. To do this, the pUAST plasmids containing P-elements up- and downstream of the 
UAS-hunchback DNA were injected into the germline of white- fly embryos that express the 
transposase gene (Greenspan, 1997). These P-elements can then "randomly" insert 
themselves stably into genomic DNA. Since pUAST also expresses the white+ gene in-frame 
with the various hunchback fragments, transformants were selected using eye color as a 
marker for successful insertion of the P-element (expression of the white+ gene results in flies 
with red eyes). To produce stable stocks, flies containing the P-elements were further crossed 
to strains containing dominantly marked balancer chromosomes and the location of the 
insertions was thereby mapped to a particular chromosome (Table 6.1; Greenspan, 1997).  
 
Number of transgenic lines 
cDNA 
X II III total 
Hd 1 3 8 12 
Hd-myc 2 2 1 5 
Hd-HA 0 4 6 10 
Hd Ik 0 1 1 2 
Hd Ik-myc 1 1 2 4 
Hd Ik-HA 1 3 4 8 
Hd TrEoEo 1 8 6 15 
Hd TrEoEo-myc 0 9 6 15 
Hd EoEoHd 0 3 5 8 
Hd EoHdHd-HA 1 6 5 12 
 
Table 6.1 Summary of transgenic flies obtained for each Hunchback construct. Locations of inserted 
constructs (left column) were mapped to a particular chromosome as indicated in column 2, 3 and 4. X indicates 
the X-chromosome, II indicates the second chromosome and III indicates the third chromosome. Note that flies 
carrying the constructs both homozygous and heterozygous were obtained, although this is not further specified 
here.  
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6.3 Expression analysis of the constructs 
 
6.3.1 Rough eye phenotype 
 
The location of the inserted P-element can greatly affect the expression level of the 
transformed gene and hence any resulting phenotype can vary even when a binary system like 
the GAL4/UAS system is used. Consequently, the levels of UAS-cDNA expression vary 
among lines harboring the same construct in the presence of equal amount of GAL4 activator. 
Thus, the expression level of various independent P-element lines was evaluated. Initially, we 
focused on the constructs containing either a myc- or a HA-tagged DZF, which could be used 
for Western-blot analysis using anti-myc or anti-HA antibodies, respectively. We decided to 
over-express these constructs in the Drosophila eye, which provides an excellent tissue to 
produce a lot of protein, even if this protein would otherwise be harmful for the fly. Although 
several genes have been described which affect eye development upon ectopic expression 
(Hay et al., 1997; Rørth et al., 1998), we were not expecting to see any side effects from 
over-expressing our proteins, since Hunchback has not been reported to be involved in eye 
development.  
 
 
 
Figure 6.5 Overexpression of Hunchback in the eye causes a rough eye phenotype. Ectopic 
expression of Hunchback using gmr-gal4 as a driver results in a rough eye phenotype with various 
levels of severity from mildly rough, almost normal sized eyes to very rough or glassy eyes (“++++” 
right column). The middle column shows a phenotype with medium (“++”) severity present in most of 
the flies after overexpression the various Hunchback constructs. A control harboring only the gmr-
gal4 driver is shown in the left column. F-2 / F-3 indicate the respective construct which was 
overexpressed in the shown flies. These pictures were taken from female flies with a Canon EOS 30D 
camera using an MP65 object lens. 
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The gmr-gal4 line is a commonly used eye-specific driver line that contains five copies of the 
Glass response element from the Rhodopsin 1 gene and drives expression in the eye in all 
cells behind the morphogenetic furrow (Freeman, 1996). It has been shown that gmr-gal4 
homozygotes have a visible rough eye phenotype (characterized by a smaller size of the eye) 
whereas heterozygotes appear normal (Freeman, 1996). Transgenic flies containing the 
tagged UAS-constructs were crossed to the gmr-gal4 driver to initiate expression of these 
constructs in the Drosophila eye. Interestingly, for some transgenic lines progenies of these 
crossings had a rough eye phenotype that was visible under the dissecting microscope (Figure 
6.5). This phenotype was only seen in flies containing both the gmr-gal4 and the UAS-
Hunchback constructs, indicating that the rough eye is due to GAL4 initiated expression of 
Hunchback in the eye. The visible phenotypes varied in severity from mildly rough, almost 
normal sized eyes to very rough or glassy eyes, which were reduced to almost 1/2 of the 
normal size (Figure 6.5, Table 6.2 and Table 6.3). Progenies with very severe eye phenotypes 
were usually obtained at lower frequency suggesting that the crossing was semi-lethal. Thus, 
regardless of the mechanism by which Hunchback disrupts eye development, it is apparent 
that it has an effect when ectopically expressed. 
 
 
Intensity of phenotype 
cDNA 
- + ++ +++ ++++ 
Hd 0 2 3 1 1 
Hd-myc 0 0 2 0 0 
Hd-HA 0 0 1 2 0 
Hd Ik 0 0 2 0 0 
Hd Ik-myc 0 0 0 2 0 
Hd Ik-HA 2 1 3 0 0 
Hd TrEoEo 1 4 5 1 0 
Hd TrEoEo-myc 1 1 7 1 0 
Hd EoEoHd 0 3 3 0 1 
Hd EoHdHd-HA 0 2 4 2 0 
 
Table 6.2 Analysis of eye phenotype severity obtained for the different Hunchback constructs. Expression 
level of constructs was estimated by analyzing the resulting eye phenotype after overexpressing the constructs in 
the eye using the gmr-gal4 driver. Digits indicate numbers of transgenic lines obtained with the particular 
phenotype. Eye phenotype was gradually and subjectively judged where “–” indicates normal wild-type eyes 
and “++++” indicates a severe phenotype with eyes almost 1/2 of the size of wild-type eyes. Note that not all 
transgenic flies obtained for a certain cDNA construct were tested in this assay.  
 
In general, there was no correlation between severity of the phenotype and a particular 
construct. In fact, different insertions lines of a particular construct seemed to cause different 
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levels of severity, although the same Hunchback protein is over-expressed in these lines 
(Table 6.2). This suggests that the severity of the phenotype depended on the expression level 
of the Hunchback protein, which in turn was depending on the location of the P-element 
insertion.  
 
6.3.2 Western blot analysis 
 
To further verify this hypothesis, Western blot analysis was performed to analyze the 
expression level of the tested transgenic lines which carried a tag epitope. Lysates from fly 
head extracts were resolved by SDS-polyacrylamide gel electrophoresis and the proteins were 
visualized using anti-myc or anti HA antibodies that recognize the respective C-terminal tag 
epitope. It was found that most of the peptides were stably expressed (Figure 6.6 and data not 
shown). Judged by their electrophoretic mobility, the relative weight of these peptides is ~ 
105 kD which is higher then the calculated molecular weight of Hunchback (~85 kD). This 
could be due to modifications of the protein in the fly. Control experiments using constructs 
without tags did not result in any bands demonstrating that the antibody stained specifically 
the respective tag (data not shown).  
 
As summarized in Table 6.3, for most of the peptides the expression level of the various 
constructs is consistent with the severity of the rough eye phenotype. Thus, the higher the 
amount of expressed peptide was, the more severe was the phenotype this peptide had caused 
(Table 6.3). An Exception was protein UAS-Hd Ik-myc, which could not be detected by 
Western blot although this peptide caused a severe rough eye phenotype suggesting that it 
was expressed at a high level. Furthermore, Western blot analysis of wild-type Hunchback 
A-1b K-1 K-4 K-5 K-5a G-6 G-6a B-3b
anti-myc anti-HA  
 
 
Figure 6.6 Western blot analysis determining the expression levels of different Hunchback 
constructs. Protein-extracts obtained from 40 fly heads for each transgenic type were resolved by SDS-
polyacrylamide gel electrophoresis and the proteins were visualized using anti-myc or anti-HA antibodies. 
Construct numbers correspond to a particular Hunchback cDNA as indicated in Table 6.3. Note that the 
bands shown (either stained with anti-myc or anti-HA) were obtained from one blot and can therefore be 
compared to each other.  
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tagged with myc exhibited a second band not present in the other samples (Table 6.3 and 
Figure 6.6). Thus, over-expressing Hunchback variants in the eye and subsequent 
examination of the eye phenotype can generally be used as a method to estimate the 
expression level of the respective constructs. Accordingly, transgenic lines with similar 
expression levels of the respective constructs as judged by the eye phenotype were selected 
for further analysis.  
 
cDNA Transgenic line  
Intensity of rough 
eye phenotype 
Band intensity of 
Western blot  
A-1 ++ + Hd--myc A-1b ++ ++ 
B-2a +++ +++ 
B-2b ++ ++ Hd--HA 
B-3b +++ +++ 
E-1 +++ - Hd--Ik--myc E-1a +++ - 
H-1c + + 
H-1d + + Hd--Ik--HA 
H-2 - - 
K-1 +++ +++ 
K-4 ++ ++ 
K-5 +++ +++ Hd--TrEoEo--myc 
K-5a ++ ++ 
G-6 ++ ++ Hd--EoHdHd--HA G-6a +++ +++ 
 
Table 6.3 Analysis of the expression level for the different Hunchback constructs. Comparison of the 
resulting eye phenotype after overexpressing the respective construct with the band intensity after Western blot 
analysis. Eye phenotype was judged as described in Table 6.2 and Figure 6.5. The band intensity obtained by 
Western blot analysis was judged in a similar manner with “–” indicating that no band was detected while 
“+++” indicates that band intensity was strong. Note that only constructs tested for both, the eye phenotype and 
Western blot band intensity are shown.  
 
 
6.4 Overexpression in Neuroblast 
 
6.4.1 Triple staining of a wild-type embryo 
 
As described above, over-expression of Hunchback and its variants can be used as a 
“functional” assay for analyzing the importance of DZF mediated dimerization. For these 
experiments, the well characterized NB lineage 7-1 was chosen as a model system which will 
be introduced in the following section. 7-1 neurons can be easily identified in stage 14 
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embryos since they express a combination of specific molecular markers as well as by their 
characteristic location in the embryo (Isshiki et al., 2001). A typical staining of a wild-type 
embryo is shown in Figure 6.7.  
 
Panel A represents a staining using an antibody against Hunchback. This staining generally 
served as a control for the expression level and location of the various Hunchback variants 
(note that in this wild-type embryo Hunchback was not over-expressed, thus, reflecting the 
background of Hunchback staining). As described in the introduction, NB 7-1 generates a set 
of defined cells that express the marker eve. Thus, by using an antibody against eve, NB 7-1 
and its progenies could be easily identified (Figure 6.7, panel B, stained in pink). Another 
molecular marker that labels late sub-lineage neurons is the transcription factor Zinc finger 
homeodomain 2 (Zfh-2) which is stained in panel C (Figure 6.7, in green) using an anti-Zfh-2 
antibody. Panel D in Figure 6.7 shows a merge of these three antibody stainings.  
 
6.4.2 Hunchback represses expression of Zfh-2  
 
To begin investigating whether dimerization of Hunchback is necessary for its function in NB 
development, the Hunchback variants were over-expressed in NB 7-1. Engrailed-gal4 (en-
gal4, Tabata et al., 1995) was used as a driver since it drives expression in defined NBs. 
Thus, en-gal4 was crossed to the different UAS-Hunchback variants to initiate expression of 
these constructs and resulting embryos together with wild-type embryos were collected after 
an overnight incubation to allow development to the desired stage. These collections were 
A B C D
 
 
 
Figure 6.7 Triple staining of a wild-type embryo at stage 14. Dorsal view of a wild-type embryo stained 
for Hunchback (A, in blue), Eve (B, in magenta) and Zfh-2 protein (C, in green). (D) shows a merge of the 
three stainings. Sections of the confocal images were combined representing various layers from dorsal to 
ventral, anterior is up. Thick dashed lines indicate the ventral midline and thin dashed lines define lateral 
borders of the ventral nerve cord. Note that the total width of the ventral nerve code (which corresponds to 
the region within the lateral borders) is approximately 60 μm. See text and Chapter 2, section 2.5.2.4 for 
details.  
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then stained, dissected and analyzed as detailed in Chapter 2, section 2.5.2.4. Staining against 
Zfh-2 in stage 14 embryos demonstrated that ectopic wild-type Hunchback expression 
resulted in an absence of Zfh-2 expression in Hunchback expressing neurons (Figure 6.8B 
and J. Urban, personal communication). While in wild-type embryos Zfh-2 is equally 
expressed in all late sub-lineage neurons, Hunchback clearly seemed to inhibit this expression 
(Figure 6.8, compare A and B). Regions where Zfh-2 expression is inhibited corresponded 
well to rows where Hunchback was over-expressed as labeling for this protein confirmed 
(data not shown). When NB 7-1 is forced to continuously express Hunchback containing 
either the Ikaros or the synthetic Eo-Eo-Hd DZF domain, Zfh-2 expression was also absent in 
these neurons (Figure 6.8C, E). In contrast, embryos over-expressing Hunchback with the 
synthetic Tr-Eo-Eo DZF domain displayed a different phenotype with Zfh-2 equally 
expressed as it was the case for wild-type embryos (Figure 6.8D). This suggested that the C-
terminal domain in Hunchback can be replaced by another dimerization domain although it 
remains unknown if this domain has to be functional. Both the Eo-Eo-Hd and the Tr-Eo-Eo 
DZF domain have been shown not to mediate homo-dimerization and were therefore 
expected to display a similar mutant phenotype when introduced into the Hunchback protein. 
However, only Tr-Eo-Eo affected the Hunchback function of inhibiting the Zfh-2 expression.  
 
 
WT UAS-Hd UAS-Hd Ik UAS-Hd EoEohdUAS-Hd TrEoEo
A B C D E
 
 
 
Figure 6.8 Ectopic expression of Hunchback in the NB 7-1 inhibits Zfh-2 expression. Dorsal view of 
embryos at stage 14 stained for the Zfh-2 protein (green). Anterior is up, dashed lines indicate the ventral 
midline. Square brackets indicate the engrailed expression domain where Hunchback expression was 
driven. (A) In wild-type embryos Zfh-2 is equally expressed in all segments. (B) Ectopic expression of 
Hunchback using engrailed (en) gal4 as a driver diminishes expression of Zfh-2 in these segments. (C) 
Over-expression of Hunchback harboring the DZF domain of Ikaros also inhibits Zfh-2 expression in the 
en-gal4 expression domain. (D) Forcing the NB to express Hunchback containing the TrEoEo DZF 
domain results in a wild-type like phenotype and Zfh-2 is equally expressed in all segments. (E) Over-
expressing Hunchback harboring the EoEoHd DZF domain abolishes Zfh-2 expression in the ectopic 
expression segments. Figure 6.8A was kindly provided by Ulricke Mettler. 
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6.4.3 Hunchback misexpression changes identity of Motoneurons 
 
To further investigate whether the C-terminal DZF domain in Hunchback has to be functional 
for dimerization, double stainings with antibodies against Zfh-2 and eve were analyzed. The 
molecular marker Eve is only present in five motor neurons which are derived from NB 7-1.  
 
 
 
 
Figure 6.9 Ectopic expression of Hunchback in the NB 7-1 results in the over-production of early born 
motoneurons. Embryos at stage 14 either double labeled for the 7-1 progeny marker Eve (pink) and Zfh-2 
(green) are shown in the left panel. The same images are shown again as single staining labeled for Zfh-2 in 
the middle panel where cells expressing eve are indicated by white dashed circles (Note that these cells are not 
visible in these images because the staining was performed only against Zfh-2 and the two proteins are not co-
expressed in the same cells). A summary of the phenotypes is indicated in the right column. White circles 
represent cells which do not express Zfh-2, while green circles indicate cells that express either weak (light 
green) or normal amounts (dark green) of Zfh-2. All panels represent combined confocal images consisting of 
multiple focal planes. Anterior is up, midline is to the left. Note that the width of the region comprehending the 
group of five U-motoneurons is approximately 15 μm. (A) In wild-type embryos, motoneuron U1-U5 can be 
identified by Eve expression (magenta) and their typical position (see also top right panel). U1 and U2 
motoneurons are known to express Hunchback (Isshiki et al., 2001) which inhibits the expression of Zfh-2 
completely (U1) or partly (U2). (B, C) Ectopic expression of wild-type Hunchback (B) or Hunchback 
harboring the Ikaros DZF domain (C) results in the production of extra Eve+ cells and the expression of Zfh-2 
in these cells is inhibited. (D) Ectopic expression of Hunchback containing the TrEoEo DZF domain produces 
five motoneurons and 1 or 2 of these cells are Zfh-2-. (E) Over-expressing of Hunchback containing the 
EoEoHd DZF domain reduces the amount of Eve+ cells compared to ectopic expression of wild-type 
Hunchback, although there are still excessive motoneurons present. These cells partly express Zfh-2. Figure 
6.9A was kindly provided by Ulricke Mettler.
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Thus, in wild-type embryos these five neurons (U1, U2, U3, U4 and U5) can be uniquely 
identified by Eve expression as well as their stereotyped cell position (Figure 6.9A, Isshiki et 
al., 2001). The first two motor neurons U1 and U2 are Hunchback+ while later progeny (U3, 
U4 and U5) do not express Hunchback. Closer examination of these two neurons in wild-type 
embryos indicates that they did not (U1) or only mildly (U2) express Zfh-2 whereas the 
remaining motor neurons were Zfh-2+ (Figure 6.9A). This further confirmed that Hunchback 
represses the expression of Zfh-2. When NB 7-1 was forced to continuously express wild-
type Hunchback, additional Eve+ cells were found (average of 14 cells, Table 6.4), which 
were all Zfh-2- (Figure 6.9B). Thus, ectopic expression of Hunchback resulted in an over-
production of early-born neurons at the cost of later-born cells. Over-expression of 
Hunchback with the swapped Ikaros DZF had the same phenotype producing extra Eve+ cells 
that did not express Zfh-2 (Figure 6.9C, Table 6.4). In contrast, when Hunchback containing 
the synthetic Tr-Eo-Eo DZF domain was misexpressed a phenotype similar to wild-type 
embryos was obtained (Figure 6.9D, Table 6.4). Again, five Eve+ motor neurons were 
detected with the first two not expressing Zfh-2. Forcing the NB to over-express Hunchback 
with the synthetic Eo-Eo-Hd DZF domain resulted in extra Eve+ cells although the number 
was reduced compared to overexpression of wild-type Hunchback (average of 9 cells for Eo-
Eo-Hd compared to 14 for wild-type Hunchback, Table 6.4). Furthermore, several of these 
cells expressed Zfh-2 which was not the case after ectopic expression of wild-type 
Hunchback (Figure 6.9E). Thus, closer examination of the overexpression responses for the 
various Hunchback variants indicates that the DZF domain had to be functional to replace the 
wild-type Hunchback DZF. While the Ikaros DZF could fully replace the Hunchback DZF 
domain, the two synthetic DZFs could not, suggesting that DZF mediated dimerization of 
Hunchback may be important for regulation of NB competence.  
 
cDNA Number of U-neurons Zfh-2
- 
-- 5 1.5 
Hd 13,9 13.9 
Hd Ik 12.9 12.6 
Hd TrEoEo 5.5 1.8 
Hd EoEoHd 8.9 4.4 
 
Table 6.4 Average number of U-neurons in NB 7-1. Number of motoneurons (U-neurons) present in NB 7-1 
were counted after ectopic expression of the different Hunchback constructs (left column). Zfh-2- neurons in 
these sets of motoneurons are also indicated (right column). These numbers represent the mean of 18 scored 
hemisegments. Note that wild-type flies are presented in the first row indicated by a “--” since no cDNA was 
overexpressed in these flies.  
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6.5 Discussion 
 
6.5.1 The DZF domain is important for regulating NB competence in Drosophila 
 
This chapter aimed to understand the importance of DZF mediated dimerization for 
Hunchback in terms of its function as a regulator of CNS development. Hunchback is 
involved in specifying early-born temporal identity in Drosophila neural stem cell lineages 
and the C-terminal domain in Hunchback seems to be important for maintaining this function 
(Isshiki et al., 2001; Novotny et al., 2002; Pearson and Doe, 2003; J. Urban, personal 
communication). This is in contrast to its function in early embryonic development where the 
C-terminal C2H2 ZFs are not required (J. Urban, personal communication). To distinguish 
whether these C-terminal C2H2 ZFs must mediate dimerization for biological function or are 
merely required for the stability of Hunchback, we constructed plasmids expressing 
Hunchback in which the C-terminal DZF domain was replaced with other DZFs that either do 
or do not support dimerization. The expectation was that these domains would fold in a 
manner similar to the Hunchback DZF and therefore should not disturb the overall folding 
and integrity of the Hunchback protein. Thus, importance of dimerization itself could be 
analyzed by testing the ability of these DZF variants to fulfill the biological function of wild-
type Hunchback. Ectopic expression of wild-type Hunchback in NBs can transform all GMCs 
towards a first-born fate resulting in an overproduction of neurons with early fates at the 
expense of later born neurons. Interestingly, this phenotype was also reported when the NB 
was forced to express Hunchback containing the homo-dimer forming Ikaros DZF domain. 
However, misexpression of a Hunchback construct in which the C-terminal domain was 
replaced by a DZF domain that did not support homodimerization (Tr-Eo-Eo) resulted in 
generation of later-born neurons, representing a phenotype similar to the one seen in wild-
type embryos. In summary, these results lead to two major conclusions: First, the DZF 
domain in Hunchback participates and is necessary for maintaining the competence of NBs to 
generate early born progeny during CNS development. Introduction of “mutant” DZFs by 
replacing the wild-type DZF domain with a nonfunctional DZF abolished this function. 
Second, the importance of the DZF domain is an outcome of its ability to mediate 
dimerization since it can be swapped by another functional dimerization domain. Thus, the C-
terminal C2H2 ZFs in the Hunchback protein appear to be required for generating first-born 
cell fates only because dimerization is essential for this process.  
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6.5.2 Subjects for future studies to confirm these findings 
 
It is important to note that when the NB was forced to express Hunchback containing the 
synthetic Eo-Eo-Hd DZF, there were still some extra early-fate cells although this domain 
should have displayed a similar phenotype to cells misexpressing Hunchback Tr-Eo-Eo. We 
do not have an explanation for this, but speculate that the expression level of our constructs 
may have influenced the outcome of the experiment. Although care was taken to choose 
transgenic lines displaying a similar expression level, we can not rule out that some of these 
constructs produced more protein then others due to position effects (see Tables 6.2 and 6.3). 
Another concern was that the amount of protein expressed in the NBs was generally too high 
to be sensitive enough to detect “mutant” phenotypes. In fact, a similar problem was obtained 
in our original attempts to perform an alanine-scan of the Hunchback DZF domain where the 
expression level was too high to detect any mutations in the B1H assay (see chapter 4 and 
data not shown). Thus, additional experiments will be required to reliably uncover a mutant 
phenotype. More transgenic lines have to be tested and it might be reasonable to decrease the 
temperature for inducing the expression because it is known that higher temperatures increase 
the expression level in the GAL4/UAS system (Brand and Perrimon, 1993; Phelps and Brand, 
1998).  
It is noteworthy, that initial experiments co-expressing the two heterodimeric Hunchback 
variants containing the synthetic DZFs (Eo-Eo-Hd and Tr-Eo-Eo) in NBs were performed. 
The result of these experiments suggested that the two proteins may mediate 
heterodimerization since co-expression resulted in a phenotype similar to that obtained when 
over-expressing wild-type Hunchback (data not shown). On the other hand, this phenotype 
might have been caused by the high amount of protein present (because two proteins were 
simultaneously expressed) that might have resulted in the same phenotype compared to the 
one obtained after overexpressing the wild-type Hunchback protein. Thus, controls 
expressing equally high amounts of the same Hunchback protein (either Hunchback Eo-Eo-
Hd or Hunchback Tr-Eo-Eo ) have to be tested to rule out the possibility of such a dosis 
effect.  
Furthermore, it will also be important to determine if a Hunchback dimer exists in 
Drosophila since this would further confirm the importance of DZF mediated dimerization. 
Transgenic flies expressing tagged versions of the various Hunchback constructs were 
generated in this study and have been shown to be stably expressed. Thus, these lines will be 
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subject to future co-immunoprecipitation experiments aimed to reveal if Hunchback homo-
dimers exist in vivo.  
 
6.5.3 Biological role of dimerization at a mechanistic level 
 
It is interesting to speculate on the biological role of Hunchback dimerization. The 
competence of NB 7-1 to respond to Hunchback has been further characterized (Pearson and 
Doe, 2003; Grosskortenhaus et al., 2005; Cleary and Doe, 2006). NB 7-1 shows progressive 
limitations in its ability to produce early fates if only pulses of Hunchback are provided at 
different time points of the lineage (Pearson and Doe, 2003). However, if Hunchback levels 
are kept constantly high throughout the lineage, the NB will extend its competence and will 
produce early fates even after several cell divisions. After subsequent down-regulation of 
Hunchback the NB takes on the normal fate again by producing later born type neurons. 
Thus, the NB responds to Hunchback in a well defined manner by extending its ability to 
react to Hunchback over-expression but also by maintaining full competence to generate 
later-born neurons (Grosskortenhaus et al., 2005). The ability of Hunchback to keep the NB 
in a “young” state despite many cell divisions raises the question of how Hunchback acts at a 
mechanistic level. In the case of Ikaros, the mammalian homologue of Drosophila 
Hunchback, several models have been proposed of how transcriptional regulation occurs. It 
has been shown that Ikaros associates with chromatin and remodeling proteins and is 
essential for silencing gene expression in mature B cells during hematopoiesis (Kim et al., 
1999; Sabbattini et al., 2001; see also section 1.3.3.1). Furthermore, Ikaros seems to co-
localize to pericentromeric heterochromatin (PC-HC) together with transcriptionally silenced 
genes suggesting that it recruits these genes to heterochromatin regions through an unknown 
mechanism (Brown et al., 1997; Klug et al., 1998; Cobb et al., 2000; Koipally et al., 2002). 
This process is dependent on both DNA binding and dimerization of Ikaros (Cobb et al., 
2000; Koipally et al., 2002; see also section 1.3.3.2). Hunchback may act in a similar matter 
to prevent expression of later temporal identity genes by repositioning these genes to 
transcriptional inaccessible regions within the nucleus and thereby silencing them. Thus, 
dimerization might permit the protein to interact simultaneously with the target genes and 
regions of pericentromeric heterochromatin (Figure 6.10A).  
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On the other hand, it has also been suggested that Ikaros enables gene expression by trapping 
repressor complexes at promoters of target genes and relocating them to PC-HC, thereby 
allowing potential activators to bind to these target sites again (Koipally et al., 2002). Thus, 
to further maintain plasticity of gene expression which keeps the NB in a multipotent state 
Hunchback may also utilize such a mechanism. In doing so, Hunchback may act as a dimer, 
with one subunit bound to centromeric regions and the other available for interactions with 
potential repressor complexes (Figure 6.10B). A combination of these mechanisms --partly 
accomplished by the DZF domain-- would allow Hunchback both to prevent expression of 
later temporal identity genes as well as maintain the multipotent state of the neuroblast.  
 
6.5.4 Using the eye phenotype to identify components of Hunchback regulated processes 
 
Finally, it is noteworthy that ectopic expression of Hunchback in the Drosophila eye caused a 
rough eye phenotype. Although the mechanism and biological significance of this result is 
not clear, it may point towards a role of Hunchback in eye development. In the past decade 
the Drosophila eye has proven to be a powerful model system to study the function of any 
gene of interest. While in vivo disruption of target genes has proven to be difficult, 
misexpression analysis in the Drosophila eye seems to be a convenient strategy aimed to 
understand the function of any gene of interest (reviewed in Thomas and Wassarman, 1999). 
Figure 6.10 Models for the biological 
role of a potential Hunchback 
homodimer. (A) Hunchback (yellow) may 
target a specific gene (orange) to 
transcriptionally inactive pericentromeric 
heterochromatin (PC-HC, dark grey wave) 
through dimerization, whereby one 
Hunchback monomer binds centromeric 
sequences while the other monomer 
interacts with sequences in a specific target 
gene. This would relocate this gene to 
regions that are inaccessible to 
transcriptional regulators including 
activators (blue circle). (B) Alternatively, 
the Hunchback dimer may stimulate gene 
activity by recruiting repressor complexes 
(red rectangle) to PC-HC. Activators would 
then be able to bind to specific genes and 
drive transcription. This figure was adapted 
from Cobb et al., (2000) and Koipally et 
al., (2002). 
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Although eye development is usually severely influenced by misexpression of a gene of 
interest this has no consequences for the viability of the fly. Thus, lessons learnt from 
studying genes in the eye have provided additional understanding of their function in other 
tissues as well. In general, the goal of such studies is to produce an eye phenotype that can 
then be used to screen for modifiers of this phenotype which are likely to be involved in the 
same biological process (Kurada and White, 1998; Carrera et al., 1998). Thus, by performing 
screens for genes that dominantly modify the rough eye phenotype caused by misexpressing 
Hunchback, new components involved in the biological pathways mediated by Hunchback 
may be identified.  
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Chapter 7. Analyzing protein-protein interactions mediated by 
different ZF motifs using the B2H system.  
 
7.1 Introduction 
 
Biological processes ranging from gene transcription and protein synthesis to cellular 
signaling and protein degradation are regulated by protein-protein interactions. Identification 
and characterization of these various protein interactions constitutes one of the most 
important goals of modern biology. Both biochemical and genetic methods have been 
described to study protein-protein interactions. Using biochemical assays (e.g. 
chromatography, co-immunoprecipitations) interacting proteins can be identified in crude 
extracts by their ability to co-purify, while in genetic assays the formation of a protein contact 
results in a detectable alteration in a phenotype of a cell (reviewed in Hu et al., 2000). The 
best characterized genetic assay is the Yeast two-hybrid (Y2H) system which was developed 
more then 15 years ago as a convenient method to identify and analyze protein-protein 
interactions (Fields and Song, 1989; reviewed in Serebriiskii et al., 2001; reviewed in Fields, 
2005). This system was recently translated into E. coli cells resulting in the development of 
the Bacterial two-hybrid (B2H) system (e.g. Hu, et al., 2000; Joung, 2001; see also section 
3.2.2). The feasibility of the B2H system for analyzing protein-protein interactions has been 
demonstrated with many protein pairs suggesting that, in theory, any protein pair of interest 
can be analyzed in this system (Dove et al., 1997; Dove and Hochschild, 1998; Blum et al., 
2000; Joung et al., 2000; Shaywitz et al., 2000; Dove and Hochschild, 2001; Saito et al., 
2004). Furthermore, this system can detect relatively weak interactions possessing 
equilibrium dissociation constants in the micromolar range and the magnitude of reporter 
gene activity increases accordingly with the strength of a particular interaction (Dove et al., 
1997).  
Although various interacting protein-protein pairs have been demonstrated to work in the 
B2H system prior to the work described in this thesis, protein-protein interactions mediated 
by ZF domains have not been investigated in this system. As described in Chapter 1 (section 
1.2.8), in addition to the classical C2H2 ZF motif, several other classes of zinc-ligating 
domains have been identified (Matthews and Sunde, 2002). Some of these ZFs are well 
known for theit ability to mediate protein-protein interactions although relatively little is 
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known about the molecular details of these interaction interfaces. Since we successfully 
validated the B2H system both as a reporter as well as a selection system for analyzing DZF 
mediated dimerization (Chapter 3), we were also interested in testing if the B2H system could 
provide a means to characterize protein-protein interactions mediated by a variety of different 
other ZF proteins (Figure 7.1).  
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Figure 7.1 Proteins analyzed in the B2H system. The domain structures of the various proteins tested 
in the B2H system are shown. The colored boxes indicate type of the respective ZF motif (Note that 
proteins without ZFs are not further classified and are summarized as “No ZF” group). Individual ZFs 
are shown as colored ovals or as double ovals for the LIM domains. Additional domains or typical 
motifs are shown as grey boxes. REST, RE-1 silencing transcription factor; FOG, Friend of GATA; 
LMO, LIM only; CRP, cysteine-rich protein; PINCH, particulary interesting new cysteine and 
histidine-rich protein; Co-REST, Co-repressor of REST; Ldb, LIM domain binding protein, ILK, 
Integrin-linked kinase; G, Glycin-rich region; SANT, SW13/ADA2/NCoR/TFIIIB domain; LID, LIM 
interaction domain; SH2/3, Src-homology 2/3; A, Ankyrin repeat.  
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7.2 Interaction between the ZF proteins REST and CoREST 
 
7.2.1 Background 
 
The transcriptional repressor REST is a biologically important example of a C2H2 protein 
that mediates protein-protein interaction. REST represses expression of neuronal genes in 
non-neuronal cells by binding to a conserved DNA sequence (RE-1, repressor element 1). In 
addition to its DNA binding domain which consists of a cluster of 8 ZFs, REST harbors two 
additional C2H2 domains at its N- and C-termini (Figure 7.1). While the N-terminal domain 
associates with the mSin3/histon deacetylase 1, 2 (HDAC1, 2) complex to mediate 
repression, the C-terminal domain mediates gene silencing by interacting with the co-
repressor CoREST (reviewed in Lunyak et al., 2004; reviewed in Lunyak and Rosenfeld, 
2005). CoREST is characterized by two SANT (SW13/ADA2/NCoR/TFIIIB) domains 
(Figure 7.1, Aasland et al., 1996, Andres et al., 1999) that may be involved in stabilizing the 
binding of REST to its DNA site. The REST interaction domain in CoREST was mapped by 
Y2H analysis and revealed that two domains (aa 102-195 and 145-225, including SANT 
motif 1) were sufficient for the interaction with REST (Ballas et al., 2001). Interestingly, the 
interaction domain of REST requires only the single C-terminal C2H2 zinc finger and point 
mutations in this motif disrupted the interaction between REST and CoREST and abolished 
REST repressor activity (Andres et al., 1999). However, little is known about the molecular 
details of how the C2H2 ZF of REST interacts with CoREST. We were therefore interested in 
testing if the B2H system could provide a means to further characterize this interaction.  
 
7.2.2 Validation of the B2H system for studying REST/CoREST interactions 
 
To test whether the REST/CoREST interaction might be detected in the B2H system we 
constructed several different plasmids encoding fusion proteins required for testing in the 
B2H system setup. In an initial experiment the C-terminal C2H2 zinc finger (F9, residues 
1008-1097) of REST (previously shown to interact with CoREST) was fused to the DNA-
binding domain of the dimeric bacteriophage lambda cI (λcI) protein. In addition, two 
fragments of the CoREST N-terminus (CoREST A, residues 102-195 and CoREST B, 
residues 130-180) were fused to the α-subunit of the E. coli RNA polymerase. To test the 
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interaction of the hybrid proteins a reporter strain harboring the binding site for the λcI 
protein upstream of the weak lacZ promoter was constructed. Combinations of plasmids 
expressing the different hybrid proteins were transformed into this reporter and β-
galactosidase activity was assessed. Neither CoREST A nor CoREST B was able to mediate 
transcriptional activation of lacZ when co-expressed with the REST F9 fusion protein (data 
not shown). Using different IPTG concentrations to increase the expression level of the 
fusion proteins was not successful (data not shown). 
Although the λcI protein has previously been used successfully to make DBD hybrid proteins 
(Dove et al., 1997) we were concerned that it might not bind properly to its binding side or 
did not provide the right conformation for REST to be able to interact with CoREST. 
Therefore, it might have been unable to recruit the E. coli RNA polymerase to the promoter. 
Thus, we decided to construct additional plasmids encoding various DBD-fusion proteins. 
One construct expressed REST F9 as a direct fusion to the REST F3-8 DBD which 
incorporated the F9 into the context of its specific natural DBD. Two additional constructs 
consisted of two segments of REST F9 (F9 long, residues 1008-1097 and F9 short, residues 
1049-1097) fused to the DNA binding domain of the Zif268 protein (see Chapter 3, section 
3.2). Combinations of plasmids expressing these hybrid proteins together with the α-CoREST 
fusion proteins were introduced into appropriate reporter strains bearing either the REST F3-
8 or the Zif268 binding site and β-galactosidase activity was assessed. Unfortunately none of 
these combinations were able to activate expression of lacZ (data not shown). Because 
efficient recruitment of the RNAP by the α-subunit depends on the right distance and 
orientation of the DNA binding site (DBS) relative to the transcription start point of the lacZ 
promoter a range of different reporter strains bearing the Zif268 binding site positioned at 
various distances and orientations of the promoter were further tested. None of these reporters 
demonstrated interactions of REST/CoREST as evidenced by the lack of activation of lacZ 
(data not shown).  
Since the interaction between REST and CoREST has been previously demonstrated, this 
suggests that these proteins might not be expressed sufficiently in bacteria which would 
explain why their interaction could not be detected in the B2H system.  
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7.3 Interaction between the ZF proteins GATA-1 and FOG-1 
 
7.3.1 Background 
 
Interaction of the mammalian FOG-1 protein with the GATA-1 protein is a biologically 
important example of a protein-protein interaction mediated by zinc fingers. GATA-1 
belongs to a small family of transcription factors that were originally found in erythroid cell 
lines (Evans and Felsenfeld 1989; Tsai et al., 1989; Trainor et al., 1990; Pevny et al., 1991). 
FOG-1 is co-expressed with GATA-1 during embryonic and hematopoietic development and 
functions as an in vivo cofactor for GATA-1. It has been shown that the GATA-1/FOG-1 
interaction is necessary for proper hematopoiesis and thrombopoiesis (reviewed in Cantor et 
al., 2002). The GATA-1/FOG-1 interaction is mediated by two different zinc finger motifs: 
GATA-1 contains two zinc fingers of the Cys4 type (where zinc ligands are represented by 
four cysteines) that fold into a structure termed the treble clef motif which is composed of 
two irregular β-hairpins and an α-helix (e.g. Kowalski et al., 1999; Grishin, 2001; Krishna et 
al., 2002; Figure 7.1). While the C-terminal finger (GATA-1 CF) binds to DNA, the N-
terminal finger (GATA-1 NF) mediates interaction with FOG-1 (Kowalski et al., 2002). 
FOG-1 contains nine putative ZFs (F1-F9) that are of two different types: four belong to the 
classical C2H2 finger-type (F2, F3, F4 and F8) whereas the other five are of the C2HC type 
(F1, F5, F6, F7 and F9) (Figure 7.1). The sequence of the C2HC ZFs conforms well to the 
C2H2 ZF consensus with the exception of a cysteine replacing the final histidine (Tsang et 
al., 1997). Structural studies of C2HC fingers indicate that their overall fold is similar to the 
ββα fold of C2H2 fingers but with a more extended structure at the C-terminal end (Liew et 
al., 2000). Different reports suggest that C2HC fingers do not bind to DNA but instead 
mediate interactions with other proteins (Matthews et al., 2000).  
It has previously been shown that the GATA-1 NF can interact with the C2HC fingers F1, F6, 
or F9 of FOG-1(Fox et al. 1999). By contrast, GATA-1 CF fails to bind to the FOG-1 zinc 
fingers. Interestingly, FOG-1 fingers that are involved in protein contact are exclusively of 
the C2HC type, whereas the four C2H2 FOG-1 fingers are unable to mediate protein-protein 
interactions with GATA-1. Using the Y2H system and alanine scanning mutagenesis, several 
residues important for this interaction were defined for both GATA-1 and FOG-1 (Fox et al., 
1999; Fox et al., 1998). Although these amino acid residues were identified, additional study 
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and definition of the protein interface is still required to define the specific amino acid-amino 
acid interactions that occur at the interaction interface. Thus, we wished to determine whether 
this interaction can also be detected in the B2H system to further analyze and characterize the 
interaction surface.  
 
7.3.2 Validation of the B2H system for studying GATA/FOG interactions 
 
7.3.2.1 GATA-1 and FOG-1 interactions can be detected in the B2H system 
To test whether GATA/FOG interactions can be detected in the B2H system a plasmid 
encoding a GATA-1/DBD hybrid protein consisting of the N-terminal zinc finger of GATA-1 
(residues 200-254) was constructed. The DBD protein in this hybrid protein is the λcI protein. 
Additionally, three plasmids encoding hybrid proteins consisting of either FOG-1 zinc finger 
1 (residues 241-295), 6 (residues 677-760), or 9 (residues 945-995) fused to the α-subunit of 
the E. coli RNA-polymerase were created. All of these zinc fingers have been shown to be 
involved in protein-protein contact between GATA-1 and FOG-1 in yeast (see section 7.3.1). 
Combinations of plasmids expressing these hybrid proteins were then introduced into a 
reporter strain bearing the λcI binding site positioned upstream of the lacZ gene and β-
galactosidase activity was measured. None of the FOG-1 fingers was able to mediate 
transcriptional activation of lacZ when co-expressed with the GATA-1 fusion protein (data 
not shown). To vary the expression level of the fusion proteins, different concentrations of 
IPTG were used to induce the expression of the constructs in the reporter cells. It was found 
that IPTG concentrations above 30 μM inhibited the growth of the bacteria and the optical 
densities of these cells were extremely low even after 6 hr of growth. This suggested that 
high levels of the fusion proteins might be toxic to the bacterial strains. Experience with the 
B2H system has demonstrated that certain λcI-hybrid proteins can be toxic to bacterial strains 
(K. Joung, personal communication).  
Therefore we decided to construct an additional plasmid encoding GATA-1 fused to the 
DNA binding domain of the Zif268 protein (see Chapter 3, section 3.2). Combinations of the 
α-fusion proteins together with this new plasmid were then introduced into a reporter strain 
containing the binding site for the Zif268 protein and β-galactosidase activity was assessed. 
As shown in Figure 7.2A two of the FOG-1 fingers (F1 and F6) mediated transcriptional 
activation of lacZ when co-expressed with the GATA-1 NF fusion protein. The strongest 
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activation (4-fold) was observed with GATA-1 NF and FOG-1 F1 (Figure 7.2A). Control 
experiments expressing either the Zif-hybrid or the α-hybrid protein alone did not show 
increased β-galactosidase expression (data not shown). 
To further test if activation of lacZ is depended on the expression of the two fusion proteins, 
we performed an IPTG titration experiment where the expression of the fusion proteins was 
induced using increasing concentrations of IPTG. Increased lacZ expression only occurred 
when the amount of IPTG used for induction reached a certain level (>25 μM) indicating that 
the activation depended on expression of both fusion proteins (Figure 7.2B).  
Since activation of lacZ depends on the distance and orientation of the DBD-binding site 
relative to the promoter, the interaction between GATA-1 NF and FOG-1 F1 was further 
analyzed using various Zif268 binding site reporter strains. As shown in Figure 7.2C, the 
strongest activation was observed with reporter strains bearing the Zif268 binding site at 
position -61 and -65 relative to the promoter of the reporter gene. Further decreasing or 
increasing of the distance relative to the promoter did abolish the ability of GATA-1 and 
FOG-1 to activate lacZ (Figure 7.2C and data not shown). Interestingly, the binding site at -
61 was positioned such that the C-terminal part of the Zif268 fusion protein is most proximal 
to the promoter while the orientation of the -65 binding site brought the N-terminal part of the 
Zif268 fusion protein close to the promoter. Although different from each other, both 
orientations seemed to provide the essential geometry for the GATA-1-Zif268 fusion protein 
to mediate interaction with FOG-1 (Figure 7.2C and data not shown).  
 
7.3.2.2 Mutations in GATA-1 and FOG-1 disrupted the interactions 
To obtain additional evidence that the transcriptional activation detected in the B2H system 
reflects the physiological GATA-1/FOG-1 interaction, various GATA-1 NF and FOG-1 F1 
mutations known to disrupt their interaction (Fox et al., 1998; 1999) were introduced into our 
hybrid proteins using site-directed PCR mutagenesis (as described in section 2.1.2.2). We 
tested whether these mutations would affect the ability of GATA-1 NF and FOG-1 F1 to 
mediate transcriptional activation of the lacZ reporter gene. Indeed, substitution of FOG 
residue I262 with alanine resulted in a strong inhibition of the interaction with wild type 
GATA-1 whereas replacement of R265A had a weaker impact on binding (Figure 7.2D). The 
same differential effects were found when these mutants were tested in the Y2H system (Fox 
et al., 1999). Similarly, substitution of the GATA-1 residues E203 with valine and V205 with 
threonine also disrupted the interaction just as they did in the yeast-based system, with the 
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mutation at residue position E203 displaying a stronger impact on interaction then the 
mutation at residue position 205 (Figure 7.2D, Fox et al., 1998).  
 
Taken together, these results suggest that interactions between GATA-1 NF and fingers from 
FOG-1 interaction can mediate transcriptional activation in the B2H system. Importantly, 
these experiments further establish the feasibility of using the B2H system for studying 
protein-protein interactions mediated by different types of ZF proteins.  
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Figure 7.2 Analysis of the interaction between GATA-1 and FOG-1 in the B2H system. B2H reporter 
strains expressing pairwise combinations of plasmids encoding domains from GATA-1 and FOG-1 were 
assayed for β-galactosidase activity. In these assays GATA-1 NF was fused to the DBD of Zif268 while ZFs 
1, 6 and 9 from FOG-1 were connected to the α-subunit of the RNAP. If not mentioned otherwise an IPTG 
concentration of 50 μM was used. (A) The reporter strain harboring the Zif268 DBS at position -61 in 
orientation 123 relative to the promoter was transformed with combinations of plasmids and β-galactosidase 
assays were performed. A control expressing Zif268 and the α-subunit alone is shown to the right. (B) β-
galactosidase activities of -61 reporter cultures grown at various IPTG concentrations were measured to 
analyze the effect of different hybrid-protein expression levels. Fold activation was normalized to cells 
expressing only Zif268 and the α-subunit. (C) The interaction between GATA-1 NF and FOG-1 F1 was 
further analyzed using reporter strains that differ in their location and orientation of the Zif268 DBS relative 
to the promoter. Position of the binding site is indicated on the X-axis. Purple bars represent reporter strains 
with the Zif268 binding site in orientation 123 and blue bars indicate orientation 321. (D) Specific mutations 
in FOG-F1 (m1=I262A, m2=R265A) and in GATA-1 (m1= E203V, m2= V205T) were analyzed for their 
ability to abolish the interaction between GATA-1 NF and FOG-1 F1. In this assay, the reporter strain 
harboring the Zif268 DBS at position -65 in orientation 321 relative to the promoter was used. 
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7.4 LIM domain mediated protein-protein interactions 
 
7.4.1 Background 
 
The LIM domain (termed after the initials of the founding members of this class, Lin-11, Isl1 
and MEC-3) is defined as a cysteine-histidine rich domain consisting of two tandemly 
repeated zinc-coordinating fingers (for comprehensives reviews see: Dawid et al., 1998; 
Jurata and Gill, 1998; Bach, 2000; Kadrmas and Beckerle, 2004). Because of their abundance 
and diversity, LIM domain proteins are further classified by sequence similarity and on the 
basis of the presence and nature of associated domains (Dawid et al., 1998; Bach, 2000; 
Kadrmas and Beckerle, 2004). For example, LIM homeodomain (LHX), LIM only (LMO) 
and LIM kinase (LIMK) proteins all contain paired LIM domains at the N-terminus and form 
Group 1. Group 2 proteins are mainly composed of the LIM domains. LIM proteins of Group 
3 are more heterogeneous in sequence than Group 1 and 2 and the LIM domains are localized 
at the C-terminus. Like GATA-1, the LIM domain ZF motif belongs to the structural treble 
clef motif consisting of two treble-clef fingers that are separated by two amino acids 
(Kadrmas and Beckerle, 2004). Although LIM proteins share several structural similarities 
with GATA ZFs, they do not seem to bind DNA. Rather, LIM domains have been implicated 
to mediate protein-protein interactions and are found in proteins with a wide variety of 
functions (Bach, 2000; Kadrmas and Beckerle, 2004). Many different types of proteins are 
described that can interact with LIM domain proteins including kinases, transcription factors 
and other LIM domains. In addition, a few LIM proteins have been reported to mediate 
homodimerization. While some LIM proteins seem to be exclusively involved in protein 
contacts, others have additional separate functional domains. Examples for such functional 
domains are the homeodomain in LHXs or the kinase domain in LIMK proteins.  
Since the LIM domain proteins provide an example of ZF proteins that are thought to 
exclusively mediate protein-protein interactions we were interested in analyzing the LIM 
domain using the B2H system. We chose several well characterized LIM domains and their 
partners that all mediate interaction through LIM domains in at least one of the partners. 
These proteins partly belong to different classes of LIM domain proteins providing a 
representative selection of LIM domain proteins (Figure 7.1, summarized in Table 7.1).  
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7.4.2 Validation of the B2H system for studying LIM domain mediated interactions 
 
To test whether LIM domain mediated interactions can be detected in the B2H system we 
constructed several different plasmids encoding various fusion proteins. Combinations of 
plasmids expressing these hybrid proteins were then introduced into the different reporter 
strains bearing the Zif268 binding site at various positions and orientations relative to the test 
promoter, and β-galactosidase activity was measured. Although these proteins have been 
previously described and characterized as interacting domains, most of the tested 
combinations were not able to mediate transcriptional activation of the lacZ reporter (Table 
7.2 and data not shown). However, co-expression of LMO2 and LMO4 with the LID fusion 
protein was able to activate lacZ transcription. The strongest activation was observed for 
LMO4 LIM1 and LID with the reporter strain that bears the Zif268 binding site at position -
65 (orientation 321). In this initial experiment an IPTG concentration of 50 μM was used 
which inhibited the growth of the bacteria suggesting that the produced level of fusion 
proteins was toxic to the bacterial strains. 
 
 
Therefore, an IPTG titration experiment was performed using various amounts of IPTG 
below 50 μM. As shown in Figure 7.3, the highest lacZ expression for all four tested 
Table 7.2 Analysis of interactions 
mediated by LIM domains in the 
B2H system. Tested protein pairs 
are shown in the first two columns. 
Column 3 summarizes the result of 
interactions assessed in duplicates 
using various conditions. + indicates 
increased reporter gene activity 
while – indicates that no reporter 
gene activity was detected. An IPTG 
concentration of 50 μM was used for 
all assays and different reporter 
strains were analyzed.  
+LIDLMO4 LIM1
+LIDLMO4
+LIDLMO2 LIM1
+LIDLMO2 
-Nck2PINCH LIM4
-ILKPINCH LIM1
-CRP1 c-zyxin
-CRP1 h-zyxin
-c-zyxinCRP1 
-h-zyxinCRP1 
-CRP1 LIM2 CRP1 LIM2 
-CRP1 CRP1 LIM2 
-CRP1 LIM2 CRP1 
-CRP1 CRP1 
Activation of 
reporterRNAP fusion protein 
DNA-binding 
fusion protein
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interactions occurred with 10 μM IPTG and higher concentrations inhibited growth. 
Interestingly, reporter activation was already observed even without induction of expression 
suggesting that basal expression levels of the hybrid proteins are sufficient to activate lacZ 
expression.  
 
Control experiments expressing either the Zif-hybrid or the α-hybrid proteins alone did not 
show increased β-galactosidase Units (data not shown). Thus, the B2H can generally be used 
to study certain LIM domains although most of the tested pairs were not able to mediate 
transcriptional activation.  
 
 
7.5 Discussion 
 
7.5.1 Protein-protein interactions mediated by ZF proteins can be studied in the B2H 
system 
 
The work in this chapter aimed to further validate the B2H system for analyzing protein-
protein interactions mediated by ZF proteins. Different ZF-protein pairs know to interact with 
each other were introduced into the B2H system and their abilities to activate a reporter gene 
were analyzed. These pairs consisted of different classes of ZF proteins with distinct 
structural and functional features. To test for transcriptional activation of the reporter gene, 
one of the potentially interacting peptides was fused to the α-subunit of the RNAP while the 
other peptide was connected to various DBDs. Although only some of the previously 
described interactions could be detected in the B2H system, the results of this chapter 
(together with Chapter 3) provide further evidence that it is in principle possible to study 
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Figure 7.3 Analysis of the interaction 
between LMO and LID in the B2H 
system. The -65 (orientation 321) 
reporter was transformed with plasmids 
encoding the appropriate fragments and 
β-galactosidase activity was assessed 
over increasing IPTG concentrations. 
Fold activation was normalized to cells 
expressing Zif268 together with the α-
subunit.  
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protein-protein interactions mediated by ZF proteins using the B2H system. Results obtained 
for particular pairs that did work in this system were generally very reliable and consistent 
with previously described observations obtained using different methods including the Y2H 
system. For example, mutations characterized in the Y2H system capable of abolishing a 
defined interaction displayed a similar effect when analyzed in the B2H (e.g. mutations that 
destroyed the interaction between GATA-1 and FOG-1). Furthermore, negative controls 
expressing either the DBD-hybrid or the α-hybrid protein alone did not show increased 
activation of lacZ suggesting that the activation depends on the presence of the two 
interacting proteins. Hence, the activation of the reporter gene is due to an interaction with 
similar characteristics compared to those described in previous studies. This work (together 
with Chapter 3) provided examples of protein-protein interactions mediated by ZF proteins 
analyzed in the B2H system. In addition, it confirmed that particular ZF proteins can be 
involved in contacting other proteins. 
 
7.5.2 B2H versus Y2H 
 
Unfortunately, not all of the tested pairs could activate the reporter gene, although these pairs 
were previously tested for their ability to interact with each other using different methods. 
Several reasons might explain this lack of detection in the B2H system. For example, some 
peptides may have been unable to fold properly or may have been insoluble or toxic to 
bacterial cells (as opposed to yeast cells) and were therefore not expressed at high levels. 
Some peptides may have required posttranslational modifications which the bacteria cells 
were not able to provide. Other reasons could be that they did not provide the right geometry 
for the existing setup which could be due to certain properties of the peptides, including size 
or folding conformation. On the other hand, these pairs may just be unable to interact at all in 
bacteria or the interactions are too weak to be detected in the B2H system.  
Assuming that it is not possible to test every single interacting pair in the B2H system, why is 
it still worth trying it? It definitely provides some advantages compared to the well described 
Y2H system, mainly the fast growth and high transformation efficiency obtained in bacteria. 
Furthermore, some proteins can not be analyzed in yeast because they may require nuclear 
localization or activate transcription of the reporter in an unspecific manner (reviewed in Hu 
et al., 2000; reviewed in Hu, 2001). In addition, certain cellular processes can not be studied 
in yeast because of the capability of endogenous yeast proteins to influence these events. For 
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example, it has proven difficult to study the effect of phosphorylation on protein-protein 
interactions in yeast due to present endogenous kinases. Bacteria on the other hand provide 
an isolated system where these effects could easily be studied (Shaywitz et al., 2002; 
Shaywitz et al., 2000). Thus, each system has advantages and disadvantages and can not be 
considered as better or worse but rather will provide complementary information (reviewed in 
Hu, 2001; Serebriiskii et al., 2005).  
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Summary 
 
The C2H2 ZF motif is a compact ~ 30 amino acid molecular recognition domain that 
comprises a β-hairpin followed by an α-helix (ββα fold). In proteins, these domains are 
typically found as tandem arrays that mediate specific interactions with various 
macromolecules including DNA, RNA and other proteins. Although very well characterized 
as a DNA-binding domain, relatively little is currently understood about the molecular details 
of protein-protein interactions mediated by C2H2 ZFs. The Ikaros and Hunchback 
transcription factor family provides an ideal model system for studying ZF mediated protein-
protein interactions. Ikaros, the founding member of this family is defined as a classical 
C2H2 ZF protein composed of a cluster of four C2H2 ZFs at the N-terminus and two 
additional C2H2 ZFs at the C-terminus. While the N-terminal ZFs are involved in specific 
DNA recognition, the C-terminal domain (termed as Dimerization Zinc Finger or DZF 
domain) has been shown to mediate the homo- and hetero-typic interactions.  
 
In this thesis, the DZF domains found in the Ikaros and Hunchback transcription factor 
family have been examined using a combination of genetic, biochemical and functional 
assays. We first established a bacterial-based genetic system for studying C2H2 ZF mediated 
protein-protein interactions. This system is more rapid then previously described methods and 
allows the performance of complex genetic selections.  
To test, if protein-interacting C2H2 ZFs, in analogy to DNA-binding ZFs, can be used to 
create novel protein-protein interaction specificities, we constructed libraries of synthetic 
DZFs by shuffling individual C2H2 ZFs from DZF domains found in the human Ikaros and 
other related transcription factors. Using a bacterial-based selection system, we identified 
synthetic heterodimeric DZFs that can mediate activation of a single copy reporter gene in 
bacterial cells. These synthetic protein-protein interaction domains can also be used to 
reconstitute a synthetic bi-partite activator in the nucleus of a human cell which results in a 
transcriptional activation of the endogenous VEGF-A gene. In addition, these synthetic two-
finger domains can be linked together to create more extended protein-protein interaction 
interfaces. These results demonstrate that certain protein-interacting C2H2 ZFs (like their 
DNA binding counterparts) can function in a modular fashion. Furthermore, analysis of the 
interaction specificities of these synthetic domains led to the discovery of a novel anti-
parallel interaction mode for the DZF domain.  
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The homo-typic interaction mediated by different DZF domains was examined in greater 
detail using mutational analysis. These studies narrowed down residues that are likely to be 
important for dimerization mediated by the Hunchback DZF domain. Comparing these amino 
acids to residue positions previously identified as important for dimerization of Ikaros and 
Eos highlights both similarities and differences. To obtain further information about the 
physical and chemical interaction surface we attempted to purify active peptides consisting of 
different DZF domains for X-ray crystallography. Although highly purified DZF peptides 
were successfully obtained, various attempts to refold these peptides into active domains 
resulted in the formation of aggregates consisting of the various DZFs.  
Based on findings in the bacterial and cell culture systems, we started exploring if Hunchback 
dimerizes in Drosophila melanogaster using its DZF domain and if dimerization is essential 
for the function of the protein. Therefore, constructs encoding the full-length Hunchback 
protein harboring various natural and modified DZF domains were generated and expressed 
in transgenic flies. These transgenics were used to perform functional in vivo studies of the 
Hunchback DZF domain in Neuroblast specification during Drosophila melanogaster 
development. We confirmed previous studies that the C-terminal domain in Hunchback is 
important for maintaining the function of Hunchback in specifying early-born temporal 
identity in Drosophila neural stem cell lineages. Importantly, our results indicate that this 
domain can be functionally replaced with a heterologous (i.e.: non fly) DZF domain, 
suggesting that the importance of the DZF domain is due to its ability to mediate 
dimerization.  
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Appendix.  
 
 
Plasmid name Description / purpose Source / Method of constructing 
Cloning sites used 
for further cloning 
procedures 
pBR-UV5-λcI  
Phagemid used in the B2H system to 
clone protein X as a C-terminal fusion to 
the DBD of the λcI protein. Expression is 
driven by the IPTG-inducible lacUV5 
promoter; plasmid has f1 ori of 
replication. 
Kindly provided by K. Joung. See also Giesecke and Joung 
(2005). BglII-XbaI 
pBR-UV-REST F3-8 
Phagemid used in the B2H system to 
clone protein X as a C-terminal fusion to 
the DBD of REST represented by ZF3-8. 
Expression is driven by the IPTG-
inducible lacUV5 promoter; plasmid has 
f1 ori of replication. 
Plasmid was constructed by replacing the SalI-BamHI 
fragment of the pBR-GP-Z12BbsI phagemid (Joung et al., 
2000) with a PCR amplified fragment consisting of the UV5 
promoter region (starting at the SalI site) of the pBR plasmid 
and the F3-8 fragment. An additional NotI cloning site was 
included at the C-terminus (N-terminal to the BamHI site).  
NotI-BamHI 
pBR-UV5-Zif268 
Phagemid used in the B2H system to 
clone protein X as an N-terminal fusion to 
the DBD of the murine Zif268 (residues 
327-421). Expression is driven by the 
IPTG-inducible lacUV5 promoter; 
plasmid has f1 ori of replication. 
Plasmid was generated by replacing the SalI-NotI fragment 
of the pBR-GP-Z123 (Joung et al., 2000) with a short DNA 
fragment consisting of two annealed oligonucleotides that 
incorporated a NdeI site. 
NdeI-XhoI. Note 
that there are two 
more NdeI sites. 
pACYC-α 
Plasmid used in the B2H system to clone 
protein Y as a C-terminal fusion to the α-
subunit (residues 1-248) of the E. coli 
RNAP. Expression is driven by the IPTG-
inducible tandem lpp/lacUV5 promoter. 
Original plasmid pACYC-α (Joung et al., 2000) was 
modified by introducing a short DNA fragment consisting of 
two annealed oligonucleotides that incorporated a BamHI, 
KpnI and XhoI site into the NotI-BglII site of the original 
plasmid (R. Fang). 
BamHI-XhoI 
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pBR- UV5-Zif268 
BbsI stuffer 
Phagemid used to create libraries of 
shuffled DZF domains for B2H 
selections. Shuffled fragments were 
cloned into the BbsI site, thereby creating 
N-terminal fusions to the DBD of the 
murine Zif268 (residues 327-421). 
Expression is driven by the IPTG-
inducible lacUV5 promoter; plasmid has 
f1 ori of replication. 
A BbsI “stuffer” fragment containing two BbsI restriction 
sites was designed by annealing two complementary 
oligonucleotides together. In addition, a 5’ Sal I and a 3’ 
BspEI overhang was created which was used to clone the 
annealed product into the Sal I and BspEI sites of the pBR- 
UV5-Zif268 plasmid.  
BbsI 
pSB stuffer  
Plasmid used to assemble DBS to 
construct reporter strains for the B2H 
system. 
Plasmid is a derivate of pFW11 (Whipple, 1998) and was 
kindly provided by K. Joung. EcoRI-SalI or SapI 
pcDNA5-p65 
Plasmid used in the mammalian cell-
based activator reconstitution assay to 
clone protein X as a C-terminal fusion to 
the human NF-κB p65 subunit (residues 
283-551). Plasmid harbors an N-terminal 
nuclear localization signal (NLS) from 
SV40 large T antigen and expression is 
driven by a modified cytomegalovirus 
(CMV) promoter that can be repressed by 
the tetracycline repressor.  
pcDNA5 was obtained from Invitrogen. Plasmid pcDNA5-
p65 was made by amplifying the p65 fragment using PCR 
with two specific external primers. The Top strand PCR 
primer introduced a nuclear localization signal from the 
simian virus 40 (SV40) large T antigen at the N-terminus of 
p65 and incorporated a HindIII site. A BamHI and XhoI site 
for further cloning procedures was introduced at the C-
terminus of p65 by the bottom strand primer. The amplified 
DNA was cloned into the HindIII and XhoI sites of the 
pcDNA5 expression vector.  
BamHI-XhoI 
pcDNA5-SpI 
Plasmid used in the mammalian cell-
based activator reconstitution assay to 
clone protein Y as a C-terminal fusion to 
the synthetic VZ+434b DBD, (Liu et al., 
2001) that binds to the human VEGF-A 
gene. Plasmid harbors an N-terminal NLS 
from SV40 large T antigen and expression 
is driven by a modified CMV. 
Plasmid pcDNA5-SpI was made by replacing the p65 
fragment of the pcDNA5-NA-VZ+434b plasmid (K. Joung) 
with a BamHI-XhoI cloning site. Complementary 
oligonucleotides were annealed together to generate a DNA 
fragment that bear BamHI and XhoI sticky ends which was 
then cloned into the BamHI and XhoI sites of the pcDNA5-
NA-VZ+434b plasmid vector.  
BamHI-XhoI 
pcDNA5-FLAG-p65 Plasmid is the same as pcDNA5-p65 but harbors a N-terminal FLAG-tag to 
The FLAG-tag encoding sequence was incorporated in one of 
the external primers used to amplify a left cassette fragment. BamHI-XhoI 
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perform quantitative Western blot 
analysis. 
This fragment was then fused to the right cassette fragment 
encoding the p65 protein. The resulting PCR fragments were 
cloned into the HindIII and BamHI sites of the pcDNA5-p65 
plasmid. 
pcDNA5-FLAG-SpI 
Plasmid is the same as pcDNA5-SpI but 
harbors a N-terminal FLAG-tag to 
perform quantitative Western blots. 
Fragment encoding FLAG-SpI was made as described for 
FLAG-p65 (see above) and cloned into the HindIII and 
BamHI sites of the pcDNA5-SpI plasmid. 
BamHI-XhoI 
pcDNA3.1-IkI 
Plasmid used in mammalian cell based 
co-immunoprecipitation assay to express 
protein X as a fusion to the C-terminus of 
the Ikaros isoform I (Ik-I, residues 1-222). 
Expression of the fusion protein is driven 
by a modified CMV promoter and no 
NLS is present.  
pcDNA3.1 was obtained from Invitrogen. The Ik I was 
assembled from overlapping oligonucleotides using PCR and 
cloned into the EcoRI-BamHI site of pcDNA3.1 (R. Fang). 
KpnI-HindIII 
pcDNA3.1-FLAG-
NTS 
Plasmid used in mammalian cell based 
co-immunoprecipitation assay to express 
protein Y as a fusion to the N-terminal 
fragment of Ik-I (NTS) Plasmid also 
contained a N-terminal FLAG-tag. 
Expression is driven by a modified CMV 
promoter and the NLS is missing.  
NTS was assembled from oligonucleotides and cloned into 
the BamHI-KpnI site of pcDNA3.1. An assembled FLAG tag 
was included at the N-terminus of the fusion protein by 
cloning it into the EcoRI-BamHI (R. Fang). 
KpnI-HindIII 
pACYC-λcI 
Plasmid used in the B1H system to 
express protein X as a C-terminal fusions 
to the N-terminal DNA binding domain of 
the lambda cI repressor (λcI NTD). 
Expression is driven by the IPTG-
inducible lacUV5 promoter. 
Plasmid was originally made in Ann Hochschilds lab and was 
further modified by introducing a KpnI-HindIII cloning site 
incorporated in overlapping oligonucleotides which was 
cloned into the NotI-BamHI site of pACYC-λcI (Rui Fang).  
KpnI-HindIII 
pET3a 
Plasmid used to express peptides under 
the control of an IPTG-inducible 
promoter. 
pET3a was obtained from Novagene NdeI-BamHI 
pUAST Plasmid used to express cDNAs in the GAL4-UAS system under control of the 
pUAST containing the wild-type Hunchback cDNA 
(including extra non translated C-terminal sequence) was XhoI-KpnI 
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UAS promoter (Brand and Perrimon, 
1993). Plasmid also contained P-elements, 
the Hsp70 promoter, a Poly-adenylation 
site from SV40 and the white+ gene (in-
frame with the cDNA of interest). 
kindly provided by J. Urban.  
 
A1. Description of primary plasmids. The plasmid name is indicated in the first column. A brief description of the plasmid is shown in the second column. The third 
column describes the source of the plasmid or techniques employed to construct the plasmid. Note that PCR and primer annealing strategies are described in Chapter 2, 
sections 2.1.2.2 and 2.1.2.3. Restriction sites used for further cloning procedures (see A2) are indicated in the last column. 
 
 
 
 
Fragment name Plasmid Amino acids Method of gene synthesis and cloning 
REST F9 
pBR-UV5-λcI  
pBR-UV-REST F3-8 
pBR-UV5-Zif268 
Human REST:  
1008-1097 Amplified from IMAGE clone (ATCC).  
REST F9 long pBR-UV5-Zif268 Human REST:  1008-1097 De novo synthesis using PCR strategy B. Codons optimized for E. coli. 
REST F9 short pBR-UV5-Zif268 Human REST:  1049-1097 De novo synthesis using PCR strategy A. Codons optimized for E. coli. 
CoREST A pACYC-α Human CoREST:  102-195  Amplified from human cDNA (Panomics). 
CoREST B pACYC-α Human CoREST:  130-180 Amplified from human cDNA (Panomics). 
GATA-Nf pBR-UV5-λcI  pBR-UV5-Zif268 
Mouse GATA-1:  
200-254 De novo synthesis using PCR strategy B.  
FOG-1 F1 pACYC-α Mouse FOG-1:  241-295 Amplified from IMAGE clone (ATCC). 
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FOG-1 F6 pACYC-α Mouse FOG-1:  677-760 De novo synthesis using PCR strategy B. 
FOG-1 F9 pACYC-α Mouse FOG-1:  945-995 Amplified from IMAGE clone (ATCC). 
CRP1 pBR-UV5-Zif268 pACYC-α 
Human CRP1: 
6-175 Amplified from human cDNA (Panomics). 
CRP1 LIM2 pBR-UV5-Zif268 pACYC-α 
Human CRP1: 
115-175 Amplified from human cDNA (Panomics). 
Zyxin LIM1 pBR-UV5-Zif268 pACYC-α 
Human Zyxin: 
351-409 Amplified from human cDNA (Panomics). 
Chicken Zyxin LIM1 pBR-UV5-Zif268 pACYC-α 
Chicken Zyxin:  
351-409 De novo synthesis using PCR strategy B. 
PINCH LIM1 pBR-UV5-Zif268  
Human PINCH:  
6-68 Amplified from human cDNA (Panomics). 
PINCH LIM4 pBR-UV5-Zif268  
Human PINCH:  
189-248 Amplified from human cDNA (Panomics). 
LMO2 pBR-UV5-Zif268  
Human LMO2: 
22-150 Amplified from human cDNA (Panomics). 
LMO2 LIM1 pBR-UV5-Zif268  
Human LMO2: 
22-88 Amplified from plasmid encoding LMO2. 
LMO4 pBR-UV5-Zif268  
Human LMO4: 
15-145 De novo synthesis using PCR strategy B. Codons optimized for E. coli. 
LMO4 LIM1 pBR-UV5-Zif268  
Human LMO4: 
15-81 Amplified from plasmid encoding LMO4. 
ILK pACYC-α Human ILK: 1-162 Amplified from human cDNA (Panomics). 
Nck2 pACYC-α Human Nck2: 161-273 Amplified from human cDNA (Panomics). 
LID pACYC-α Human ldb1: 299-238 De novo synthesis using PCR strategy B. 
Ik pBR-UV5-Zif268 pACYC-α 
Human Ikaros: 
456-519 Amplified from human cDNA (Panomics) (R. Fang). 
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Ai pBR-UV5-Zif268 pACYC-α 
Human Aiolos: 
446-509 De novo synthesis using PCR strategy B. Codons optimized for E. coli. 
He pBR-UV5-Zif268 pACYC-α 
Human Helios: 
465-526 Amplified from human cDNA (Panomics). 
Eo pBR-UV5-Zif268 pACYC-α 
Human Eos: 
471-532 Amplified from human cDNA (Panomics). 
Pe pBR-UV5-Zif268 pACYC-α 
Human Pegasus: 
358-420 
Amplified from human cDNA (Panomics), used Strategy D to silence 
internal NdeI site. 
Tr pBR-UV5-Zif268 pACYC-α 
Human TRPS-1: 
1209-1272 De novo synthesis using PCR strategy B. Codons optimized for E. coli. 
Hd pBR-UV5-Zif268 pACYC-α 
Hunchback from D.m.: 
699-758 De novo synthesis using PCR strategy B.  
Hl pBR-UV5-Zif268 pACYC-α 
Hunchback from L.m.: 
453-512 De novo synthesis using PCR strategy B. 
Hh pBR-UV5-Zif268 pACYC-α 
Hunchback from H.t.: 
409-468 De novo synthesis using PCR strategy B. 
Hc pBR-UV5-Zif268 pACYC-α 
Hunchback from C.e.: 
923-982 De novo synthesis using PCR strategy B. Codons optimized for E. coli. 
Tr-Eo-Eo pBR-UV5-Zif268 pACYC-α 
TRPS-1: 1209-1238 
Eos: 504-532 
Amplified from respective plasmid which was isolated from B2H 
selection strain. 
Eo-Eo-Hd pBR-UV5-Zif268 pACYC-α 
Eos: 471-504  
Hunchback D.m.: 733-758 “ 
Pe-Hd-Hd pBR-UV5-Zif268 pACYC-α 
Pegasus: 358-386 
Hunchback D.m.: 728-758 “ 
Hl-Eo-Eo pBR-UV5-Zif268 pACYC-α 
Hunchback L.m.: 453-481 
Eos: 504-532 “ 
Ik-Hd-Hd pBR-UV5-Zif268 pACYC-α 
Ikaros: 456-484 
Hunchback D.m.: 728-758 “ 
Pe-Pe-Eo pBR-UV5-Zif268 pACYC-α 
Pegasus: 358-391 
Eos: 509-532 “ 
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Ik pcDNA5-SpI pcDNA-p65 
Human Ikaros:  
456-519 
Subcloned from pACYC construct containing the respective DZF domain 
using BamHI and XhoI. 
Eo pcDNA5-SpI pcDNA-p65 
Human Eos: 
471-532 “ 
Pe pcDNA5-SpI pcDNA-p65 
Human Pegasus 
358-420 “ 
Tr 
pcDNA5-SpI 
pcDNA-p65 
pcDNA-FLAG-SpI 
pcDNA-FLAG-p65 
Human TRPS-1: 
1209-1272 “ 
Hd pcDNA5-SpI pcDNA-p65 
Hunchback from D.m.: 
699-758 “ 
Hl pcDNA5-SpI pcDNA-p65 
Hunchback from L.m.: 
453-512 “ 
Tr-Eo-Eo 
pcDNA5-SpI 
pcDNA-p65 
pcDNA-FLAG-SpI 
pcDNA-FLAG-p65 
TRPS-1: 1209-1238 
Eos: 504-532 “ 
Eo-Eo-Hd 
pcDNA5-SpI 
pcDNA-p65 
pcDNA-FLAG-SpI 
pcDNA-FLAG-p65 
Eos: 471-504  
Hunchback D.m.: 733-758 “ 
Pe-Hd-Hd 
pcDNA5-SpI 
pcDNA-p65 
pcDNA-FLAG-SpI 
pcDNA-FLAG-p65 
Pegasus: 358-386 
Hunchback D.m.: 728-758 “ 
Hl-Eo-Eo 
pcDNA5-SpI 
pcDNA-p65 
pcDNA-FLAG-SpI 
pcDNA-FLAG-p65 
Hunchback L.m.: 453-481 
Eos: 504-532 “ 
Ik-Hd-Hd pcDNA5-SpI pcDNA-p65 
Ikaros: 456-484 
Hunchback D.m.: 728-758 “ 
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pcDNA-FLAG-SpI 
pcDNA-FLAG-p65 
Pe-Pe-Eo 
pcDNA5-SpI 
pcDNA-p65 
pcDNA-FLAG-SpI 
pcDNA-FLAG-p65 
Pegasus: 358-391 
Eos: 509-532 
 
“ 
dDZF-1 pcDNA5-SpI 
Residues as described for 
the individual synthetic 
DZFs.  
Construct was made using PCR Strategy C. Individual DZF fragments 
were first amplified by PCR and identical regions in the internal 
oligonucleotides were used for a subsequent fusion PCR. BamHI and 
XhoI sites were incorporated in the external primers which were applied 
to clone the various PCR fragments as fusions to SpI. 
dDZF-2 pcDNA5-SpI “ “ 
dDZF-3 pcDNA5-SpI “ “ 
dDZF-4 pcDNA5-SpI “ “ 
dDZF-5 pcDNA-p65 “ Construct was made as described for dDZF-1 and cloned as a fusion to p65. 
dDZF-6 pcDNA-p65  “ “ 
dDZF-7 pcDNA-p65  “ “ 
dDZF-8 pcDNA-p65  “ “ 
VP16- Pe-Hd-Hd pcDNA-p65  
Herpes simplex virus VP16 
activation domain:  
414-491 
Pegasus: 358-386 
Hunchback D.m.: 728-758 
Fragment was made using PCR Strategy C. Individual fragments 
encoding the VP16 and the Pe-Hd-Hd peptides were amplified first. An 
identical linker region encoding a BamHI site was used as internal 
primers for the subsequent fusion PCR step. An N-terminal HindIII site 
followed by the NLS from the simian virus 40 (SV40) large T antigen and 
a C-terminal XhoI site were introduced by the external primers. The 
resulting PCR fragment was used to replace the HindIII - XhoI fragment 
(including p65) of pcDNA5-p65.  
Tr-Eo-Eo pcDNA3.1-IkI TRPS-1: 1209-1238 Eos: 504-532 
Subcloned from pACYC construct containing the respective DZF domain 
using KpnI and HindIII. 
Appendix. 
 212
Eo-Eo-Hd pcDNA3.1-FLAG-NTS 
Eos: 471-504  
Hunchback D.m.: 733-758 “ 
Pe-Hd-Hd pcDNA3.1-IkI Pegasus: 358-386 Hunchback D.m.: 728-758 “ 
Hl-Eo-Eo pcDNA3.1-FLAG-NTS 
Hunchback L.m.: 453-481 
Eos: 504-532 “ 
Ik-Hd-Hd pcDNA3.1-FLAG-NTS 
Ikaros: 456-484 
Hunchback D.m.: 728-758 “ 
Pe-Pe-Eo pcDNA3.1-IkI Pegasus: 358-391 Eos: 509-532 “ 
Ik-Zif268-GP-FLAG pBR-UV5-Zif268 
Human Ikaros: 456-519 
Murine Zif268: 334-421 
Yeast Gal11P: 263-352 
Construct was made using PCR Strategy C. Individual fragments 
expressing the Zif268 and the GP domain were amplified first. The 
identical linker region encoding the GGGGS linker including a BamHI 
site was used as internal primers for the fusion PCR step. An N-terminal 
XhoI site and a C-terminal FLAG tag followed by a XbaI site were 
introduced by the external primers. The resulting PCR product was used 
to replace the XhoI-XbaI fragment of the pBR-Ik-Zif268 plasmid in order 
to create the pBR-Ik-Zif268-GP-FLAG plasmid.  
Ik-Z23-GP-FLAG pBR-UV5-Zif268 
Human Ikaros: 456-519 
Murine Zif268: 367-421 
Yeast Gal11P: 263-352 
Plasmid pBR-Ik-Z23-GP carried a deletion of F1 of Zif268 and was made 
by replacing the XhoI-BamHI segment containing the Zif268 domain 
with a PCR amplified fragment consisting of F23 of Zif268. 
Ik-(L1-L6)-Z23-GP-
FLAG pBR-UV5-Zif268 
Human Ikaros: 456-519 
Murine Zif268: 367-421 
Yeast Gal11P: 263-352 
Plasmids expressing various linker in between the Ik-DZF domain and 
F23 of Zif268 were constructed using PCR Strategy C. Left cassette 
fragments expressing the Ik-DZF domain including region up to the SalI 
site and right cassette fragments encoding the Z23 fragment were fused 
together using the various linker as identical regions. The resulting PCR 
fragments were then cloned into the SalI-BamHI site of the pBR-Ik-Z23-
GP plasmid. 
Ik pACYC-λcI Human Ikaros:  456-519 
Subcloned from pACYC construct containing the respective DZF domain 
using KpnI and HindIII. 
Pe pACYC Human Pegasus: 358-420 “ 
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Hd pACYC Hunchback from D.m.: 699-758 “ 
Ik pET3a Human Ikaros: 457-519 Amplified from plasmid encoding the respective DZF domain (R. Fang).  
Pe pET3a Human Pegasus: 360-420 “ 
Tr pET3a Human TRPS-1: 1211-1272 “ 
Hd pET3a Hunchback from D.m.: 702-758 “ 
Hc pET3a Hunchback from C.e.:  925-982 “ 
Tr-Eo-Eo pET3a TRPS-1: 1211-1238 Eos: 504-532 “ 
Zif268-Pe pET3a murine Zif268: 333-421 Pegasus: 360-420 
Constructed using PCR Strategy C. Left cassette fragments encoding the 
Zif268 domain and right cassette fragments encoding the Pegasus DZF 
domain were fused together via an identical region in the internal primer. 
The resulting PCR fragment was cloned into the pET3a expression 
plasmid. 
Ik Nf pET3a Human Ikaros:  457-489 Amplified from plasmid DNA. 
Ik Cf pET3a Human Ikaros:  485-519 “ 
Hd Nf pET3a Hunchback from D.m.: 702-732 “ 
Hd Cf pET3a Hunchback from D.m.: 728-758 “ 
Hd Original pUAST-Hd cDNA 
Hunchback D.m.: 
1-758 
 
Constructed using PCR Strategy C. Left cassette fragments encoding the 
Hunchback upstream of and including an internal XhoI site and right 
cassette fragments encoding the respective DZF domain were fused 
together via an identical region in the internal primer. The fused PCR 
fragment was then used to replace the XhoI-KpnI fragment in the original 
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pUAST-Hunchback cDNA plasmid. 
Hd-myc pUAST Hunchback D.m.: 1-758 Constructed as described above (for Hd) whereas the external C-terminal primer introduced an additional myc-tag.  
Hd-HA pUAST Hunchback D.m.: 1-758 Constructed as described above (for Hd-myc) whereas the external C-terminal primer incorporated a HA-tag encoding sequence.  
Hd Ik pUAST Hunchback D.m.: 1-704 Ikaros: 462-519 
Constructed as described for Hd using the Ikaros DZF domain as a 
template for generating the right cassette.  
Hd Ik-myc pUAST Hunchback D.m.: 1-704 Ikaros: 462-519 
Constructed as described for Ik whereas the external C-terminal primer 
introduced an additional myc-tag. 
Hd Ik-HA pUAST Hunchback D.m.: 1-704 Ikaros: 462-519 
Constructed as described for Ik whereas the external C-terminal primer 
introduced an additional HA-tag. 
Hd TrEoEo pUAST  
Hunchback D.m.: 1-704 
TRPS-1: 1215-1238 
Eos: 504-532 
Constructed as described for Hd using the Tr-Eo-Eo DZF domain as a 
template for generating the right cassette. 
Hd TrEoEo-myc pUAST  
Hunchback D.m. 1-704 
TRPS-1: 1215-1238 
Eos 504-532 
Constructed as described for Tr-Eo-Eo whereas the external C-terminal 
primer incorporated a myc-tag encoding sequence. 
Hd EoHdHd pUAST  
Hunchback D.m.: 1-704 
Eos: 477-504  
Hunchback D.m.: 733-758 
Constructed as described for Hd using the Eo-Eo-Hd DZF domain as a 
template for generating the right cassette. 
Hd EoHdHd-HA pUAST  
Hunchback D.m.: 1-704 
Eos: 477-504  
Hunchback D.m.: 733-758 
Constructed as described for Eo-Eo-Hd whereas the external C-terminal 
primer introduced an additional HA-tag.  
 
A2. Description of constructs. The fragment name and plasmid it was cloned into are indicated in the first two columns. The third column shows the residue numbers the 
fragment corresponds to in the full-length protein. The organism the fragment is derived from is also indicated. A description if the cloning techniques used to generate the 
construct is shown in the last column. PCR strategies are indicated and described in section 2.1.2.2. D.m. = Drosophila melanogaster, L.m. = Locusta migratoria, H.t. 
= Helobdella triserialis, C.e. = Caenorhabditis elegans, Ik = human Ikaros, Eo = human Eos, Pe = human Pegasus, Tr = human TRPS1, Hd = D.m. Hunchback, Hl = 
L.m. Hunchback, Hc = C.e. Hunchback. 
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Reporter 
name Description / of reporter strain Source / Method of constructing the respective pSB stuffer plasmid 
RP28 
Expression of the lacZ reporter gene is controlled by a 
promoter harboring the λcI DBS at position -62 relative 
to this promoter.  
The pSB plasmid containing the λcI binding site at position -62 was made by 
subcloning the λcI binding site (derived from plasmid KJ1567 provided by 
K. Joung) into the EcoRI-SalI site of pSB. The corresponding reporter strain 
was constructed by R. Fang. 
KJST178 
Expression of the lacZ reporter gene is controlled by a 
promoter harboring the REST F3-8 DBS in orientation 
345678 relative to the promoter. 
Reporter strain was kindly provided by S. Thibodeau and K. Joung. 
KJ1697, 
KJ1701 
Expression of the lacZ reporter gene is controlled by a 
promoter harboring the REST F3-8 DBS at two positions 
in orientation 876543 relative to this promoter. 
Reporter strains were kindly provided by K. Joung. 
KJAG275A 
Expression of the lacZ reporter gene is controlled by a 
promoter harboring the Zif268 DBS at position -46 in 
orientation 321 relative to this promoter. 
SapI “stuffer” plasmids containing the SapI restriction sides at various 
positions relative to the promoter were designed. To do this, 4 overlapping 
primers (P1, P2, P3 and P4) were annealed and amplified with a pair of 
external primers (P1 and P4) using PCR. While P1 and P2 were constant 
primers that encoded the right cassette of the construct, P3 and P4 
represented unique primers that created various left cassettes of the 
constructs by introducing ascending numbers of spacer nucleotides in 
between the SapI restriction side and the promoter. An EcoRI and a SalI 
restriction site were incorporated in the external primers. Each resulting 
stuffer cassette was cloned into the EcoRI and SalI sites of the pSB stuffer 
plasmid. To create the Zif 268 binding side, two complementary primers 
were annealed together and cloned into the Sap I sites of the pSB stuffer 
plasmids constructed as described above. 
KJAG293A Reporter strain harboring the Zif268 DBS at position -48 in orientation 321 relative to the lacZ promoter. “ 
KJAG324A Reporter strain harboring the Zif268 DBS at position -50 in orientation 321 relative to the lacZ promoter. “ 
CC2-A Reporter strain harboring the Zif268 DBS at position -61 in orientation 321 relative to the lacZ promoter. Reporter strain was kindly provided by K. Joung. 
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KJAG232A Reporter strain harboring the Zif268 DBS at position -63 in orientation 321 relative to the lacZ promoter. “ 
KJAG242A Reporter strain harboring the Zif268 DBS at position -65 in orientation 321 relative to the lacZ promoter. “ 
KJAG338B Reporter strain harboring the Zif268 DBS at position -67 in orientation 321 relative to the lacZ promoter. “ 
KJAG311A Reporter strain harboring the Zif268 DBS at position -69 in orientation 321 relative to the lacZ promoter. “ 
KJAG319B Reporter strain harboring the Zif268 DBS at position -71 in orientation 321 relative to the lacZ promoter. “ 
KJAG290A Reporter strain harboring the Zif268 DBS at position -42 in orientation 123 relative to the lacZ promoter. “ 
KJAG267A Reporter strain harboring the Zif268 DBS at position -44 in orientation 123 relative to the lacZ promoter. “ 
KJAG274A Reporter strain harboring the Zif268 DBS at position -46 in orientation 123 relative to the lacZ promoter. “ 
KJAG294A Reporter strain harboring the Zif268 DBS at position -48 in orientation 123 relative to the lacZ promoter. “ 
KJAG326A Reporter strain harboring the Zif268 DBS at position -50 in orientation 123 relative to the lacZ promoter. “ 
KJAG386A Reporter strain harboring the Zif268 DBS at position -55 in orientation 123 relative to the lacZ promoter. “ 
KJAG383A Reporter strain harboring the Zif268 DBS at position -57 in orientation 123 relative to the lacZ promoter. “ 
KJAG378A Reporter strain harboring the Zif268 DBS at position -59 in orientation 123 relative to the lacZ promoter. “ 
CC1-A Reporter strain harboring the Zif268 DBS at position -61 in orientation 123 relative to the lacZ promoter. Reporter strain was kindly provided by K. Joung. 
KJAG237A Reporter strain harboring the Zif268 DBS at position -63 in orientation 123 relative to the lacZ promoter. “ 
KJAG243A Reporter strain harboring the Zif268 DBS at position -65 in orientation 123 relative to the lacZ promoter. “ 
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KJAG336A Reporter strain harboring the Zif268 DBS at position -67 in orientation 123 relative to the lacZ promoter. “ 
KJAG300B Reporter strain harboring the Zif268 DBS at position -69 in orientation 123 relative to the lacZ promoter. “ 
KJAG302A Reporter strain harboring the Zif268 DBS at position -71 in orientation 123 relative to the lacZ promoter. “ 
KJ0A 
Expression of the lacZ reporter gene is controlled by a 
promoter harboring a composite DBS for binding of 
Finger 2 and 3 of Zif268 with 0 bp present in between the 
two half-sites.. 
Complementary primers encoding the half-sites with various spacings were 
annealed together to make double stranded DNA fragments bearing SapI 
sticky ends. The annealed oligonucleotides were cloned into the Sap I sites 
of the pSB stuffer plasmid. 
KJ1A Reporter strain harboring a composite DBS with 1 bp in between the two half-sites. “ 
KJ3A Reporter strain harboring a composite DBS with 3 bp in between the two half-sites. “ 
KJ5A Reporter strain harboring a composite DBS with 5 bp in between the two half-sites. “ 
KJ7A Reporter strain harboring a composite DBS with 7 bp in between the two half-sites. “ 
KJ9A Reporter strain harboring a composite DBS with 9 bp in between the two half-sites. “ 
KJ11B Reporter strain harboring a composite DBS with 11 bp in between the two half-sites. “ 
KJ13B Reporter strain harboring a composite DBS with 13 bp in between the two half-sites. “ 
KJ16A Reporter strain harboring a composite DBS with 16 bp in between the two half-sites. “ 
KJ22A Reporter strain harboring a composite DBS with 22 bp in between the two half-sites. “ 
FW123 
Expression of the lacZ reporter gene is controlled by a 
promoter harboring the λcI DBS positioned between the -
35 and -10 promoter region.  
Reporter strain was kindly provided by F. Whipple.  
 
RP45 Selection strain in which the expression of the his3 and Reporter strain was kindly provided by R. Fang. 
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the aadA reporter genes is controlled by a weak promoter 
bearing an upstream Zif268 binding side at position -65 
in orientation 321.  
 
A3. Description of reporter strains. The reporter name is indicated in the first column. A brief description of the reporter is shown in the second column. Note that the DNA 
binding sites (DBSs) for the various DNA-binding domains are placed at various distances and orientations relative to the promoter that controls lacZ expression. The 
transcription startpoint of the reporter gene is defined as position +1 and the DBS sits therefore variable numbers of nucleotides upstream of the startpoint Individual fingers 
in the DBD bind to corresponding subsite marked by a number. For example, finger 1 of Zif268 binds to subsite 1. Thus, in orientation 321, the binding site is positioned in a 
way that the N-terminal Zif268 finger (finger 1) points toward the promoter while orientation 123 positions the C-terminal finger (finger 3) close to the promoter. The third 
column describes the source of the plasmid or techniques employed to construct the plasmid used to make the respective reporter strain (see section 2.2.2.1).  
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